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Copper is an essential trace element that is important for a broad range of biological 
processes. Increasing evidence links impaired copper homeostasis to a variety of diseases, 
including Menkes disease, Wilson’s disease, Parkinson’s disease, Alzheimer’s disease, 
amyotrophic lateral sclerosis (ALS), and more recently to cancer, diabetes, cardiovascular 
disease, and atherosclerosis. Despite the significant progress has been made in 
characterizing the copper trafficking pathways, the overall understanding of copper 
metabolism is still incomplete particularly in relation to the subcellular distribution and 
storage of the kinetically labile copper pool. Copper is predominantly present in its 
monovalent oxidation state in the reducing intracellular environment and consequently 
Cu(I)-selective fluorescent probes are useful for the detection of exchangeable copper(I) 
ions in biological systems. One of the objectives of this dissertation is, therefore, 
characterization of the coordination properties of Cu(I) sensors in order to apply them for 
cellular imaging and other biochemical applications. Furthermore, inconsistent data on 
the Cu(I)-stability constants of proteins in the literature limit our knowledge regarding the 
thermodynamics of copper binding to proteins in vivo. Cu(I)-binding affinities of proteins 
are often determined by the competition titrations using Cu(I) affinity standards, 
however, the binding affinity values of these standards are discordant owing to the redox 
instability of the aquated Cu
+ 
ions and the formation of ternary complexes between Cu(I)-
ligands and proteins. Therefore, the second objective of this work is to determine the 
binding affinities of a set of copper(I) chelators unequivocally as these well-characterized 
Cu(I) ligands will be instrumental as affinity standards to study copper biochemistry of 
proteins. The final objective of this dissertation is to develop detection methods to 
selectively identify copper proteins from cellular extract which will be useful in 
identifying putative copper binding proteins. 
xxi 
 
Chapter 1 summarizes the current knowledge regarding mammalian copper 
homeostasis and coordination chemistry of endogenous copper proteins. This chapter also 
discusses the pathways in copper metabolism that are yet to be deciphered. 
 
Chapter 2 begins with a detailed discussion about various thermodynamic aspects of 
copper(I)-ligand binding which is a prerequisite to understand different methods that can be 
employed to measure Cu(I) binding affinity of a ligand. In this chapter, we characterized a set 
of affinity standards including three new sulfonated thioether-based ligands that form 
colorless, water-soluble, and air-stable copper(I) complexes and three previously reported 
Cu(I) chelators. Together these compounds constitute a web of accurately cross-verified 
Cu(I) affinities which will be useful in determining binding affinities of copper proteins 
unequivocally as exemplified with a bacterial copper chaperone CusF.  
 
Chapter 3 first gives an introduction about the analytical techniques available for 
in situ detection of copper in biological samples including total and kinetically labile 
cellular copper and protein-bound copper ions. The introductory section also presents the 
photophysical concepts behind the fluorescence turn-on probes based on photoinduced 
electron transfer (PET). Coordination properties of a water soluble, high contrast Cu(I)-
selective fluorescent probe CTAP-2 were determined in this chapter. The anticipated 
formation of nanoparticles of several previously published poorly water soluble Cu(I)-
selective fluorescence turn-on probes was first time confirmed by dynamic light scattering in 
this work. CTAP-2 was also applied to develop a novel analytical method featuring in-gel 
detection of a copper chaperone containing an accessible Cu(I) site under non-denaturing 
condition. 
 
Chapter 4 starts with the discussion on a ligand design that evolved in the Fahrni 
laboratory resulting in a methanolic Cu(I)-selective fluorescent probe with an astonishingly 
xxii 
 
high fluorescence contrast ratio and quantum yield. Integration of this ligand design with 
the original solubilizing framework of CTAP-2 was expected to improve the fluorescence 
properties of CTAP-2, however, the fluorescence contrast ratio and quantum yield of the 
new probe 4.3 did not improve over CTAP-2. Further thermodynamic and photophysical 
studies uncovered two separate factors responsible for the low fluorescence quantum 
yield and contrast ratio: one was the incomplete Cu(I)-N coordination in the copper 
bound probes  and the other was the two distinct excited-state proton transfer (ESPT) 
pathways in neutral and acidic solutions.  
 
Chapter 5 first discusses the available protein separation methods in relation to 
copper proteome and highlights the limitations of these techniques in preserving the native 
copper-protein interactions which is crucial to identify the copper proteins from cellular 
extract by the available microanalytical techniques as described in chapter 3. In this work, 
several “metal free” techniques were developed which did not require the imaging of 
protein bound copper ions but rather involved in translating the copper binding to a 
protein into a measurable and quantifiable signal. While some methods suffered from 
poor resolution of proteins and insurmountable technical difficulties, two of the newly 
developed methods, including copper-dependent labeling of cysteines with heavy and 
light isotopes and difference gel electrophoresis with Cy3 and Cy5 meleimide dyes, were 
able to differentiate between apo and copper-bound form of known copper-proteins. 
Therefore, these methods showed potentials for future applications in identifying copper-









Copper is an essential trace element and is required for various biological 
processes such as cellular respiration, connective tissue cross-linking, pigment formation, 
and antioxidant defense (1). Table 1.1 gives examples of human copper binding proteins 
and their physiological roles. Despite the utility of copper in diverse biological functions, 
free copper ions, either Cu(I) or Cu(II), are highly toxic and hence copper has to be 
tightly regulated in living cells. In order to achieve the proper intracellular balance of 
copper, nature has evolved sophisticated homeostatic machinery in all forms of life (2). 
Accordingly, disruptions in copper homeostasis are implicated in numerous diseases, 
including Menkes disease, Wilson’s disease, Parkinson’s disease, Alzheimer’s disease, 











Involved in copper homeostasis in neurons presumably through 
copper ion reduction; proteolytic cleavage leads to generation of 
Aβ peptide that aggregates in amyloid plaques associated with 
Alzheimer’s disease 
Atox1 Copper chaperone that delivers Cu(I) to ATP7A and ATP7B 
ATP7A Cu(I)-transporting P-type ATPase expressed in all tissues except 
liver, delivers copper to proteins during biosynthesis, mediates 










ATP7B Cu(I)-transporting P-type ATPase expressed primarily in the 
liver, supplies copper in biosynthetic pathways, responsible for 
biliary excretion of excess copper  
Ceruloplasmin Major copper-carrying protein in the blood, functions as a 





subsequent incorporation into transferrin 
CCS Copper chaperone that delivers Cu(I)  to Cu/Zn superoxide 
dismutase (SOD) 
COMMD1 Primary function is down-regulation of NF-kappa-B activity and   
a possible role  in regulation of copper metabolism 
Cox11 Metallate CuB site into subunit I of cytochrome c oxidase in 
mitochondria     
Cox17 Copper chaperone that transfers Cu(I) to Sco1 and Cox11 for 
incorporating Cu(I) into cytochrome c oxidase in mitochondria 
CTR1 High affinity Cu(I)  transporter involved in cellular copper 
uptake 
CTR2 Probable low affinity Cu(I)  transporter involved in cellular 
copper uptake 
Cu/Zn SOD Antioxidant enzyme that catalyzes the disproportionation of 
superoxide to hydrogen peroxide and oxygen 
Cytochrome c 
oxidase (CCO) 
Terminal enzyme in the mitochondrial respiratory chain that 
catalyzes the reduction of dioxygen to water 
Dopamine β-
hydroxylase (DBH) 










Hephaestin Implicated in iron and copper homeostasis 
Lysyl Oxidase Catalyzes formation of aldehydes from lysine residues in 
collagen and elastin precursors for connective tissue cross-
linking 




Catalyzes conversion of peptidylglycine substrates into α-
amidated products; an important step for biological activities of 
neuropeptides  
Prion protein This protein binds Cu via the N-terminal octapeptide repeats; 
misfolding of the protein is associated with neurodegenerative 
disorders 
Sco1/ Sco2 Metallate CuA site into subunit II of cytochrome c oxidase in 
mitochondria 









 List compiled from the UniProtKB/Swiss-Prot database 
 
 
1.1. Interconnected Pathways in Mammalian Copper Homeostasis 
In biological systems, several copper binding proteins are integral parts of copper 
homeostatic machinery and work in conjunction to regulate cellular copper uptake, 
distribution, and excretion (4). Knowledge of the copper coordination sites, the mode of 
interaction among protein partners, and the thermodynamic and kinetic parameters of 





transport processes, their selectivity and specificity. Significant progress has been made 
in characterizing the copper trafficking pathways in mammalian cells and this subsection 






Figure 1.1. Copper Distribution Pathways in a Generalized Mammalian Cell. CTR1 
accepts cooper from the extracellular copper carriers and transfers copper into cytosol; 
changes in copper levels induce reversible trafficking of CTR1 between the plasma 
membrane and intracellular vesicles. CTR2 is predominantly intracellular but can be 
found at the plasma membrane. Entering copper is escorted by copper chaperones to 
multiple destinations; CCS distributes copper to SOD1 in cytosol and mitochondria, 
while Atox1 transfers copper to Cu-ATPases in the secretory pathway. An ensemble of 
proteins regulates copper delivery to cytochrome c oxidase (CCO) in mitochindria. Cu-
ATPases transport copper to the secretory pathways for incorporation into cuproenzumes 
and mediate copper excretion by sequestering excess copper in vesicles. The trafficking 
of Cu-ATPases between these two locations is associated with phosphorylation by a 
kinase (indicated by stars), which increases in response to copper elevation. Reproduced 










1.1.1. Copper Import into the Cytosol 
Under physiological conditions, Cu ions can exist in two oxidation states: the 
reduced form is Cu(I) and the oxidized form is Cu(II). This redox activity has been 
harnessed by cuproenzymes where copper acts as a redox cofactor and thus not 
surprisingly 93% of the enzymes that use copper are oxidoreductases (EC 1) (5). The 
dietary copper predominantly exists in its oxidized form (Cu
2+
), but inside the reducing 
cytosolic environment (-260 mV) (6), copper is primarily present in form of Cu(I). 
Therefore, prior to import across the plasma membrane, extracellular Cu
2+
 has to be 
reduced by reductases in membrane. Although these cupric reductases have not yet been 
identified definitively, the Steap proteins, a family of metalloreductases in humans, are 
one of the prominent candidates for this role (7).  
Copper enters the cell via a high affinity membrane permease copper transporter 1 
(CTR1) which is present as a homotrimer in the membrane (8-10). A single CTR1 
polypeptide contains three transmembrane domains: a methionine-rich N terminus, a 
cysteine-histidine cluster in the C terminus and an MX3M motif in the second 
transmembrane domain which is essential for copper import. The trimer forms a channel-
like permeation pathway for copper (11, 12). The transcriptional regulation of CTR1 was 
shown by Song et al. where human CTR1 (hCTR1) mRNA level was up-regulated under 
copper-depleted conditions and down-regulated under copper-replete conditions (13). 
They have also shown that expression of exogenous hCTR1 is accompanied by the down-
regulation of the endogenous hCTR1 mRNA. The modulation of CTR1 activity also 
occurs by the intracellular distribution of the protein. CTR1 is present at the plasma 
membrane during cellular demand for Cu, whereas elevation of extracellular copper 
induces endocytosis of CTR1 to vesicles and thus decreasing copper uptake across the 
membrane (14, 15). Moreover, elevated Cu levels have been shown to increase CTR1 
protein degradation (16) which is considered as one of the mechanisms to control cellular 





A second transporter protein, structurally related to CTR1, has also been 
identified in mammals and designated as CTR2. The occurrence of this low-affinity 
copper transporter is largely intracellular and may function to release copper from 
intracellular vesicles into the cytosol (17). Moreover, a small fraction of CTR2 is 
detected at the plasma membrane (18), but the biological role of the protein at this 
location remains to be explored. 
1.1.2. Copper Chaperones 
Once inside the cell, copper binds to cytosolic copper chaperones which then 
transfer copper to specific cellular destinations. CCS (copper chaperone for superoxide 
dismutase) activates cytosolic Cu/Zn superoxide dismutase (SOD1), facilitating both 
Cu(I) transfer and disulfide bond formation; while Atox1 transfers copper to the copper-
transporting ATPases in the secretory pathway. A low molecular weight carrier or a yet-
to-be characterized protein initiates a series of transfer reactions that result in copper 
delivery to cytochrome c oxidase (CCO) in mitochondria. 
a) Metallation of  Cu/Zn SOD 
Copper chaperone for superoxide dismutase (CCS) has three structural domains 
(19). Domain II structurally resembles Cu/Zn SOD and is engaged in the CCS-SOD1 
interactions, but the copper is not bound in this site. Domains I and III have CXXC and 
CXC Cu
+
 binding motifs, respectively. Heterodimerization between a monomer of Cu-
bound CCS and Zn-loaded SOD1 results in the transfer of Cu onto SOD1, where four 
histidine ligands coordinate the copper ion in square pyramidal geometry with water as 
the fifth ligand (20). In the process, Cu-CCS catalyzes the oxygen-dependent formation 
of an intramolecular disulfide bond in SOD1 which is required for its catalytic activity 
(21). Additionally, both CCS and Cu/Zn SOD are localized to the inter-membrane space 





superoxide generated from the incomplete reduction of oxygen during mitochondrial 
electron transport (22). 
Cellular Cu status regulates CCS at a post translational level through protein 
degradation, resulting in high CCS levels during Cu deficiency and low protein levels 
during times of elevated intracellular Cu (23-25). Although alterations in CCS expression 
do not affect SOD1 protein levels, the activity of the enzyme changes as a function of 
CCS and thus the copper levels (26). Mutant forms of SOD1 protein aggregate in the 
motor neurons of a familial form of amyotrophic lateral sclerosis (ALS) patients (27-29). 
Given that the posttranslational modifications of SOD1, including copper/zinc binding 
and disulfide formation, generally increase protein structural stability, it is expected that 
the immature mutant forms, which is devoid of metals and the disulfide bond, are more 
prone to unfolding and aggregation, underscoring the importance of this enzyme (30, 31). 
b) Copper Delivery to Secretory Compartments   
Several Cu-containing proteins travel through the secretory pathway for the metal 
incorporation during their biosynthesis where copper is supplied by Cu-transporting 
ATPases, ATP7A and ATP7B. The ATPases are transmembrane proteins in the Golgi 
network which acquire copper from cytosolic chaperone Atox1. A ββββ ferredoxin 
fold is the key structural feature of Atox1 which coordinates to a solvent-exposed Cu
+
 ion 
by a CXXC motif (32). Cu is transferred from Atox1 to a metal binding domain, 
MTCXXC, in the N terminus of the ATPases, ATP7A and ATP7B (33). This transfer 
occurs via a series of inter-protein ligand exchange reactions (34, 35), ultimately leading 
to the movement of Cu(I) across the membrane of the secretory compartment utilizing the 
energy released from ATP hydrolysis (36).  
In addition to its role in delivering copper to ATPases, it has been suggested that 
Atox1 can also function as a transcription factor, which translocates into the nucleus 





extracellular SOD3 as well as other genes involved in cell proliferation such as cyclin D1 
(37, 38). However, the mechanisms that govern the translocation of Atox1 from cytosol 
to the nucleus are yet to be deciphered. 
c) Copper Insertion into Cytochrome c Oxidase 
Unlike Atox1 and CCS which escort copper directly to their targets, copper 
insertion into cytochrome c oxidase (CCO) is mediated by the concerted action of several 
Cu-binding proteins, Cox17, Cox 11, Sco1 and Sco2.  In the IMS, copper chaperone 
Cox17 escorts copper to Sco1 and Cox11, which are implicated in the sequential transfer 
of the metal to CuA site on the Cox2 subunit and CuB site of the Cox1 subunit of CCO 
respectively. Although a basic understanding of the key steps of copper insertion in CCO 
is developing (39), it is currently unclear how Cu travels from the site of import at the 
plasma membrane to the mitochondria.  Cobine et al. have purified a not yet fully 
characterized nonproteinaceous ligand that is present in the cytosol and mitochondrial 
matrix and may function in mitochondrial Cu delivery (40, 41). Sco2 is structurally 
similar to Sco1 and both of them are essential for CCO assembly (42), yet the 
physiological role of Sco2 has not been fully elucidated.   
1.1.3.  Cellular Copper Storage  
The wide range of catalytic functions performed by copper-binding enzymes is 
attributed to the ability of copper to cycle between the oxidized Cu(II) and reduced Cu(I) 
forms making it a suitable redox cofactor. The same redox activity is paradoxically 
responsible for cellular oxidative damage mediated by “free” aqueous copper ion. 
Therefore, one essential component in copper regulation is the cell’s ability to store 
excess Cu and to mobilize Cu reserves during times of cellular need. Metallothionein and 
glutathione are examples of ligands that are presumably involved in copper storage in 





Mammalian metallothioneins (MT) are small cysteine-rich polypeptides that bind 
up to 12 Cu
+
 ions through cysteine thiols. MT expression is regulated at the transcription 
level by MTF1 (metal transcription factor 1), which in response to elevated Cu levels 
binds to the metal responsive elements (MRE) in the promoter regions of its target genes 
(43). It has also been proposed that MT may act as a copper storage protein that could be 
mobilized during cellular demand of Cu. In support of this hypothesis, it has been shown 
that mouse embryonic fibroblasts lacking MT have reduced viability under Cu limiting 
conditions (44). 
Copper bound to glutathione (GSH), a low molecular weight cysteine containing 
tripeptide present at millimolar concentrations in the cytosol, represents a potential pool 
of exchangeable Cu. Although affinity of GSH is too weak to compete for Cu(I) binding 
with endogenous copper chaperone proteins (45), it has been proposed that GSH might be 
involved in complexing the copper ions soon after its import in the cytosol. The 
complexed metal is then transferred to MT where it is stored and mobilzed during cellular 
need (46). 
1.1.4. Copper Efflux 
The two mammalian Cu-transporting ATPases, ATP7A and ATP7B, are 
responsible for the speciation of Cu into the lumen of the secretory compartment for its 
insertion into Cu-dependent enzymes such as ceruloplasmin, tyrosinase, and lysyl 
oxidase. Moreover, ATP7A and ATP7B play key roles in exporting excess Cu from cells 
by primarily engaging in a copper-dependent trafficking. Although there are divergent 
explanations in the literature delineating the actual mechanism of copper efflux by 
ATPases, the general picture is that the Cu-ATPases undergo a post-translational kinase-
mediated phosphorylation in response to elevated copper. The copper-loaded 





cellular membrane. Copper is subsequently excreted by fusion of these vesicles with the 
membrane (4).     
Mutations in the ATP7A gene result in Menkes disease, characterized by a defect 
in the mobilization of copper from intestine resulting in peripheral Cu deficiency and 
inadequate metal supply to Cu-dependent enzymes. Mutations in the ATP7B gene cause 
Wilson's disease, characterized by excessive accumulation of Cu in hepatic and neuronal 
tissues. Both copper homeostasis disorders present with severe neurological, 
developmental, and cognitive defects, in addition to hypopigmentation, skin laxity, and 
kinky hair for Menkes disease, and hepatitis and liver cirrhosis for Wilson's disease 
patients. 
1.2. Metal Coordination in Copper Homeostatic Proteins 
The elemental composition, number, and geometry of the ligands in copper 
coordination in proteins provide information about their selectivity towards Cu(I) or 
Cu(II) ions and the relative thermodynamic stabilities of the resulting complexes. 
Following the principles of hard and soft acids and bases (HSAB) theory (47), Cu(I) can 
be assigned as a soft Lewis acid and therefore is expected to bind to soft ligand like 
sulfur, whereas Cu(II) is a borderline Lewis acid and thus favors hard Lewis base like 
carboxylate oxygen and borderline base like imidazole nitrogen. A bioinformatics study 
with the copper-proteins in Protein Data Bank (PDB) (48) showed that Cu(I) binding 
sites in nature are indeed dominated by Cys residues, 74% of all Cu(I) sites in various 
proteins contain cysteine followed by 16% methionine and 10% histidine. The amino 
acid cysteine is especially abundant in copper transport proteins where 97% of these 
proteins bind Cu(I) with this ligand. In contrast, the major amino acid in the Cu(II)-







Table 1.2. Copper Binding Sites in Homeostatic Proteins 
 
Organism Protein Binding Site Cellular Location 
Human Atox1 MXCXXC  Cytosol 
 ATP7A  MXCXXC  trans-Golgi membrane 
 ATP7B  MXCXXC  trans-Golgi membrane 
 CCS Domain 1: MXCXXC   
Domain 3: CXC  
Cytosol 
 Cox 11 CXC   Mitochondrial inter-
membrane space (IMS) 
 Cox 17 CC  Mitochondrial inter-
membrane space (IMS) 
 Cu/Zn superoxide 
dismutase (SOD1) 
Four His ligands  
plus a water molecule 
Cytosol 
 Sco1/ Sco2 CPDVC sequence  
plus a histidine 
Mitochondrial inter-
membrane space (IMS) 








Although HSAB theory acts as a guideline in understanding copper coordination 
in biology, the redox potential of the cellular compartment and electrostatic contribution 
of the ligands are major factors determining which side chain is employed in a biological 
copper binding site. For instance, cysteine and methionine are both sulfur-containing 





environment as in the cytosol, whereas methionine is common in an oxidizing 
environment as in the periplasm of Gram-negative bacteria. This is because cysteine thiol 
sulfur is susceptible to oxidation and the oxidized disulfide form is incapable to bind 
Cu(I).  
The nature of the copper binding site also gives an indication about the specific 
role of these proteins in regulating copper inside the cell. For example, surface-exposed 
Cu(I)-binding site is a general feature of copper chaperones to ensure facile metal transfer 
to the partner proteins. This is indeed the case for Atox1-like copper chaperones and their 
target ATPases. These proteins contain highly conserved solvent-exposed CXXC motifs 
where two cysteines bind Cu(I) in a linear geometry (32). Such protein conformation 
allows for flexible coordination chemistry, and thus a third ligand can be accommodated 
during the copper transfer process resulting in heterodimeric complexes of chaperones 
and their targets (33, 34). It is also worth noting that in some of the copper chaperones, 
such as Atox1 and Cox17, a conserved lysine residue is located close to the copper 
center, most likely stabilizing the overall negative charge of the [Cu(I)(Cys)2]
-1
 complex. 
Periplasmic copper-trafficking proteins in Gram-negative bacteria contain 
methionine residue in the surface-exposed Cu(I)-binding site. The methionine thioether is 
more difficult to oxidize than cysteine thiol in oxidizing environment like periplasm. 
Another difference between these two ligands is that the methionine thioether group lacks 
the electrostatic component of the cysteine thiolate ligand and is expected to have weaker 
Cu(I) affinities. Therefore, methionine usually forms high-coordinate Cu(I)-complexes 
(three or four coordinate) to compensate for this lower Cu(I) affinity. Met2His binding 
site is found in the periplasmic copper chaperone CusF, with an unusual contribution 
from a strong cation-pi interaction with a tryptophan residue in copper recognition (49). 
Similarly, in mitochondrial inter-membrane space (IMS) which is more oxidizing than 
the cytosol, a third ligand is present in the Cu(I)-binding site where the metal is bound by 





In the enzymes where copper is used as a redox cofactor, the binding sites are 
usually buried in the protein and can adopt various geometries according to the copper 
oxidation state. For example, in the active site of Cu/Zn superoxide dismutase (SOD1), 
one Cu ion is ligated by three histidines in a trigonal planar geometry when in the 
reduced state and one Zn ion is ligated by one aspartic acid and three histidines. One of 
the histidine ligands of the Zn ion also ligates the Cu ion when in the oxidized state and 
thus has been termed the bridging histidine. The Cu(II) ion is additionally coordinated by 
a water molecule and thus forms a five coordinate square pyramidal geometry (51, 52). 
These conformational changes especially the bridging histidine plays an important role in 
the disproportionation of superoxide. 
Table 1.2 shows that there are a limited number of structural motifs associated 
with Cu(I)-binding sites in proteins. Different coordination motifs also seem to be 
tailored to different functional properties of proteins and their cellular localizations with 
an ultimate goal to stabilize the copper ion in a biological environment. Therefore, the 
structural patterns in conjunction with information on the cellular compartmentalization 
of the proteins can be used to understand the molecular components of copper 
management. 
1.3. Understanding Copper Biochemistry: Bridging the Gaps  
Copper is essential as a  cofactor for many proteins and enzymes involved in key 
biological processes as compiled in Table 1.1. Given the importance of copper in human 
physiology and the potential toxicity of the free metal ion, malfunction in copper 
regulatory mechanisms is typically associated with severe pathological conditions. 
Defective copper transport is directly responsible for genetic diseases, such as Menkes 
disease, Wilson’s disease, and cytochrome c oxidase deficiency (42, 53). Copper has also 
been implicated, though not causally associated, to neurological diseases such as 





(54). Moreover, copper-trafficking proteins are also considered as critical components in 
cancer cell proliferation (55), host-pathogen interactions in infectious diseases (56), and 
resistance to chemotherapeutic drugs (57). Accordingly, it is important to understand the 
cellular components involved in Cu homeostasis which is critical to prevent diseases 
related to copper imbalance. Significant research efforts have been made in elucidating 
structure, function, interaction partners of several copper proteins, however many 
fundamental questions about copper biochemistry still remain unanswered, particularly 
with regard to storage, mobilization, and subcellular distribution.  
Based on the binding affinity of superoxide dismutase (SOD1), Rae et al. 
estimated that under normal growth conditions the concentration of cytosolic free copper 
to be less than 10
-18 
M, corresponding to one free copper atom per cell (58). This 
proposition can be perceived in the light of redox lability of copper ions. Aqueous Cu(I) 
ion is highly reactive toward molecular oxygen. For example, in air-saturated water at 
25°C , Cu(I) is rapidly oxidized to Cu(II) with a half-life in millisecond time scale (59). 
Moreover, at micromolar concentrations aqueous Cu(I) would either disproportionate into 
Cu(II) and Cu(s) at acidic pH, or precipitate as Cu2O under neutral or basic conditions. 
As a consequence of its redox activity, “free” aquated Cu
+
 ion is toxic in the cellular 
environment because of its capability to induce oxidative damages through different 
mechanisms. For instance, both aerial oxidation of intracellular Cu
+
 (aq) ion to Cu
2+
 (aq) 
ion and the reverse reduction by glutathione are very rapid (60); they occur in the 
millisecond range. This redox shuttling will eventually deplete the cellular reservoir of 
glutathione and other reductants such as ascorbic acid. Additionally, Cu
+
 ion can 
participate in Fenton-type chemistry with H2O2, leading to the generation of highly 
reactive free radicals which can cause damage to a wide variety of biomolecules, 
including lipids, proteins, and DNA (61, 62). Furthermore, Cu(II) is located at the top of 
the Irving-Williams series which means Cu(II)-complexes are relatively more stable than 





from endogenous metalloproteins. Consequently, free copper ions, either Cu(I) or Cu(II), 
can exert detrimental effects in living organisms. For all of these reasons, it is not 
surprising that cellular copper pool is buffered at a low concentration by coordination to 
endogenous ligands. Metallothionein and glutathione in the cytosol are possible 
candidates to serve this purpose; however, there is a lack of compelling evidence to 
support this conjecture. In addition to the cytosolic copper reservoirs, Cobine et al. 
isolated a small ligand in the mitochondrial matrix of yeast and human cells which binds 
Cu(I) in an anionic complex, but its chemical nature has yet to be elucidated (40, 41). 
Contrary to the notion of low cytosolic free copper content, literature evidence 
supports the existence of a kinetically labile intracellular copper pool. Herd et al. showed 
rapid uptake and release of radioactive copper, 
64
Cu, from mammalian cells depending on 
the copper concentration of the surrounding medium (63). However, with the exception 
of the small ligand purified by Cobine et al. from the mitochondrial matrix whose 
chemical identity and functions are yet to be investigated (40, 41), little is currently 
known about the chemical nature and the subcellular localization of this labile copper 
pool. 
Although a multitude of genes and proteins associated with copper homeostasis 
were identified, many pathways are yet to be deciphered with respect to the intracellular 
copper distribution (1). Among them, the copper delivery to mitochondria and nucleus 
are the most intriguing ones. The copper chaperone Cox17, which is required for CCO 
assembly, was initially thought to deliver cytosolic copper to mitochondria based on its 
presence in both the cytosol and IMS (64). However, yeast cells lacking Cox17 retain 
wild type mitochondrial copper levels (40). In addition, tethering Cox17 to the 
mitochondrial inner membrane resulted in its exclusive localization within the organelle, 
and CCO assembly was not interrupted (65). These studies thus refute the proposition 
that Cox17 functions as copper chaperone for mitochondrial copper, rather transportation 





pathway. Cobine et al. suggested the possible role of the small molecule ligand discussed 
in the preceding paragraph as a copper transporter to mitochondria based on the 
localization of the apo-ligand in the cytosol (41). It has been proposed in this study that 
Cu(I) binding to the ligand within the cytosol initiates the translocation of the copper-
bound ligand to the mitochondria for storage and subsequent use in insertion of the metal 
in CCO. 
Accumulating literature evidence suggests that copper plays a fundamental role in 
regulating cell proliferation critical in physiological repair processes such as wound healing 
and angiogenesis as well as in various pathophysiologies including tumor growth, 
atherosclerosis, and neuron degenerative diseases (66-74). Synchrotron X-ray fluorescence 
(SXRF) images showed presence of copper in the nucleus of a mammalian cell (75) and a 
recent study by SXRF revealed marked redistribution of Cu and Zn ions during mitosis (76),  
thus emphasizing an essential role of copper in cell growth and proliferation. Nevertheless, 
little is known about the underlying molecular mechanisms of copper-regulated cell growth 
as well as the mode of transportation and storage of copper inside the nucleus. In the latter 
context, Hamza et al. provided the first clue when they demonstrated that the copper 
chaperone protein Atox1 is distributed throughout the cytosol and nucleus of a 
mammalian cell (77). In agreement with this observation, further studies indicate that 
Atox1 may function as a copper-responsive transcription factor regulating cell 
proliferation (by cyclin D1 expression) and oxidative stress (by SOD3 expression) (38, 
78, 79). However, Atox1-deficient fibroblast cells (Atox1
-/-
) showed an elevated nuclear 
Cu content compared to wild-type (Atox1
+/+
) cells contradicting the potential role of the 
protein as nuclear copper transporter (80). Consequently, identifying the pathway of 
translocation of copper into the nucleus still remains a fascinating area for future 
research.  
There are additional reasons that support the presence of copper-containing 





activate transcription in response to low and high intracellular concentrations of copper 
respectively (81, 82). Both of these proteins bind Cu
+
 ion tightly, Kd being 9.7 x 10
-20
 M 
for Mac1 and 4.7 x 10
-18
 for Ace1 (83). One striking feature of transcriptional regulation 
of copper in yeast is the complementarities of Ace1 and Mac1 in gene activation. 
Specifically, the apo form of Ace1 has a low affinity for DNA, but upon copper binding, 
Ace1 binds to a specific promoter DNA activating copper-detoxification genes (84). In 
contrast, Mac1 activates the expression of high affinity copper uptake genes in its metal-
free apo form and the copper-bound form is inactive (85). The reversible Cu(I)-binding in 
Ace1 and Mac1 induces conformational changes, which are pivotal in regulation of gene 
expression. Intuitively, this might appear paradoxical in the light of high binding 
affinities of Ace1 and Mac1 as metal dissociation from such binding sites are expected to 
be very slow, however, the metal exchange reaction can also occur by associative 
mechanism whose rate is independent of the metal dissociation kinetics. In fact, copper 
chaperones insert the metal ions into target proteins by such associative mechanism (20, 
33, 34). Similar to the yeast cell, a host of proteins controlling the translocation, storage, 
and utilization of copper in the nuclei of mammalian cells seems highly plausible.  
In order to shed new light on these poorly understood fundamental processes of 
copper homeostasis, the author of this dissertation created valuable chemical and 
biological tools for investigating copper biochemistry by combining the coordination 
chemistry, cellular imaging, and proteomics. This work included (i) development of 
robust Cu(I) affinity standards to understand the thermodynamics of copper-protein 
binding, (ii) characterization of Cu(I)-selective fluorescent sensors to probe the 
subcelllular localization of kinetically labile copper, (iii) in-gel detection of copper 
chaperones under non-denaturing condition creating a novel role for water soluble Cu(I)-
sensors,  and (iv) selective detection of copper-binding proteins exploiting the differential 







1. Kim BE, Nevitt T, & Thiele DJ (2008) Mechanisms for copper acquisition, 
distribution and regulation. Nature Chemical Biology 4(3):176-185. 
2. Nevitt T, Ohrvik H, & Thiele DJ (2012) Charting the travels of copper in 
eukaryotes from yeast to mammals. Biochimica Et Biophysica Acta-Molecular 
Cell Research 1823(9):1580-1593. 
3. Kozlowski H, Janicka-Klos A, Brasun J, Gaggelli E, Valensin D, & Valensin G 
(2009) Copper, iron, and zinc ions homeostasis and their role in 
neurodegenerative disorders (metal uptake, transport, distribution and regulation). 
Coordination Chemistry Reviews 253(21-22):2665-2685. 
4. Lutsenko S (2010) Human copper homeostasis: a network of interconnected 
pathways. Current Opinion in Chemical Biology 14(2):211-217. 
5. Waldron KJ, Rutherford JC, Ford D, & Robinson NJ (2009) Metalloproteins and 
metal sensing. Nature 460(7257):823-830. 
6. Go YM & Jones DP (2008) Redox compartmentalization in eukaryotic cells. 
Biochimica Et Biophysica Acta-General Subjects 1780(11):1271-1290. 
7. Ohgami RS, Campagna DR, McDonald A, & Fleming MD (2006) The Steap 
proteins are metalloreductases. Blood 108(4):1388-1394. 
8. Eisses JF & Kaplan JH (2002) Molecular characterization of hCTR1, the human 
copper uptake protein. Journal of Biological Chemistry 277(32):29162-29171. 
9. Lee J, Pena MMO, Nose Y, & Thiele DJ (2002) Biochemical characterization of 
the human copper transporter CTR1. Journal of Biological Chemistry 
277(6):4380-4387. 
10. Eisses JF & Kaplan JH (2005) The mechanism of copper uptake mediated by 
human CTR1 - A mutational analysis. Journal of Biological Chemistry 
280(44):37159-37168. 
11. Aller SG & Unger VM (2006) Projection structure of the human copper 
transporter CTR1 at 6-angstroms resolution reveals a compact trimer with a novel 
channel-like architecture. Proceedings of the National Academy of Sciences of the 
United States of America 103(10):3627-3632. 
12. De Feo CJ, Aller SG, Siluvai GS, Blackburn NJ, & Unger VM (2009) Three-
dimensional structure of the human copper transporter hCTR1. Proceedings of the 






13. Song IS, Chen HHW, Aiba I, Hossain A, Liang ZD, Klomp LWJ, & Kuo MT 
(2008) Transcription factor Sp1 plays an important role in the regulation of 
copper homeostasis in mammalian cells. Molecular Pharmacology 74(3):705-
713. 
14. Guo Y, Smith K, Lee J, Thiele DJ, & Petris MJ (2004) Identification of 
methionine-rich clusters that regulate copper-stimulated endocytosis of the human 
CTR1 copper transporter. Journal of Biological Chemistry 279(17):17428-17433. 
15. Molloy SA & Kaplan JH (2009) Copper-dependent recycling of hCTR1, the 
human high affinity copper transporter. Journal of Biological Chemistry 
284(43):29704-29713. 
16. Petris MJ, Smith K, Lee J, & Thiele DJ (2003) Copper-stimulated endocytosis 
and degradation of the human copper transporter, hCTR1. Journal of Biological 
Chemistry 278(11):9639-9646. 
17. Van den Berghe PVE, Folmer DE, Malingre HEM, Van Beurden E, Klomp AEM, 
De Sluis BV, Merkx M, Berger R, & Klomp LWJ (2007) Human copper 
transporter 2 is localized in late endosomes and lysosomes and facilitates cellular 
copper uptake. Biochemical Journal 407:49-59. 
18. Bertinato J, Swist E, Plouffe LJ, Brooks SPJ, & L'Abbe MR (2008) CTR2 is 
partially localized to the plasma membrane and stimulates copper uptake in COS-
7 cells. Biochemical Journal 409:731-740. 
19. Schmidt PJ, Rae TD, Pufahl RA, Hamma T, Strain J, O'Halloran TV, & Culotta 
VC (1999) Multiple protein domains contribute to the action of the copper 
chaperone for superoxide dismutase. Journal of Biological Chemistry 
274(34):23719-23725. 
20. Lamb AL, Torres AS, O'Halloran TV, & Rosenzweig AC (2001) Heterodimeric 
structure of superoxide dismutase in complex with its metallochaperone. Nature 
Structural Biology 8(9):751-755. 
21. Furukawa Y, Torres AS, & O'Halloran TV (2004) Oxygen-induced maturation of 
SOD1: a key role for disulfide formation by the copper chaperone CCS. Embo 
Journal 23(14):2872-2881. 
22. Okado-Matsumoto A & Fridovich I (2001) Subcellular distribution of superoxide 
dismutases (SOD) in rat liver - Cu,Zn-SOD in mitochondria. Journal of 
Biological Chemistry 276(42):38388-38393. 
23. Prohaska JR, Broderius M, & Brokate B (2003) Metallochaperone for Cu,Zn-
superoxide dismutase (CCS) protein but not mRNA is higher in organs from 






24. Bertinato J & L'Abbe MR (2003) Copper modulates the degradation of copper 
chaperone for Cu,Zn superoxide dismutase by the 26 S proteosome. Journal of 
Biological Chemistry 278(37):35071-35078. 
25. Caruano-Yzermans AL, Bartnikas TB, & Gitlin JD (2006) Mechanisms of the 
copper-dependent turnover of the copper chaperone for superoxide dismutase. 
Journal of Biological Chemistry 281(19):13581-13587. 
26. Prohaska JR, Geissler J, Brokate B, & Broderius M (2003) Copper,zinc-
superoxide dismutase protein but not mRNA is lower in copper-deficient mice 
and mice lacking the copper chaperone for superoxide dismutase. Experimental 
Biology and Medicine 228(8):959-966. 
27. Shibata N, Hirano A, Kobayashi M, Sasaki S, Kato T, Matsumoto S, Shiozawa Z, 
Komori T, Ikemoto A, Umahara T, & Asayama K (1994) Cu/Zn Superoxide 
dismutase-like immunoreactivity in lewy body-like inclusions of sporadic 
amyotrophic-lateral-sclerosis. Neuroscience Letters 179(1-2):149-152. 
28. Shibata N, Hirano A, Yamamoto T, Kato Y, & Kobayashi M (2000) Superoxide 
dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral 
sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 
1(3):143-161. 
29. Shibata N & Kobayashi M (1997) Familial amyotrophic lateral sclerosis and 
Cu/Zn superoxide dismutase mutation. Neuropathology 17(4):255-262. 
30. Furukawa Y & O'Halloran TV (2005) Amyotrophic lateral sclerosis mutations 
have the greatest destabilizing effect on the apo- and reduced form of SOD1, 
leading to unfolding and oxidative aggregation. Journal of Biological Chemistry 
280(17):17266-17274. 
31. Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, Cashman 
NR, Kondejewski LH, & Chakrabartty A (2002) Oxidation-induced misfolding 
and agagaregation of superoxide dismutase and its implications for amyotrophic 
lateral sclerosis. Journal of Biological Chemistry 277(49):47551-47556. 
32. Anastassopoulou I, Banci L, Bertini I, Cantini F, Katsari E, & Rosato A (2004) 
Solution structure of the apo and copper(I)-loaded human metallochaperone 
HAH1. Biochemistry 43(41):13046-13053. 
33. Wernimont AK, Huffman DL, Lamb AL, O'Halloran TV, & Rosenzweig AC 
(2000) Structural basis for copper transfer by the metallochaperone for the 
Menkes/Wilson disease proteins. Nature Structural Biology 7(9):766-771. 
34. Pufahl RA, Singer CP, Peariso KL, Lin SJ, Schmidt PJ, Fahrni CJ, Culotta VC, 
PennerHahn JE, & Ohalloran TV (1997) Metal ion chaperone function of the 





35. Bancl L, Bertini I, Chasapis CT, Rosato A, & Tenori L (2007) Interaction of the 
two soluble metal-binding domains of yeast Ccc2 with copper(I)-Atx1. 
Biochemical and Biophysical Research Communications 364(3):645-649. 
36. La Fontaine S & Mercer JFB (2007) Trafficking of the copper-ATPases, ATP7A 
and ATP7B: Role in copper homeostasis. Archives of Biochemistry and 
Biophysics 463(2):149-167. 
37. Itoh S, Ozumi K, Kim HW, Nakagawa O, McKinney RD, Folz RJ, Zelko IN, 
Ushio-Fukai M, & Fukai T (2009) Novel mechanism for regulation of 
extracellular SOD transcription and activity by copper: Role of antioxidant-1. 
Free Radical Biology and Medicine 46(1):95-104. 
38. Itoh S, Kim HW, Nakagawa O, Ozumi K, Lessner SM, Aoki H, Akram K, 
McKinney RD, Ushio-Fukai M, & Fukai T (2008) Novel role of antioxidant-1 
(Atox1) as a copper-dependent transcription factor involved in cell proliferation. 
Journal of Biological Chemistry 283(14):9157-9167. 
39. Cobine PA, Pierrel F, & Winge DR (2006) Copper trafficking to the 
mitochondrion and assembly of copper metalloenzymes. Biochimica Et 
Biophysica Acta-Molecular Cell Research 1763(7):759-772. 
40. Cobine PA, Ojeda LD, Rigby KM, & Winge DR (2004) Yeast contain a non-
proteinaceous pool of copper in the mitochondrial matrix. Journal of Biological 
Chemistry 279(14):14447-14455. 
41. Cobine PA, Pierrel F, Bestwick ML, & Winge DR (2006) Mitochondrial matrix 
copper complex used in metallation of cytochrome oxidase and superoxide 
dismutase. Journal of Biological Chemistry 281(48):36552-36559. 
42. Shoubridge EA (2001) Cytochrome c oxidase deficiency. American Journal of 
Medical Genetics 106(1):46-52. 
43. Heuchel R, Radtke F, Georgiev O, Stark G, Aguet M, & Schaffner W (1994) The 
transcription factor MTF-1 is essential for basal and heavy metal-induced 
metallothionein gene-expression Embo Journal 13(12):2870-2875. 
44. Ogra Y, Aoyama M, & Suzuki KT (2006) Protective role of metallothionein 
against copper depletion. Archives of Biochemistry and Biophysics 451(2):112-
118. 
45. Xiao ZG, Brose J, Schimo S, Ackland SM, La Fontaine S, & Wedd AG (2011) 
Unification of the copper(I) binding affinities of the metallo-chaperones Atx1, 
Atox1, and related proteins. Detection probes and affinity standards. Journal of 
Biological Chemistry 286(13):11047-11055. 
46. Freedman JH, Ciriolo MR, & Peisach J (1989) The role of glutathione in copper-





47. Pearson RG (1963) Hard and soft acids and bases. Journal of the American 
Chemical Society 85(22):3533-&. 
48. Bertini I, Cavallaro G, & McGreevy KS (2010) Cellular copper management-a 
draft user's guide. Coordination Chemistry Reviews 254(5-6):506-524. 
49. Xue Y, Davis AV, Balakrishnan G, Stasser JP, Staehlin BM, Focia P, Spiro TG, 
Penner-Hahn JE, & O'Halloran TV (2008) Cu(I) recognition via cation-pi and 
methionine interactions in CusF. Nature Chemical Biology 4(2):107-109. 
50. Banci L, Bertini I, Calderone V, Ciofi-Baffoni S, Mangani S, Martinelli M, 
Palumaa P, & Wang SL (2006) A hint for the function of human Sco1 from 
different structures. Proceedings of the National Academy of Sciences of the 
United States of America 103(23):8595-8600. 
51. Strange RW, Antonyuk SV, Hough MA, Doucette PA, Valentine JS, & Hasnain 
SS (2006) Variable metallation of human superoxide dismutase: Atomic 
resolution crystal structures of Cu-Zn, Zn-Zn and as-isolated wild-type enzymes. 
Journal of Molecular Biology 356(5):1152-1162. 
52. Murphy LM, Strange RW, & Hasnain SS (1997) A critical assessment of the 
evidence from XAFS and crystallography for the breakage of the imidazolate 
bridge during catalysis in Cu/Zn superoxide dismutase. Structure 5(3):371-379. 
53. de Bie P, Muller P, Wijmenga C, & Klomp LWJ (2007) Molecular pathogenesis 
of Wilson and Menkes disease: correlation of mutations with molecular defects 
and disease phenotypes. Journal of Medical Genetics 44(11):673-688. 
54. Gaggelli E, Kozlowski H, Valensin D, & Valensin G (2006) Copper homeostasis 
and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and 
amyotrophic lateral sclerosis). Chemical Reviews 106(6):1995-2044. 
55. Merlot AM, Kalinowski DS, & Richardson DR (2013) Novel chelators for cancer 
treatment: Where are we now? Antioxidants & Redox Signaling 18(8):973-1006. 
56. Hodgkinson V & Petris MJ (2012) Copper homeostasis at the host-pathogen 
interface. Journal of Biological Chemistry 287(17):13549-13555. 
57. Casini A & Reedijk J (2012) Interactions of anticancer Pt compounds with 
proteins: an overlooked topic in medicinal inorganic chemistry? Chemical Science 
3(11):3135-3144. 
58. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, & O'Halloran TV (1999) 
Undetectable intracellular free copper: The requirement of a copper chaperone for 





59. Morgan MT, Bagchi P, & Fahrni CJ (2013) Fluorescent probes for monovalent 
copper. Encyclopedia of Inorganic and Bioinorganic Chemistry,  (John Wiley & 
Sons, in press). 
60. Gorren ACF, Schrammel A, Schmidt K, & Mayer B (1996) Decomposition of S-
nitrosoglutathione in the presence of copper ions and glutathione. Archives of 
Biochemistry and Biophysics 330(2):219-228. 
61. Burkitt MJ (2001) A critical overview of the chemistry of copper-dependent low 
density lipoprotein oxidation: Roles of lipid hydroperoxides, alpha-tocopherol, 
thiols, and ceruloplasmin. Archives of Biochemistry and Biophysics 394(1):117-
135. 
62. Jomova K & Valko M (2011) Advances in metal-induced oxidative stress and 
human disease. Toxicology 283(2-3):65-87. 
63. Herd SM, Camakaris J, Christofferson R, Wookey P, & Danks DM (1987) Uptake 
and efflux of copper-64 in Menkes-disease and normal continuous lymphoid-cell 
lines. Biochemical Journal 247(2):341-347. 
64. Beers J, Glerum DM, & Tzagoloff A (1997) Purification, characterization, and 
localization of yeast Cox17p, a mitochondrial copper shuttle. Journal of 
Biological Chemistry 272(52):33191-33196. 
65. Maxfield AB, Heaton DN, & Winge DR (2004) Cox17 is functional when 
tethered to the mitochondrial inner membrane. Journal of Biological Chemistry 
279(7):5072-5080. 
66. Hu GF (1998) Copper stimulates proliferation of human endothelial cells under 
culture. Journal of Cellular Biochemistry 69(3):326-335. 
67. McAuslan BR & Gole GA (1980) Cellular and molecular mechanisms in 
angiogenesis. Transactions of the Ophthalmological Societies of the United 
Kingdom 100(SEP):354-358. 
68. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, & Roy S 
(2002) Copper-induced vascular endothelial growth factor expression and wound 
healing. American Journal of Physiology-Heart and Circulatory Physiology 
282(5):H1821-H1827. 
69. Volker W, Dorszewski A, Unruh V, Robenek H, Breithardt G, & Buddecke E 
(1997) Copper-induced inflammatory reactions of rat carotid arteries mimic 
restenosis/arteriosclerosis-like neointima formation. Atherosclerosis 130(1-2):29-
36. 
70. Birkaya B & Aletta JM (2005) NGF promotes copper accumulation required for 






71. Brewer GJ (2005) Copper lowering therapy with tetrathiomolybdate as an 
Antiangiogenic strategy in cancer. Current Cancer Drug Targets 5(3):195-202. 
72. Goodman VL, Brewer GJ, & Merajver SD (2004) Copper deficiency as an anti-
cancer strategy. Endocrine-Related Cancer 11(2):255-263. 
73. Harris ED (2004) A requirement for copper in angiogenesis. Nutrition Reviews 
62(2):60-64. 
74. Mandinov L, Mandinova A, Kyurkchiev S, Kyurkchiev D, Kehayov I, Kolev V, 
Soldi R, Bagala C, de Muinck ED, Lindner V, Post MJ, Simons M, Bellum S, 
Prudovsky I, & Maciag T (2003) Copper chelation represses the vascular response 
to injury. Proceedings of the National Academy of Sciences of the United States of 
America 100(11):6700-6705. 
75. Yang LC, McRae R, Henary MM, Patel R, Lai B, Vogt S, & Fahrni CJ (2005) 
Imaging of the intracellular topography of copper with a fluorescent sensor and by 
synchrotron x-ray fluorescence microscopy. Proceedings of the National 
Academy of Sciences of the United States of America 102(32):11179-11184. 
76. McRae R, Lai B, & Fahrni CJ (2013) Subcellular redistribution and mitotic 
inheritance of transition metals in proliferating mouse fibroblast cells. 
Metallomics 5(1):52-61. 
77. Hamza I, Schaefer M, Klomp LWJ, & Gitlin JD (1999) Interaction of the copper 
chaperone HAH1 with the Wilson disease protein is essential for copper 
homeostasis. Proceedings of the National Academy of Sciences of the United 
States of America 96(23):13363-13368. 
78. Jeney V, Itoh S, Wendt M, Gradek Q, Ushio-Fukai M, Harrison DG, & Fukai T 
(2005) Role of antioxidant-1 in extracellular superoxide dismutase function and 
expression. Circulation Research 96(7):723-729. 
79. Muller PAJ & Klomp LWJ (2009) ATOX1: A novel copper-responsive 
transcription factor in mammals? International Journal of Biochemistry & Cell 
Biology 41(6):1233-1236. 
80. McRae R, Lai B, & Fahrni CJ (2010) Copper redistribution in Atox1-deficient 
mouse fibroblast cells. Journal of Biological Inorganic Chemistry 15(1):99-105. 
81. Keller G, Bird A, & Winge DR (2005) Independent metalloregulation of Ace1 
and Mac1 in Saccharomyces cerevisiae. Eukaryotic Cell 4(11):1863-1871. 
82. Gross C, Kelleher M, Iyer VR, Brown PO, & Winge DR (2000) Identification of 
the copper regulon in Saccharomyces cerevisiae by DNA microarrays. Journal of 





83. Wegner SV, Sun F, Hernandez N, & He C (2011) The tightly regulated copper 
window in yeast. Chemical Communications 47(9):2571-2573. 
84. Dobi A, Dameron CT, Hu S, Hamer D, & Winge DR (1995) Distinct regions of 
Cu(I)-center-dot-Ace1 contact 2 spatially-resolved DNA major groove sites. 
Journal of Biological Chemistry 270(17):10171-10178. 
85. Joshi A, Serpe M, & Kosman DJ (1999) Evidence for (Mac1p)(2)center dot DNA 
ternary complex formation in Mac1p-dependent transactivation at the CTR1 




CHAPTER 2  
COORDINATION CHEMISTRY OF MONOVALENT COPPER 
LIGANDS: A NEW SET OF COLORLESS, WATER-SOLUBLE, AND 
AIR-STABLE AFFINITY STANDARDS  
 
Copper(I) binding affinities of small molecules and proteins reported in the 
literature are largely inconsistent and thus incomparable. This is primarily because of a 
lack of unified affinity standards. In this chapter, Cu(I) stability constants of several 
monovalent ligands were determined unequivocally and a new set of sulfonated 
thioether-based ligands were developed that form colorless, water-soluble, and air-stable 
copper complexes. These robust Cu(I) affinity standards were then applied to measure 
stability constants of other Cu(I)-ligands or proteins.  
2.1. Background 
The major challenge of copper homeostasis is to strike a balance between 
maintaining bioavailability of copper and controlling free intracellular copper 
concentration. Numerous copper binding proteins are critical components of this 
homeostatic machinery. They function in unification to buffer the cellular copper pool 
such that to ensure the accessibility of the metal ion for the intended cellular functions 
while protecting the cells from copper toxicity (1). In order to understand the mechanism 
of copper transport through these interconnected pathways at the molecular level, 
knowledge about the Cu(I)-binding affinities of these proteins is crucial. This section will 
discuss different aspects of metal-ligand equilibrium encountered in binding affinity 




2.1.1. Metal Affinity of a Ligand 
The experimental determination of binding affinity of a ligand L (or protein) to a 
metal ion (M) with 1:1 stoichiometry relies on the equilibrium description according to 
eqn. (2.1): 
 
                         
    




where Kc refers to the stoichiometric equilibrium constant. Binding affinity of a ligand 
can also be described as stability constant or formation constant. On the other hand, the 
metal binding affinity of a protein is often expressed in terms of dissociation constant 
which can be defined by eqn. (2.2):  
 
      
 
   
    
      




Similar to eqn. (2.1), binding interaction for a 1:2 complex formation is given by 
eqn. (2.3),  
 
                            
     





where  2 is known as the overall stability constant. Eqn. (2.3) can also be written in terms 
of stepwise equilibrium constants (K1 and K2) according to eqn. (2.6): 
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2.1.2. Ionic Strength Dependence of Binding Affinity 
In Section 2.1.1, binding affinity (Kc) was defined as stoichiometric stability 
constant where all species in the equilibrium were expressed in terms of molar 
concentrations. However, the position of most solution equilibria involving ions is 
dependent on the concentrations and the charges of the electrolytes present in the 
medium. This electrolyte effect results from the attractive and repulsive electrostatic 
forces that exist between the ions of an electrolyte and the ions involved in a metal-
binding equilibrium. To account for the effects of electrolytes on chemical equilibria, 
binding affinities should ideally be expressed as thermodynamic stability constants (K°) 
by eqn. (2.7),  
 
      
   
       
 (2.7)  
 
where ax represents the activity of each species.  
The activity, or effective concentration, of a species X is defined by eqn. (2.8),  
   
               (2.8)  
  
where [X] is the molar concentration of X and x is the activity coefficient. The activity 
coefficient and thus the activity of X depend on the ionic strength of the medium 
according to the Debye Huckel equation (2.9) (2): 
 
     
 
   
    
    




where zx = charge of the species X; x = effective diameter of the hydrated ion X in 
angstrom; µ = ionic strength of the solution; A and B = constants which are the functions 
of the temperature and the dielectric constant of a solvent. A and B adopt the values of 
0.51 and 0.33 , respectively at 25 °C in aqueous solution (3). The ionic strength of a 
solution is defined by eqn. (2.10),  
 
     
 
 
    
 





where ci = molar concentration of ion i, zi = charge of that ion, and the sum is taken over 
all ions in the solution.  
By substituting eqn. (2.8) in eqn. (2.7), K° can be written as: 
 
     
    
      










Combining equations (2.1) and (2.11), K° and Kc can be related by eqn. (2.12). 
 










Theoretically, K° for a metal-ligand equilibrium can be calculated from the 
knowledge of Kc and the activity coefficients of the species in equilibrium. In order to 
determine Kc, molar concentrations of the species present in a metal-binding equilibrium 
can be measured conveniently by most analytical methods. However, their activity 
coefficients cannot be computed reliably using the Debye Huckel equation (Eqn. (2.9)), 
partly because of the uncertainty in the extrapolation of the experimental parameters to 
infinite dilution, which is necessary for the measurements of the activity coefficients, and 
partly because of the inconsistencies in determining the effective diameter values (x) (4, 
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5). For these reasons, stoichiometric stability constants (Kc) are used instead of 
thermodynamic stability constants (K°) for binding affinity measurements.  
It can be followed from eqn. (2.9) th t  t very    ute s  ut   , whe  µ → 0, x → 
1, hence under this condition K° is equal to Kc, but for all practical purposes, K  ≠ Kc. 
Under such conditions, where µ is a non-zero number, activity coefficient (x) has a 
negative correlation with the ionic strength (µ) of the medium. Nevertheless, x is 
constant at a given µ and consequently the degree of deviation of K° from Kc does not 
vary when the ionic strength remains unchanged. Experimentally, this condition can be 
achieved by using a large excess of an inert background electrolyte that does not 
chemically interact with any of the species in equilibrium. Moreover, different 
electrolytes composed of ions of the same charge have same ionic strength at a given 
concentration, but their activity coefficients will vary due to different effective diameters. 
Therefore, it is utmost important to specify the concentration and the nature of the 
electrolyte while reporting binding affinity values such that the data acquired under the 
same conditions can be compared directly.  
2.1.3. Concept  of Apparent Stability Constant: pH-dependence of Binding Affinity 
The binding affinity of a ligand as defined by eqn. (2.1) is the simplest 
representation of a metal-ligand equilibrium. Usually, there are at least two other 
competing equilibria associated with metal coordination in aqueous solution; one is the 
hydrolysis of the aquated metal ion (2.13) and the other is the protonation of the ligand 
(2.14). The charges associated with metal complexes and protonated ligands are ignored 
in the following equations for the sake of convenience. 
 
                                    
 
 (2.13)  
        
 
                 (2.14)  
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In order to simplify the measurement of stability constants in presence of these 
competing equilibria, Gerold Schwarzenbach introduced the concept of apparent or 
conditional stability constants (6).  Metal-ligand equilibrium for a 1:1 complex defined in 
terms of apparent binding affinity takes the form of eqn (2.15). 
 
      
    




Here, ′ refers t      met       species that are not complexed by the ligand L, i.e., 
 
                                              (2.16)  
 
where, A refers to any auxiliary complexing agent including H2O as in eqn. (2.13). 
Similarly,  ′ refers t      f rms  f       s that are not bound to the metal ion. i.e., 
 
                                               (2.17)  
 
    r     t  S hw r e b  h’s definition, stoichiometric (as expressed by eqn. (2.1)) and 
conditional stability constants of a metal-ligand complex are related by eqn. (2.18). 
 
      
    
             
   
   




Based on eqn. (2.16), we can write 
 
     
    
   
   
                              




         
    
   
  
     
   
     
     






For metal-induced hydrolysis (eqn. (2.13)), equilibrium constant KM is given by  
 
     
                      
 
 




Thus, for a metal hydrolysis equilibrium, it can be written from eqn. (2.19),  
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where, pH = −log[H3O
+
] and pKM = −logKM. 
Similarly, for a ligand with two protonation sites, eqn. (2.14) can be written by, 
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Now, from eqn. (2.17), 
 
     
    
   
   
                    
   
      
    
   
  
     




         
    
 
 
   
  















           
                                (2.26)  
 
where, pK1 = −logKH1 and pK2 = −logKH2 
Substituting equations (2.22) and (2.26) in eqn. (2.18), the correlation between 
stoichiometric and conditional stability constants yields, 
 
      
   




The effect of pH on the apparent affinity of a ligand can be evaluated on the basis 
of eqn. (2.26) and (2.27). In an experiment, when the pKa of a ligand is higher than the 
pH of the medium, L >> 1, hence K′ << Kc. On the other hand, for a ligand whose pKa is 
lower than the pH, L ~ 1, so K′ ~ Kc, thus under this condition the effect of pH is 
negligible.  
2.1.4. Challenges in Determination of Cu(I) Stability Constants 
The major challenge in measurement of Cu(I) affinity is the redox lability of 
aqueous Cu
+
 ions which is not only susceptible towards oxidation but also towards 
disproportionation into Cu
2+
 (aq) and Cu
0
 (s) at acidic pH or precipitation as Cu2O at 
neutral or basic pH (7). However, Cu
+
 ions can be stabilized in aqueous solution in 
presence of ligands that favor Cu(I)-complexes by shifting the reduction potentials of 
ligand bound Cu(II/I) towards more positive values (8). This is indeed the case under the 
physiological condition where several high-affinity Cu(I) ligands (or proteins) sequester 
the copper ions resulting in a very low intracellular free Cu
+
 (aq) concentration in 
eukaryotic cells (9).  
Another challenge is that the binding affinities of the majority of biologically 




  or higher (10, 11); which means 
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, 50% of the ligand is 
metal bound at 10
-12
 M concentration of the copper ions. However, sensitivity of common 
detection methods is usually in the micromolar (10
-6
 M) range. At such high 
concentrations, the fractional saturation of ligands with high affinities is near unity, but 
the accurate determination of stability constants requires a fractional saturation range of 
0.2-0.8, fractional saturation being defined as the ratio of metal-complex to added metal 
ion (12). Therefore, the instability of redox active Cu
+
 (aq) ions and often the high 
affinity of ligands preclude direct measurements of stability constants of Cu(I)-complexes 
by simply titrating the Cu
+
 ions with the ligands.  
One of the solutions to the problems outlined above is determination of the Cu(I)-
stability constant of the ligand under study in presence of a competing ligand (affinity 
standard) whose Cu(I) affinity is comparable to that of the ligand being measured. This 
strategy can shift the position of the original complexation equilibrium towards a reliable 
fractional saturation window. Additionally, under this condition, the equilibrium 
concentration of free Cu
+
 (aq) is usually very low such that neither disproportionation nor 
oxidation is thermodynamically favorable. This method relies on the accurate stability 
constant data of the affinity standard. The major pitfall of this method is ternary complex 






Scheme 2.1: Thermodynamic Cycle 
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Alternatively, the Cu(I) stability constant of a ligand can be determined indirectly 
from its Cu(II)-complexation equilibrium, which is the most common approach found in 
the literature. This method takes advantage of the thermodynamic cycle as described in 
Scheme 2.1, where Cu(I) affinities are calculated from the experimentally determined 
Cu(II) stability constants and the formal potentials of the ligand-bound Cu(II/I) redox 
couples according to eqn. (2.28).  
For a thermodynamic cycle as depicted in Scheme 2.1, the free energy change of 
Cu(I)-complexation equilibrium takes the form of eqn. (2.28) by utilizing the Nernst 
relationship for a one electron redox process,  
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0           u           u           
 
or,  
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where ECu(II/I)L = formal potential of ligand bound Cu(II/I) couple; E
0
Cu(II/I)aq = standard 
reduction potential of the aqueous Cu(II/I) couple; F = Faraday constant; R = universal 
gas constant; T = temperature in Kelvin.  
This method is only applicable for complexes with thermodynamically reversible 
redox potential. Although Cu(II) affinities and ECu(II/I)L values can be determined 
conveniently, there is a discrepancy in the literature regarding the value of E
0
Cu(II/I)aq. In a 
recent publication, Xiao et al. (10) referred to a value of 0.164 V (13), whereas Bernardo 
et al. (14) calculated this value to be 0.13 V by correcting another literature value of this 
redox potential (0.153 V) (15) with the activity coefficients as described below. 
Depending on the literature value used for E
0
Cu(II/I)aq, the resultant Cu(I) stability constant 








 (aq) + e  Cu
+
 (aq)  
 
 the half-cell potential can be written as: 
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a = standard reduction potential defined by the value of E at infinite dilution 
when the ionic strength of the medium practically equals to zero and the activity 
coefficients of the ions are unity according to the IUPAC convention (16). In order to 
apply the reduction potential E
0
a in a solution of 0.1 M ionic strength, Bernardo et al. 
proposed the following conversion of the standard reduction potential (E
0
a) to the 
“    e tr t      te t   ”  
Substituting eqn. (2.8) into eqn (2.29), 
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    “    e tr t      te t   ”  
Theoretically, the activity coefficients of ions in aqueous solution can be 
determined by the Debye-Huckel equation (eqn. (2.9)); however, the validity of the 
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Debye-Huckel theory is limited to the completely dissociated electrolytes, a condition 
that can only be achieved at infinite dilution. Therefore, C.W. Davies recommended a 
correction of the original Debye-Huckel equation in order to include ion-association 
commonly present at concentrations used for any practical measurement of activity 
coefficient (17). The proposed equation for an aqueous solution at 25 °C is given by, 
 
     
 
   0     
  
  
    
  0      
(2.31)  
 
Calculating from eqn. (2.31), Cu
+
 becomes 0.78 and Cu
2+
 equals to 0.36 at 0.1 M ionic 
strength. Therefore, under this condition, following eqn. (2.30)  the “    e tr t    
  te t   ”  E
0


















CCS ESI-MS DTT 7.5 4.2 × 10
14
 (18) 
WT- CCS  UV-vis spectroscopy BCA 6.5 1.1 × 10
17
 (19) 
UV-vis spectroscopy BCS 7.5 5.5 × 10
17
 (19) 
  6.5 4.4 × 10
16
 (19) 
CCS    
Domain1 
UV-vis spectroscopy BCS 7.5 5.5 × 10
17
 (19) 
  6.5 5.6 × 10
16
 (19) 
CCS    
Domain 3 
UV-vis spectroscopy BCA 7.5 6.4 × 10
16
 (19) 
  6.5 4.2 × 10
15
 (19) 
SOD1 ESI-MS DETC 7.5 4.3  × 10
15
 (18) 
SOD1 UV-vis spectroscopy PAR 7.4 1.7 × 10
17
 (20) 
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Atox1 or Hah1 UV-vis spectroscopy BCS 7.0 5.6 × 10
17
 (21) 
  7.0 2.5  × 10
17
 (11) 
ESI-MS DTT 7.5 6.0  × 10
13
 (18) 
UV-vis spectroscopy BCA 7.5 3.5  × 10
10
 (22) 





UV-vis spectroscopy BCS 7.0 3.6 × 10
17
 (21) 









(MBD-2, 5, 6) 
ESI-MS DTT 7.5 7.7 × 10
13












UV-vis spectroscopy BCA 7.5 2.2 × 10
10





 ITC  6.5 2.1 × 10
5







UV-vis spectroscopy BCS 7.0 4.0 × 10
17
 (10) 
Cox 17 ESI-MS DTT 7.5 5.7 × 10
13
 (18) 
Sco1 ESI-MS DTT 7.5 3.2 × 10
14
 (18) 






In addition to ternary complex formation during competition experiments and 
anomalous E
0
Cu(II/I)aq values in the literature, reliable determination of binding affinity 
also suffers from other factors, including the lack of effective competition equilibrium, 
change of pH during measurement, aerial oxidation of Cu
+
 ions and binding sites, and 
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incorrect analysis of the experimental data. Therfore, it is not surprising that there is a 
lack of consensus in the literature regarding the binding affinities of Cu(I) ligands (and 
proteins). A compilation of apparent stability constants of Cu(I)-proteins in Table 2.1 
shows as large as 12-13 orders of magnitude difference in the values for some proteins 
such as Atox1. These discrepancies are too large to be explained by the differences in the 
pH values of the measurements and are much more dependent on the methods of 
determination. In this context, the reliability of the Cu(I) ligands used as affinity 
standards in the equilibrium competitions are of major contributing factors.  
Monodentate ligands such as cyanide (25) or thiourea (26) bind copper ions 
strongly but with multiple coordination stoichiometry. Although these ligands are 
employed as Cu(I) affinity standards, they are prone to ternary complex formation during 
competition experiments with ligands under study, especially in presence of vacant Cu(I) 
coordination sites as Cu(I) can adopt a coordination number of up to four (27). In fact, 
Cu(I) in low-coordinate protein complexes has been shown to form heterodimers in 
biology (28, 29). Dithiothreitol (DTT), typically employed as a reducing agent for protein 
disulfides, has also been utilized as a competing ligand in determining Cu(I)-binding 
affinities of proteins (Table 2.1). However, due to its high reactivity with oxygen and 
variable coordination stoichiometry, the utility of this ligand is dubious (10).  
It is evident from Table 2.1 that BCS and BCA are widely used as competing 
ligands. These ligands form colored 2:1 Cu(I)-complexes and the complexation can be 
easily followed by increase in the absorbance at 483 nm for BCS and at 562 nm for BCA, 
a wavelength region where most Cu(I)-ligands including proteins do not absorb. 
However, reported log  2 values for 2:1 complex formation with these ligands rarely 
converge to a consensus value (Table 2.2). Evidently use of these divergent values of 
affinity standards to determine the stability constants of other ligands (and proteins) 
results in a progression of errors in the literature. Furthermore, these bidentate chelators, 
though more sterically restricted than small monodentate ligands such as cyanide and 
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thiourea, are still likely to form ternary complex, especially with other ligands that form 
low-coordinate complexes. As previously mentioned by Xiao et al. (10), this was 
presumably a source of error in an earlier attempt to determine the Cu(I)-affinity of BCS 
by competition with cyanide (30). 
In order to address these problems, we characterized the thermodynamic 
properties of a set of copper chelators featuring a wide range of affinities which can be 
reliably used as Cu(I) affinity standards. In this work, three new monovalent copper 
ligands were developed which form air-stable, water soluble Cu(I)-complexes with 1:1 
metal-ligand stoichiometry that do not absorb in the near-UV and visible range. Their 
Cu(I) stability constants together with three other copper chelators from the literature, 
including PEMEA, BCA, and BCS, were determined reliably by independent titrations 
and cross-verifications with other ligands. The consolidated stability constants of these 
ligands encompass an affinity range over seven orders of magnitude. This will allow us to 
use this set of robust affinity standards to determine stability constants of a wide array of 




Table 2.2. Previously Reported Stability Constants of Selected Cu(I) Affinity Standards  
 
Ligand Experimental Method log β2 Ref. 
BCA ITC 14.7  (22) 
 Direct titration with Cu(I) 11.4  (30) 
 Indirect competition with BCS 16.7  (31) 
  17.2   (32) 
  17.3  (10) 
BCS  jerrum’s method 19.5  (13) 
  19.8  (33) 
  19.9 (10) 
 Competition with cyanide (CN
-
) 22.5 (30) 
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The copper(I) ligands studied in this work are shown in Figure 2.1. Three new 
ligands, MCL-1, MCL-2, and MCL-3, were synthesized by Dr. M. T. Morgan along with 
the literature compounds PEMEA and DHEAMP. The ligands BCA and BCS are 
commercially available. 
The thermodynamic properties of copper complexes with tetradentate sulfur-rich 
ligands, including tripodal thioether-amines (8) and thiocrown macrocycles (34), have 
been extensively evaluated by Rorabacher and coworkers. These ligands often form air-
stable Cu(I) complexes with 1:1 metal-ligand stoichiometry. By saturating the Cu(I) 
coordination sphere, these tetradentate chelators are expected to provide greater 
resistance to ternary complex formation than monodentate ligands, which is a prerequisite 
during competition experiments in determining stability constants of Cu(I)-complexes. 
Moreover, these ligands often exhibit a directly measurable low to moderate Cu(II)-
binding affinities and electrochemically reversible redox cycling between Cu(II) and 
Cu(I) complexes, allowing the relatively high Cu(I)-binding affinity to be calculated from 
the thermodynamic cycle (eqn. (2.28)). Furthermore, the Cu(I)-complexes of aliphatic 
polythioethers are typically colorless (8), and hence these chelators can be potentially 
used as affinity standards in spectrophotometric competition titrations where the copper 
complex formation of the ligand under study can be monitored in the near-UV and visible 
range without any interference from the standards. Despite of these favorable properties 
of the thioether-rich tetradentate Cu(I)-ligands previously characterized by Rorabacher et 
al., these compounds, being poorly water soluble, have limited applicability as affinity 
standards particularly in aqueous solution. In order to design water soluble polythioether-
based Cu(I) ligands, Dr. M. T. Morgan in the Fahrni lab introduced solubilizing groups 
by modifying the lipophilic ligand frameworks previously published in the literature. For 
example, TMMEA and TEMEA (8) were used as starting points for the design of MCL-
1, while [16]aneS4 was a precursor for MCL-3 ligand (34). 
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Protonation Constant of MCL-1 
 
 
Protonation Constant of MCL-2 
 
 
Figure 2.2. Protonation Constants of MCL-1 and MCL-2 Determined by Acid-Base 
Titrations. Fully protonated ligands (5 mM; 0.1 M KCl as an ionic background) were 
titrated with a standardized solution of 0.1 M KOH. Protonation constants were then 
determined from the potentiometric data using the Hyperquad software package (35), 
which yielded logKH1 values of 7.00±0.02 and 8.98±0.01 for MCL-1 and MCL-2, 
respectively. 
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Protonation Constant of DHEAMP 
 
 




Figure 2.3. Protonation Constants of DHEAMP and BCS Determined by Acid-Base 
Titrations. Fully protonated ligands (5 mM for DHEAMP and 1 mM for BCS; 0.1 M KCl 
as an ionic background) were titrated with a standardized solution of 0.1 M KOH. 
Protonation constants were then determined from the potentiometric data using the 
Hyperquad software package (35), which yielded logKH1 values of 6.94±0.01 and 






Figure 2.4. Protonation Constant of PEMEA Determined by UV-Vis Spectroscopy. A. 
Green trace and blue trace correspond to the UV-visible spectra at  log[H3O
+
] = 8.2 and 
3, respectively. B. Absorbance change (black points) and curve fit (solid trace) for the 
titration. Spectrophotometric titrations with PEMEA (55  M; 0.1 M KCl as an ionic 
background) were carried out by varying  log[H3O
+
] from 4 to 3 with the addition of HCl 
and from 4 to 8.2 with the addition of KOH. Protonation constants of PEMEA were then 
determined by non-linear least-squares fitting over the entire spectral range using the 











Figure 2.5. Protonation Constant of BCA Determined by UV-Vis Spectroscopy. A. Green 
trace and blue trace correspond to the UV-visible spectra at  log[H3O
+
] = 5.5 and 3.7, 
respectively. B. Absorbance change (black points) and curve fit (solid trace) for the 
titration. Spectrophotometric titrations with BCA (10  M; 0.1 M KCl as an ionic 
background) were carried out by varying  log[H3O
+
] from 5.5 to 3.7 with the addition of 
HCl. Protonation constant of BCA was then determined by non-linear least-squares 
fitting over the entire spectral range using the SPECFIT software package (36). Average 





 Table 2.3. Protonation Constants of the Monovalent Copper Ligands in Aqueous 
Solution at 25 ºC, 0.1 M KCl 
 
Ligand logKH1 logKH2 Ref.
d
 
PEMEA   7.24 (3)
a
  3.23 (4)  
7.33 (15)
b
  3.26 (8)
b
 (8) 
MCL-1 7.00 (2)   
BCA 3.80 (2)   
 3.74 (4)
c
  (37) 
MCL-2 8.98 (1)   
DHEAMP  6.94 (1)   
6.92 (1) 1.16 (9) (38) 
BCS 5.70 (2)   
5.7  (10) 
a
 The standard deviation of the mean is listed in parentheses next to the value as referenced to the last 
digits reported (e.g., 3.23 (4) means 3.23 ± 0.04). 
b
 These values were reported as mixed-mode values 
(See text). 
c
 Experiment was conducted at 0.2 M ionic strength. 
d
 Values stated without reference are 
from this work. 
 
 
2.2.1. Protonation Constants 
As discussed in section 2.1.3, Cu(I) stability constants of ligands with one or more 
basic donor atoms are pH dependent, and hence the protonation constants (logKHn) of the 
monovalent copper ligands were determined in this work using potentiometric titrations. 
With the exception of PEMEA and BCA, the fully protonated ligands were titrated with 
standardized KOH solutions, and logKHn values were determined from the half-
neutralization points of the acid-base titration curves (Figure 2.2 and Figure 2.3). This 
method often requires millimolar concentrations of compounds, for example, ligand 
concentrations used in this work were 1 mM for BCS and 5 mM for MCL-1, MCL-2, and 
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DHEAMP. However, PEMEA and BCA were not soluble at millimolar concentrations in 
aqueous solution; therefore, the protonation constants of these ligands were determined 
by spectrophotometric titrations where the changes in the UV-visible spectrum were 
monitored as a function of −     3O
+
]  (Figure 2.4 and Figure 2.5). Low micromolar 
concentrations of compounds were sufficient to obtain a measurable UV-vis response, for 
example, measurements were conducted at a concentration of 55  M for PEMEA and 10 
 M for BCA, and thus circumventing the solubility problems of BCA and PEMEA.  
The protonation constants for all copper ligands are tabulated in Table 2.3. The 
logKHn values in this work are reported as concentration constants where all species 
present in the protonation equilibria are expressed in molar concentrations. As described 
in sections 2.1.2 and 2.1.3, measurements of binding affinities require a chemically inert 
ionic background and pH buffered at a given value. However, in the laboratory, pH’s of 
buffer solutions are determined by pH-meter which records the activity of hydronium ion 
in the buffer. Such measurement of pH is influenced by the hydronium ion concentration 
as well as the ionic strength of the solution. Therefore, as Martell and Smith (39) 
suggested, at 0.1 M ionic strength, protonation constants that are based on [H3O
+
] 
(concentration constants, logKHn) must be corrected upward by 0.11 (eqn.2.32) to mixed-
mode protonation constants (log   
   where hydronium ion is expressed in terms of 
activity and all other species in terms of molar concentrations. This correction factor is 
based on Debye-Huckel equation (eqn. (2.9)) as described below. 
For the protonation of a ligand, 
 
           
 
              
 
 
the mixed-mode equilibrium constant,    
m  (where n= 1,2,3,4), is given by, 
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By applying eqn. (2.8), 
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Calculating from eqn. (2.31), −     
   
  is equal to 0.11 at 0.1 M ionic strength. Thus,  
 
      
                (2.32)  
 
where,       
     
  
 - 
       
 
Direct potentiometric titrations at 0.1 M ionic strength yielded protonation 
constant of 7.00±0.02 for the amine nitrogen of MCL-1. Conversion of this value which 
was derived from the measurement of  log[H3O
+
] to mixed-mode constant yielded a 
value of 7.11 for ligand MCL-1. This value is substantially lower than the mixed-mode 
protonation constants of 8.36 and 8.32 reported for the analogous ligands TMMEA and 
TEMEA, respectively, which were measured in aqueous solution at 0.1 M ionic strength 
(8). Cooper et al. also measured the protonation constant of TEMEA in 80% methanol 
which yielded a value of 6.34 (40). Interestingly, the authors of this paper extrapolated 
this value to the aqueous solution and predicted a mixed mode protonation constant of 7.1 
which was identical to the value we obtained for MCL-1. Additionally, previously 
reported literature values of logKHn for BCS (logKH1 = 5.7) (10), BCA (logKH1 = 3.74 at 
0.2 M ionic strength) (37), and PEMEA (log   
m
 = 7.33 and log   
m
 = 3.26) corroborated 








































































































































































































































































































































































































































































































































































































































































































































































































































































































Scheme 2.2. Schematic Representation of Thermodynamic Equilibria to Determine 
Stability Constants of Copper(I) Ligands. Orange and green boxes depict Cu(I)- and 
Cu(II)-binding to the ligands, respectively. Stability constants derived from 
thermodynamic cycle are represented by equlibria r1-4 and those derived from 
competition titrations are shown in equlibria e1-9. 2.4 
 
 
2.2.2. Stability Constants of Copper(I) Ligands 
The thermodynamic equilibria studied in this work to determine binding affinities 
of copper(I) ligands are represented in Scheme 2.2. For ligands where Cu(II) and Cu(I) 
complexes are mutually electrochemically reversible, copper(I) stability constants were 
determined from the thermodynamic cycle using the Cu(II)-affinities of the ligands and  
formal potentials of the ligand-bound Cu(II/I) reversible redox couples. The affinity 
values derived this way were then verified with the ones obtained from competition 
titrations where two ligands competed for the Cu
+
 (aq) ions. For ligands where the redox 
cycling between Cu(II) and Cu(I) complexes are electrochemically irreversible, the 
stability constants were derived from two independent competition titrations involving 
two different competing ligands. A comprehensive summary of the formal potentials and 
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stability constants for all copper ligands determined by individual equilibrium is given in 
Table 2.4.  
It is often difficult to compare relative binding affinities between complexes with 
different metal-ligand stoichiometry, e.g., 1:1 and 1:2 metal-ligand complexes. Table 2.5 
describes the Cu(I) binding affinities of different ligands in terms of pCu which is equal 
to -log[Cu(I)]free in  a solution containing 10 µM ligand and 1  M Cu(I) at pH  7. This 
concept was introduced by Raymond and coworkers who utilized pM values to compare 
the affinities of various iron-binding siderophores (41). pCu values will enable us to 
compare directly the binding affinities of different ligands with 1:1 and 1:2 metal-ligand 
stoichiometry. As an example, the absolute affinity of MCL-1 is 4.48 units lower than 
BCS on a logarithmic scale, but its pCu value is higher by 0.3 units. Therefore, under the 
same experimental conditions MCL-1 binds Cu
+
 ions more tightly than BCS, however, 




Table 2.5. Cu(I) and Cu(II) Stability Constants of the Copper(I) Ligands in Aqueous 









PEMEA   7.85 15.71 15.20 16.2 
MCL-1 6.42 16.33 15.97 16.9 
BCA - 17.66
c
 17.66 13.5 
MCL-2 - 13.08 10.99 11.9 
BCS 12.42 20.81
c
 20.76 16.6 
MCL-3 3.47 13.80 13.80 14.8 
a
 These values correspond to the  mean values obtained by taking average of logKCu(I)L values weighted by 
the standard deviations of individual methods (Table 2.4) 
 b
 pCu = −log[Cu(I)]free for  a solution containing 






2.2.2.1. Stability Constant of PEMEA 
PEMEA was first characterized by Ambundo et al. (8) who calculated the Cu(I) 
stability constant solely based on a thermodynamic cycle. PEMEA was chosen as a 
compound of interest for this work because (a) this compound forms Cu(I) and Cu(II) 
complexes with 1:1 stoichiometry, (b) both Cu(I) and Cu(II) complex formation can be 
followed by UV-vis spectroscopy, and (c) the ligand has two protonation sites. The 
apparent binding affinities (or conditional stability constants; Section 2.1.3) of PEMEA at 
different pH can be varied over a broad range because of its two substantially different 
protonation constant values (logKH1 = 7.24 and logKH2 = 3.23), thus making it useful as a 






Figure 2.6. Determination of Formal Potential of PEMEA. Cyclic Voltammogram of 
PEMEA (150 µM) in presence of CuSO4 (1 mM) at pH 5 (10 mM PIPBS, 0.1 M KClO4); 
scan rate 20 mV s
-1


























Figure 2.7. Determination of Cu(II) Stability Constant of PEMEA: Titration of PEMEA 
with CuSO4. A. Green trace and blue trace correspond to the UV-visible spectra at 
[Cu(II)] = 0 and 247 µM, respectively. B. Absorbance change (black points) and curve fit 
(solid trace) for the titration. PEMEA (96 µM) was titrated with CuSO4 at pH 5 (10 mM 
PIPBS, 0.1 M KClO4, 25 °C). Cu(II) stability constant value was then determined by 
non-linear least-squares fitting over the spectral range 300-450 nm using the SPECFIT 









Figure 2.8. Determination of Cu(I) Stability Constant of PEMEA: Titration of PEMEA 
with Cu(I) in the Presence of Acetonitrile. A. Green trace and blue trace correspond to the 
UV-visible spectra at [Cu(I)] = 0 and 236 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. PEMEA (100 µM) was titrated with 
[Cu(I)(CH3CN)4]PF6 in the presence of 958 mM acetonitrile acting as a competing ligand 
at pH 2 (14 mM HClO4, 0.1 M KClO4, 25 °C, in the presence of 100 µM sodium 
ascorbate). Cu(I) stability constant value of PEMEA was then determined by non-linear 
least-squares fitting over the entire spectral range using the SPECFIT software package 





a) Cu(I) Affinity of PEMEA from Thermodynamic Cycle (r1)  
PEMEA showed a quasi-reversible one-electron redox process with a half-wave 
potential of 0.595±0.002 V vs SHE in the presence of CuSO4 (Figure 2.6). The Cu(II)-
complex of PEMEA has an absorption maximum at 350 nm (Figure 2.7). UV-vis 
titrations of PEMEA with Cu
2+
 (aq) yielded a logKCu(II)L of 7.85±0.08; using these data, 
we obtained a logKCu(I)L value of 15.71 from eqn. (2.28). The previously published formal 
potential (ECu(II/I)L = 0.595) and stability constant values (logKCu(II)L = 7.89 and logKCu(I)L 
= 15.76) of PEMEA (8) corroborated well with our data. 
b) Cu(I) Affinity of PEMEA from Competition with Acetonitrile (e1)  
As discussed in section 2.1.4, Cu(I) stability constant determined from the 
thermodynamic cycle depends on the E
0
Cu(II/I)aq value. Therefore, we sought to verify the 
Cu(I)-stability constant value of PEMEA using an independent method.  Acetonitrile has 
the ability to stabilize Cu(I) ions upon complexation towards oxidation and 
disproportionation. The ligand binds Cu(I) with 1:1, 2:1, and 3:1 ligand-metal 
stoichiometry with stability constants of log 1 = 2.63, log 2 = 4.02, and log 3 = 4.29 (27), 
respectively. These values were directly determined previously by Kamau et al. using a 
method based on the kinetics of Cu(I)-oxidation by Co(III) complexes, which did not 
require the measurement of Cu(II)/Cu(I) reduction potential and therefore acetonitrile 
could be used as a competing ligand  to cross-validate the logKCu(I)L value of PEMEA. 
Although the absolute binding affinity of PEMEA is much higher for an effective 
competition experiment with acetonitrile, its apparent affinity at pH 2 (logK′Cu(I)L = 9.0) is 
much lower due to the presence of two protonation sites in PEMEA. Therefore, at pH 2, 
PEMEA can compete with acetonitrile ligand for the Cu
+
 (aq) ions (Figure 2.8). The 
stability constant of PEMEA determined by this competition method (logKCu(I)L = 
15.71±0.02) is exactly the same as obtained from eqn. (2.28).  
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2.2.2.2. Stability Constant of MCL-1  
MCL-1 is one of the two water soluble tripodal ligands synthesized for this work 
where three sulfur donor atoms are connected to a central amine nitrogen through 
thiaether linkages. These tripodal ligands form 1:1 Cu(I)- complexes which are 
spectroscopically silent in the near-UV and visible region. Therefore, they can be used as 
competing ligands where the second ligand forms a colored complex or absorbs in near-





Figure 2.9. Determination of Formal Potential of MCL-1. Cyclic Voltammogram of 
MCL-1 (150 µM) in presence of CuSO4 (1 mM) at pH 5 (10 mM PIPBS, 0.1 M KClO4); 
scan rate 20 mV s
-1
. Green and blue traces correspond to the forward and the backward 
























Potential (V vs Ag/AgCl)
 59 
a) Cu(I) Affinity of MCL-1 from Thermodynamic Cycle (r2)  
In the presence of CuSO4, MCL-1 showed a quasi-reversible one-electron redox 
process with a half-wave potential of 0.716±0.001 V vs SHE (Figure 2.9). UV-vis 
titrations of the ligand with Cu
2+
 (aq) can be followed by the change in the absorption 
maximum of the Cu(II)-complex at 374 nm (Figure 2.10). This experiment yielded a 
logKCu(II)L of 6.42±0.02  which subsequently gave a calculated logKCu(I)L = 16.33 for the 
ligand. 
b) Cu(I) Affinity of MCL-1 from Competition with PEMEA (e2)  
In this competition titration, the Cu(I) complex of MCL-1, isolated as Cu(I)-
MCL-1, was used as the copper source. Since free aqueous Cu
+
 ions are unstable towards 
oxidation and disproportionation, this is a convenient method of supplying Cu(I) for the 
titration. Usually Cu(I)-acetonitrile complex is used in the literature as a copper 
metallation reagent. Salts of Cu(I)-acetonitrile complexes, e.g., [Cu(I)(CH3CN)4]PF6, 
[Cu(I)(CH3CN)4]BF4, are very stable when dissolved in acetonitrile, but aqueous solution 
of these salts are not stable towards oxidation. Therefore, to prevent aqueous Cu
+
 ions 
from oxidation, a considerable amount of acetonitrile has to be present in the titration 
medium as a Cu(I) stabilizing agent. In order to avoid introduction of another competing 
ligand (acetonitrile) besides the ligands of interest, we used pre-formed Cu(I) complex of 
one of the ligands in the competition titrations wherever applicable. At pH 5, PEMEA 
ligand competes with MCL-1 for Cu
+
 ions and from this competing equilibrium a 















Figure 2.10. Determination of Cu(II) Stability Constant of MCL-1: Titration of MCL-1 
with CuSO4. A. Green trace and blue trace correspond to the UV-visible spectra at 
[Cu(II)] = 0 and 971 µM, respectively. B. Absorbance change (black points) and curve fit 
(solid trace) for the titration. MCL-1 (50 µM) was titrated with CuSO4 at pH 5 (10 mM 
PIPBS, 0.1 M KClO4, 25 °C). Cu(II) stability constant value was then determined by 
non-linear least-squares fitting over the spectral range 300-450 nm using the SPECFIT 








Figure 2.11. Determination of Cu(I) Stability Constant of MCL-1: Titration of Cu(I)-
complex of PEMEA with MCL-1. A. Green trace and blue trace correspond to the UV-
visible spectra at [MCL-1] = 200 and 978 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. Cu(I)-complex of PEMEA was initially 
formed by the addition of 200 µM Cu-MCL-1 wherein Cu(I) ions would be distributed 
between 200 µM of MCL-1 and 96 µM of PEMEA acting as a competing ligand. Cu(I)-
complex of PEMEA was then titrated with MCL-1 at pH 5 (10 mM PIPBS, 0.1 M 
KClO4, 25 °C). Finally, Cu(I) stability constant value of MCL-1 was determined by non-
linear least-squares fitting over the entire spectral range using the SPECFIT software 




2.2.2.3. Stability Constant of BCA  
 , ′-Bicinchoninic acid (BCA) is a copper(I) chelator used in the measurement of 
protein concentration commonly known as BCA assay (43). Cu(I)-complex of BCA is 
purple in color and has a 1:2 metal-ligand stoichiometry. The redox process of BCA is 
irreversible, thus preventing determination of its stability constant value from the 
thermodynamic cycle.  In this case, we employed two competition experiments, one with 
PEMEA and another with MCL-1, to obtain a reliable stability constant value of BCA. 
a) Cu(I) Affinity of BCA from Competition with MCL-1 (e3).  
As discussed in section 2.2.2.2, MCL-1 is a useful ligand to compete with BCA 
for Cu
+
 ions since Cu(I)-MCL-1 does not absorb at 562 nm where [Cu(I)(BCA)2] 
complex absorbs. In this titration pre-formed Cu(I) complex of MCL-1 is used to 
metallate BCA. When BCA and Cu(I)-MCL-1 were mixed in equimolar ratio, 50% of 
BCA was metallated, thus assuring the formation of only 2:1 complex of BCA 
throughout the titration. Under this condition, UV-vis titration with MCL-1 ligand 
provided a stability constant value of 17.67±0.03 (Figure 2.12).  
b) Cu(I) Affinity of BCA from Competition with PEMEA (e4).  
The Cu(I)-complex of PEMEA absorbs below 400 nm, thus rendering it suitable 
as a competing ligand to the determine binding affinity of [Cu(I)(BCA)2] complex, which 
 bs rbs  t λmax = 562 nm.  [Cu(I)(BCA)2] complex was formed by the addition of 
[Cu(I)(CH3CN)4]PF6 to excess BCA (molar ratio BCA:Cu(I) = 2.5) to ensure the 
exclusive presence of a 1:2 metal-ligand complex. Spectrophotometric titrations were 
performed by monitoring the change in absorption at 562 nm by the addition of PEMEA 
(Figure 2.13). The value obtained by fitting the titration data over the entire spectral 







Figure 2.12. Determination of Cu(I) Stability Constant of BCA: Titration of Cu(I)-
complex of BCA with MCL-1. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-1] = 100 and 394 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. Cu(I)-complex of BCA was initially 
formed by the addition of 100 µM Cu-MCL-1 wherein Cu(I) ions would be distributed 
between 100 µM of BCA and 100 µM of MCL-1 acting as a competing ligand. Cu(I)-
complex of BCA was then titrated with MCL-1 at pH 5 (10 mM PIPBS, 0.1 M KClO4, 25 
°C). Finally, Cu(I) stability constant value of MCL-1 was determined by non-linear least-
squares fitting over the spectral range 450-700 nm using the SPECFIT software package 
(36). Average fitted value: log 2
Cu(I)








Figure 2.13. Determination of Stability Constant of BCA: Titration of Cu(I)-complex of 
BCA with PEMEA. A. Green trace and blue trace correspond to the UV-visible spectra at 
[PEMEA] = 0 and 227 µM , respectively. B. Absorbance change (black points) and curve 
fit (solid trace) for the titration. Cu(I)-complex of BCA was initially formed by the 
addition of 40 µM [Cu(I)(CH3CN)4]PF6 to 100 µM of BCA. Cu(I)-complex of BCA was 
then titrated with the competing ligand MCL-1 at pH 5 (10 mM PIPBS, 0.1 M KClO4, 25 
°C). Finally, Cu(I) stability constant value of BCA was determined by non-linear least-
squares fitting over the spectral range 450-700 nm using the SPECFIT software package 
(36). Average fitted value: log 2
Cu(I)









Figure 2.14. Determination of Cu(I) Stability Constant of MCL-2: Titration of Cu(I)-
complex of BCA with MCL-2. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-2] = 0.04 and 4.97 mM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. Cu(I)-complex of BCA was initially 
formed by the addition of 40 µM Cu-MCL-2 wherein Cu(I) ions would be distributed 
between 40 µM of MCL-2 and 100 µM of BCA acting as a competing ligand. Cu(I)-
complex of BCA was then titrated with MCL-2 at pH 7 (50 mM PIPES, 60 mM KClO4, 
25 °C). Finally, Cu(I) stability constant value of MCL-2 was determined by non-linear 
least-squares fitting over the spectral range 450-700 nm using the SPECFIT software 




The measured stability constant of BCA is different from a recently published 
data (log 2
Cu(I)
 = 17.3) where the binding affinity of BCA was indirectly derived from 
another copper chelator BCS (10). As a general description of this method, Cu(I) stability 
constant of a Cu(I)-binding protein was determined by competition with BCS, this value 
was subsequently used to obtain log 2
Cu(I)
 value of BCA from a separate competition 
experiment between the protein and BCA under the same experimental condition.  
Therefore, the literature value of BCA depends on accurate determination of the stability 
constants of BCS and the protein involved in the study. On the contrary, we determined 
the stability constants of BCA using two different copper sources (Cu-MCL-1 and 
[Cu(I)(CH3CN)4]PF6) and two different ligands (MCL-1 and PEMEA) by direct 
competition experiments. The stability constant values of BCA generated from these two 
independent experiments are reasonably close to each other. Based on these experiments, 
we derived an average log 2
Cu(I)
 value of 17.66 for BCA, weighted by the standard 
deviations of the individual methods. 
2.2.2.4. Stability Constant of MCL-2 (e5) 
MCL-2 is a water-soluble ligand and is based on a similar tripodal architecture 
comparable to MCL-1. This ligand showed a completely irreversible redox process 
suggesting large structural changes associated with the conversion from Cu(I) to Cu(II). 
Direct titration of the ligand with aqueous Cu
+
 ions was not possible because of the 
susceptibility of Cu
+
 ions towards oxidation and the lack of spectroscopic characteristics 
of Cu(I)-MCL-2 complex in the measurable window of UV-vis spectrum. Therefore, the 
binding affinity of this ligand was determined from a competition experiment with BCA 
for the Cu
+
 ions (Figure 2.14). Pre-formed Cu(I) complex of MCL-2 was used in this 
experiment as the copper source. MCL-2 indeed forms a weaker complex with Cu(I) 
(logKCu(I)L = 13.08±0.13) compared to other ligands characterized in this study. 
Moreover, potentiometric titrations showed that MCL-2 (logKH1 = 8.98) is much more 
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basic than MCL-1 (logKH1 = 7.00) resulting in a much lower apparent affinity at 
biologically relevant pH (logK′Cu(I)L = 10.99 at pH 7). Therefore, this ligand can be used 
as a copper source to metallate other ligands and proteins. Aqueous solution of Cu(I)-
MCL-2 is much more stable towards oxidation and disproportionation compared to 
Cu(I)-acetonitrile complex dissolved in pure water. Although Cu(I)-acetonitrile complex 
is very stable in acetonitrile-water mixture, presence of acetonitrile can alter the metal 
binding property of a protein by destabilizing its tertiary structure (44, 45).  
2.2.2.5. Stability Constant of BCS  
The use of bathocuproine as a copper(I)  he  t r     be   te  b  k t     0’s (46). 
Bathocuproinedisulfonic acid (BCS) is a water soluble analog of  bathocuproine (47). 
BCS is a high-affinity ligand which binds copper with 1:2 metal-ligand stoichiometry. 
The resultant Cu(I) complex has an absorption maximum at 483 nm, hence the binding of 
Cu(I) to BCS can be easily monitored by UV-vis spectroscopy. BCS binds both Cu(I) and 
Cu(II) with high affinities and thus precludes the measurement of both affinities by direct 
titration of the ligand with either Cu(I) or Cu(II) ions (see section 2.1.4). In a recent 
publication, Xiao et al. (10) determined the Cu(II) binding affinity of BCS at 3-4 mM 
concentration by Bjerrum’s meth   (48), where they followed the competition between 
Cu
2+
 ions and protons for BCS ligand by potentiometric titration. One of the major 
limitations of this approach is that at such high concentration of BCS, the potentials of 
reference electrodes typically used in potentiometry, silver chloride (Ag/AgCl) or 
calomel (Hg/Hg2Cl2), will fluctuate as BCS is capable of stable complex formation with 
both silver and mercury ions (49-52). In our laboratory, attempt to measure the 
protonation constant of BCS above 1 mM concentration was unsuccessful due to 
destabilization of the electrode potential. Moreover, BCS has been shown to undergo 
self-association at concentrations above about 1 mM (53), hence at that concentration the 
self-association equilibrium will also compete with the metal-binding equilibrium. 
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Theref re,  jerrum’s meth    s   t    r  er  h   e t  me sure  u  I)-stability constant 
of BCS, as a high concentration of the ligand is required for this method.   
In the current study, we determined the Cu(II) affinity of BCS from a direct 
competition titration with DHEAMP by spectrophotometric titration. Low millimolar 
concentration of BCS (0.3 mM) is sufficient for this method and thus the problem of 
aggregation can be avoided. 
a) Competition with DHEAMP: Cu(I) Affinity of BCS from Thermodynamic Cycle (r3) 
DHEAMP was first characterized by Damu et al. (38) as part of a series of metal 
complexation agents that bind to various metal ions (Figure 2.15). The first protonation 
constant (logKH1 = 6.94±0.01; Figure 2.3) and Cu(II) binding affinity (logKCu(II)L = 
9.21±0.01; Figure 2.16) of this ligand were verified in the current study and they agreed 
very well with the literature values (logKH1 = 6.92 and logKCu(II)L = 9.2). The second 
protonation constant of DHEAMP was not determined in this work because of its very 
low value (logKH2 = 1.16 as determined in ref. (38)). Such a low logKH value cannot be 
determined precisely and hence logKH2 of DHEAMP was not included in our SPECFIT 
model to calculate the Cu(II) binding affinity of the ligand. Moreover, buffer pH used in 
the titrations with DHEAMP was at least one log unit higher than the second protonation 
constant value, thus our stability constant values were not expected to change much with 














Figure 2.16. Determination of Cu(II) Stability Constant of DHEAMP: Titration of 
DHEAMP with CuSO4. A. Green trace and blue trace correspond to the UV-visible 
spectra at [Cu(II)] = 0 and 393 µM, respectively. B. Absorbance change (black points) 
and curve fit (solid trace) for the titration. DHEAMP (100 µM) was titrated with CuSO4 
at pH 2.11 (10 mM HClO4, 0.1 M KClO4, 25 °C). Cu(II) stability constant value was then 
determined by non-linear least-squares fitting over the entire spectral range using the 










Figure 2.17. Determination of Cu(II) Stability Constant of BCS: Titration of BCS with 
CuSO4 in presence of DHEAMP. A. Green trace and blue trace correspond to the UV-
visible spectra at [Cu(II)] = 0 and 390 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. BCS (300 µM) was titrated with CuSO4 
in the presence of 300 µM DHEAMP acting as a competing ligand at pH 6 (10 mM MES, 
0.1 M KClO4, 25 °C). Cu(II) stability constant value of BCS was then determined by 
non-linear least-squares fitting over the entire spectral range using the SPECFIT software 
package (36). Average fitted value: log 2
Cu(II)




The competition titration between BCS and DHEAMP for Cu
2+
 ion yielded 
log 2
Cu(II)
 = 12.42±0.07 for BCS (Figure 2.17). Copper bound to BCS showed a 
reversible redox process with a half-wave potential of 0.626±0.001 V vs. SHE (Figure 
2.18). Based on this data we obtained a value of log 2
Cu(I)
 = 20.81 for [Cu(I)(BCS)2]  
complex from eqn. (2.28). Although our log 2
Cu(II)
 of BCS differs by 0.6 log units 
compared to the value in ref. (10) (log 2
Cu(II)
  = 11.8), the calculated Cu(I) stability 
constant is one log unit higher than the previously published value (log 2
Cu(I)
 = 19.9). As 
discussed in section 2.1.4, this additional discrepancy is due to the different E
0
Cu(II/I)aq 
values used in eqn. (2.28). While we used 0.13 V as suggested by Bernardo et al. (14), 
Xiao et al. adopted the value 0.164 V from a different literature (13). This difference in 
E
0





Figure 2.18. Determination of Formal Potential of BCS. Cyclic Voltammogram of BCS 
(150 µM) in presence of CuSO4 (50 µM) at pH 5 (10 mM PIPBS, 0.1 M KClO4); scan 
rate 50 mV s
-1
























Figure 2.19. Determination of Cu(I) Stability Constant of BCS: Titration of Cu(I)-
complex of BCS with MCL-1. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-1] = 0 and 391 µM, respectively. B. Absorbance change (black points) 
and curve fit (solid trace) for the titration. Cu(I)-complex of BCS was initially formed by 
the addition of 5 µM Cu(I)-MCL-2  to 50 µM of BCS. Cu(I)-complex of BCS was then 
titrated with the competing ligand MCL-1 at pH 7 (10 mM PIPES, 0.1 M KClO4, 25 °C). 
Finally, Cu(I) stability constant value of BCS was determined by non-linear least-squares 
fitting over the spectral range 400-600 nm using the SPECFIT software package (36). 
Average fitted value: log 2
Cu(I)








Figure 2.20. Determination of Cu(I) Stability Constant of BCS: Titration of Cu(I)-
complex of BCS with MCL-1. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-1] = 50 and 978 µM, respectively. B. Absorbance change (black points) 
and curve fit (solid trace) for the titration. Cu(I)-complex of BCS was initially formed by 
the addition of 50 µM Cu-MCL-1 wherein Cu(I) ions would be distributed between 100 
µM of BCS and 50 µM of MCL-1 acting as a competing ligand. Cu(I)-complex of BCS 
was then titrated with MCL-1 at pH 7 (10 mM PIPES, 0.1 M KClO4, 25 °C). Finally, 
Cu(I) stability constant value of BCS was determined by non-linear least-squares fitting 
over the spectral range 400-600 nm using the SPECFIT software package (36). Average 
fitted value: log 2
Cu(I)





b) Cu(I) Affinity of BCS from Competition with MCL-1 (e7).  
The stability constant of [Cu(I)(BCS)2] complex was cross-verified from a 
competition titration with MCL-1 for Cu
+
 ions. In this method, [Cu(I)(BCS)2] complex 
was titrated with MCL-1 which was monitored by decrease in the absorbance at 483 nm 
 λmax of Cu(I) complex of BCS). Two different copper sources, pre-formed Cu(I)-MCL-2 
(Figure 2.19) and Cu(I)-MCL-1 (Figure 2.20), were used in these titrations to compare 
the stability constant values of BCS. Under both experimental conditions there were 
negligible concentrations of free Cu
+
 (aq) present as the Cu
+
 ions were either exclusively 
bound to BCS when Cu(I)-MCL-2 was used, or it was partitioned between BCS and 
MCL-1 in addition of Cu(I)-MCL-1. In both cases, spectrophotometric titrations revealed 
stability constant values (log 2
Cu(I)
 = 20.81±0.04 for Cu(I)-MCL-2 and 20.80±0.03 for 
Cu(I)-MCL-1) which matched exactly with that obtained from the thermodynamic cycle 
(log 2
Cu(I)
 = 20.81±0.08).  
2.2.2.6. Stability Constant of MCL-3  
MCL-3 is a water-soluble copper chelator, which is based on a 16-membered 
macrocycle with four sulfur donor atoms. The copper binding moiety of this ligand has 
no ionizable group, thus it has an unique advantage as an affinity standard as the Cu(I)-
binding affinity of MCL-3 is independent of the pH of the medium. 
a) Cu(I) Affinity of MCL-3 from Thermodynamic Cycle (r4)  
Titration of MCL-3 with Cu
2+
 (aq) at pH 5 gave us a stability constant value 
logKCu(II)L of 3.47±0.04 (Figure 2.22). However, cyclic voltammetry of Cu(I)/Cu(II)-
MCL-3 revealed a one-electron irreversible redox process with a large peak separation of 
90 mV (at 20 mV s
-1
 scan rate) and a E1/2 value of 0.729±0.003 V vs SHE (Figure 2.21). 
Given this large peak separation, the measured potential is not suitable to determine a 
reliable Cu(I) affinity based on thermodynamic cycle and the experimental Cu(II) 
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stability constant. Instead, Cu(I) affinity of MCL-3 was determined from two separate 





Figure 2.21. Determination of Formal Potential of MCL-3. Cyclic Voltammogram of 
MCL-3 (150 µM) in presence of CuSO4 (1 mM) at pH 5 (10 mM PIPBS, 0.1 M KClO4); 
scan rate 20 mV s
-1




b) Cu(I) Affinity of MCL-3 from Competition with BCS (e8) or BCA (e9)  
Derivation of Cu(I)-affinities of MCL-3 in competition with BCA or BCS for Cu
+
 
ion are based on the same general method. In both experiments, pre-formed Cu(I)-MCL-3 
was used to metallate the competing ligands (BCA or BCS). Titration of these copper 
complexes with MCL-3 was monitored by the change in absorbance either at 562 nm for 
BCA (Figure 2.23) or at 483 nm for BCS (Figure 2.24), where the free ligands do not 
absorb. The stability constant values obtained from both sets of data converged at 























Figure 2.22. Determination of Cu(II) Stability Constant of MCL-3: Titration of MCL-3 
with CuSO4. A. Green trace and blue trace correspond to the UV-visible spectra at 
[Cu(II)] = 0 and 198 µM, respectively. B. Absorbance change (black points) and curve fit 
(solid trace) for the titration. MCL-3 (100 µM) was titrated with CuSO4 at pH 5 (10 mM 
PIPBS, 0.1 M KClO4, 25 °C). Cu(II) stability constant value was then determined by 
non-linear least-squares fitting over the spectral range 300-700 nm using the SPECFIT 








Figure 2.23. Determination of Cu(I) Stability Constant of MCL-3: Titration of Cu(I)-
complex of BCA with MCL-3. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-3] = 100 and 682 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. Cu(I)-complex of BCA was initially 
formed by the addition of 100 µM Cu-MCL-3 wherein Cu(I) ions would be distributed 
between 100 µM of MCL-3 and 200 µM of BCA acting as a competing ligand. Cu(I)-
complex of BCA was then titrated with MCL-3 at pH 5 (10 mM PIPBS, 0.1 M KClO4, 25 
°C). Finally, Cu(I) stability constant value of MCL-3 was determined by non-linear least-
squares fitting over the spectral range 450-700 nm using the SPECFIT software package 







Figure 2.24. Determination of Cu(I) Stability Constant of MCL-3: Titration of Cu(I)-
complex of BCS with MCL-3. A. Green trace and blue trace correspond to the UV-visible 
spectra at [MCL-3] = 50 and 1020 µM, respectively. B. Absorbance change (black 
points) and curve fit (solid trace) for the titration. Cu(I)-complex of BCS was initially 
formed by the addition of 50 µM Cu-MCL-3 wherein Cu(I) ions would be distributed 
between 50 µM of MCL-3 and 100 µM of BCS acting as a competing ligand. Cu(I)-
complex of BCS was then titrated with MCL-3 at pH 5 (10 mM PIPBS, 0.1 M KClO4, 25 
°C). Finally, Cu(I) stability constant value of MCL-3 was determined by non-linear least-
squares fitting over the spectral range 420-600 nm using the SPECFIT software package 




2.2.3. Determination of Cu(I) Affinity of a Protein using Copper Ligands  
Accurate measurement of Cu(I) affinities of proteins is pivotal to understand the 
rationale behind the exchange of copper between protein partners leading to the 
distribution of cellular copper.  However, determination of metal binding affinities of 
copper proteins encounter similar challenges as discussed in section 2.1.4 including redox 
lability of aqueous Cu
+
 ions and usually high Cu(I) affinities of proteins inhibiting direct 
estimation of stability constants. Cu(I) binding sites in proteins are more susceptible 
towards oxidation as cysteine is the preferred ligand for Cu(I) among biomolecules (54). 
Additionally, precise estimation of protein concentrations is not trivial especially for 
proteins lacking tryptophan residue, such as hAtox1, Atx1, Copz, where concentration 
cannot be measured by absorbance of protein at 280 nm (55). Consequently, as discussed 
in section 2.1.4, the reported stability constants of copper proteins are largely 
controversial (Table 2.1). These values were often determined using competing ligands 
with divergent published Cu(I) affinities (Table 2.2). Therefore, the binding affinities of 
copper proteins found in the literature are not comparable, thus impeding the 
understanding of the molecular mechanism of copper homeostasis. The set of affinity 
standards thoroughly characterized in this work covers a broad range of stability 
constants (10
13
   10
21
) and hence they can be utilized to study Cu(I) binding of a wide 
array of proteins. The binding affinity of a copper chaperone, CusF, was determined in 
this work as a first example. 
CusF is a periplasmic copper chaperone protein found in Escherichia coli. In this 
protein, Cu(I) is bound by Met2His motif, which is typical in oxidizing environments 
including the periplasm (56). A tryptophan residue in the vicinity of the Cu(I) binding 






















MCL-3 Fluorescence 7.0 1.95 × 10
14
  
BCA UV-vis Spectroscopy 7.0 1.62 × 10
14
  
  7.0 6.31 × 10
13a 
(57) 











 This value was published as Kd ×  2 = 7.3 x 10
3
, where Kd is the dissociation constant of the protein 
and  2 is the overall stability constant of Cu(I)(BCA)2 complex. Using the  2 value from this work, we 
arrived at the tabulated value. 
b







Figure 2.26. Determination of Protein Concentration of CusF.  Mole-ratio titration of 
CusF with Cu(I) (provided by in-situ reduction of Cu(II)SO4 with 100 µM sodium 
ascorbate) at pH 7 (50 mM MOPS, 150 mM NaCl).  
 
 
2.2.3.1. Stability Constant of Cu(I) binding to CusF 
In this work, Cu(I) binding affinity of CusF was determined by competition 
titrations using the two affinity standards, MCL-3 and BCA (Table 2.6). 
a) Cu(I) Affinity of CusF from Competition with MCL-3 
Fluorescence emission of CusF at 343 nm decreases linearly with addition of 
Cu(I) and quenches almost completely at 1:1 Cu(I)-protein stoichiometry. The metal 
induced quenching is due to the close proximity of the Cu(I) ion to the indole side chain 
of the tryptophan residue. Therefore, the concentration of CusF can be measured directly 
from the saturation point of the anaerobic titration of Cu(I) (provided by in-situ reduction 
of Cu(II)SO4 with 100 µM sodium ascorbate) with the apo-protein (Figure 2.26). Cu(I)-
bound protein (holo-protein) prepared in situ can then be titrated with the ligand MCL-3, 
such that the metal will equilibrate between the apo-protein and the free ligand (Figure 























non-linear least-squares fitting of the fluorescence response over the entire spectral range 
using the SPECFIT software package.  
Cu(I) binding affinities of proteins are usually pH-dependent due to variability in 
the protonation of the amino acid side chains in and around the metal binding sites with 
the alteration in pH. However, there is no reliable method to determine the protonation 
constant of a protein, thus binding affinities of proteins are always reported as apparent 
affinities (See Section 2.1.3) at a given pH.  
b) Cu(I) Affinity of CusF from Competition with BCA 
The binding affinity of CusF was previously estimated by Xue et al. by 
competition titration with BCA (57).  However, in the absence of a cohesive value for 
log 2
Cu(I)
 of BCA, these authors reported only a relative affinity of  Kd ×  2 = 7.3 x 10
3
, 
where Kd is the dissociation constant of the protein and  2 is the overall stability constant 
of Cu(I)(BCA)2 complex. Substituting the  2 value of BCA from our work (log 2
Cu(I)
 = 
17.66) into the above relationship, we calculated the logKCu(I)L of 13.8 for CusF, which is 
0.5 log units lower than the value (logKCu(I)L = 14.29) determined by the competition 
titration with MCL-3. Due to this discrepancy, we reexamined the Cu(I)-affinity of CusF 
by direct competition with BCA under spectrophotometric monitoring.. Cu(I) was added 
to a solution of BCA in 1:3 molar ratio to ensure 2:1 binding. The absorption of the 
purple colored Cu(I)(BCA)2 complex at 562 nm decreases as the apo-protein being 
titrated (Figure 2.28). This is because of the shift in the initial metal binding equilibrium 
of BCA in presence of protein where both the ligand and the protein compete for the 







Figure 2.27. Determination of Cu(I) Stability Constant of CusF: Titration of Cu(I)-
complex of CusF with MCL-3. A. Green trace and blue trace correspond to the 
fluorescence spectra at [MCL-3] = 0 and 283 µM, respectively. B. Absorbance change 
(black points) and curve fit (solid trace) for the titration. 20 µM of Cu(I)-complex of 
CusF (Cu(I) was provided by the in-situ reduction of Cu(II)SO4 with sodium ascorbate) 
was titrated with the competing ligand MCL-3 at pH 7 (50 mM MOPS, 150 mM NaCl, 
25 °C). Finally, Cu(I) stability constant value of CusF was determined by non-linear 
least-squares fitting over the entire spectral range using the SPECFIT software package 








Figure 2.28. Determination of Cu(I) Stability Constant of CusF: Titration of Cu(I)-
complex of BCA with CusF. A. Green trace and blue trace correspond to the UV-visible 
spectra at [CusF] = 0 and 72 µM, respectively. B. Absorbance change (black points) and 
curve fit (solid trace) for the titration. Cu(I)-complex of BCA was initially formed by the 
addition of 16 µM [Cu(I)(CH3CN)4]PF6 to 50 µM of BCA. Cu(I)-complex of BCA was 
then titrated with CusF at pH 7 (50 mM MOPS, 150 mM NaCl, 25 °C). Finally, Cu(I) 
stability constant value of CusF was determined by non-linear least-squares fitting over 
the spectral range 450-700 nm using the SPECFIT software package (36). Average fitted 









Figure 2.29. Determination of Cu(I) Stability Constant of CusF: Titration of CusF with 
Cu(I) in Presence of BCA. A. Green trace and blue trace correspond to the UV-visible 
spectra at [Cu(I)] = 0 and 87 µM, respectively. B. Absorbance change (black points) and 
curve fit (solid trace) for the titration. CusF (65 µM) was titrated with 
[Cu(I)(CH3CN)4]PF6 in the presence of 80 µM BCA acting as a competing ligand at at pH 
7 (50 mM MOPS, 150 mM NaCl, 25 °C). Cu(I) stability constant value of CusF was then 
determined by non-linear least-squares fitting over the spectral range 450-700 nm using 





CusF can be easily expressed and purified in milligram quantities, but the yield of 
the purified proteins is often limited by reduced solubility or complex multi-step 
purification process. The titration strategy discussed above requires millimolar stock 
concentrations of the protein to avoid excessive dilution of the titration medium. 
Therefore, to determine binding affinities for proteins with limited yield, a modification 
of the above mentioned approach was examined in this work, where aqueous Cu(I) ions 
were added to a mixture of the apo-CusF and BCA. Since both BCA and CusF bind Cu(I) 
strongly, the concentration of free Cu
+ 
ion is negligible under this condition. The 
distribution of the Cu
+
 ions between BCA and the protein can be followed by the increase 
in the absorption of Cu(I)(BCA)2 complex at 562 nm (Figure 2.29). Cu(I) was added until 
~70% of BCA was bound to copper to ensure 1:2 stoichiometry of  Cu(I)(BCA)2 complex 
throughout the titration. Acetonitrile addition was confined to < 2% of the total volume to 
prevent any protein denaturation. The binding affinity values obtained by both methods 
converged at logKCu(I)L = 14.21±0.03. 
2.3. Conclusion 
Knowledge of Cu(I) stability constants of proteins is important to elucidate the 
mechanisms of cellular copper homeostasis. This information provides a guideline in 
tailoring the Cu(I)-affinities of synthetic fluorescent sensors to an optimum value which 
would be suitable for the detection of labile cellular copper. Furthermore, alteration in the 
original copper affinity of a protein is often associated with impaired copper transport 
resulting in a pathological condition. For example, a fatal neonatal hepatopathy can be 
linked to the P174L mutation in Sco1, where the substitution of a proline with a leucine 
reduces the Cu(I) binding affinity of the protein by a five orders of magnitude (60).  The 
mutated Sco1 thus becomes unsuitable for copper exchange with the chaperone Cox17 
which ultimately impairs the cascade of copper transfer reactions required for the CCO 
assembly in the mitochondria.  
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Accurate determination of Cu(I) stability constants of proteins critically depend 
on the Cu(I) affinity standards. This is because majority of the proteins bind the Cu(I) 
ions too tightly negating the measurement of their stability constants by direct titrations 
of proteins with Cu
+
 (aq) ions. Instead, the stability constants are determined from the 
equilibrium competitions between the proteins and the affinity standards for the same Cu
+
 
(aq) ions. However, the previously reported binding affinity values of the frequently used 
Cu(I) affinity standards are largely inconsistent impeding reliable data acquisition for the 
Cu(I) stability constants of proteins. In this chapter, we developed a set of affinity 
standards which included three new sulfonated thioether-based ligands that form 
colorless, water-soluble, and air-stable copper complexes and three previously reported 
Cu(I) chelators. The Cu(I)-complex stability constants of each of these ligands were 
determined and cross-validated by independent methods, namely thermodynamic cycle 
and equilibrium competitions. The results from this work constitute a web of accurately 
cross-verified Cu(I)-affinity standards encompassing a wide range of affinities which will 
be useful in determining binding affinities of copper proteins unequivocally. 
2.4. Experimental Methods 
2.4.1. Determination of Protonation Constants   
Protonation constants (logKHn) of PEMEA and BCA were determined by 
spectrophotometric titrations as a function of −log [H3O
+
]. For all other compounds, 
logKHn values were obtained from acid-base titrations. An ionic background of 0.1 M 
KCl was used in both methods. In all experiments, a combination glass electrode was 
calibrated for  log [H3O
+
] before and after the measurement of protonation constants. 
The calibration was done by acid-base titration of a 5 mM HCl solution (prepared from a 
volumetric standard) with 0.1 M KOH (volumetric standard added stepwise from a 
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motorized burette) at 0.1 M ionic strength (KCl). The endpoint, electrode potential, and 
s   e were  eterm  e  by Gr  ’s meth   using GLEE software (61). 
2.4.1.1. Acid-base Titrations  
The measurements of protonation constants were carried out at 25 °C in a titration 
cell fitted with a temperature-controlled jacket. For BCS, MCL-1, and MCL-3, a known 
amount of standardized HCl was added to the ligand solution to protonate them 
completely. Ligand concentration of BCS was kept at 1 mM to avoid substantial 
complexation of the Ag
+
 of the electrode, while 5 mM compounds were used for MCL-1 
and MCL-2. DHEAMP was isolated as a hydrochloride salt, thus addition of HCl was 
unnecessary and 5 mM of the compound was used for the titration. Solutions containing 
fully protonated compounds were then titrated with a standardized KOH solution (added 
stepwise from a motorized burette). The Hyperquad software (35) was used to analyze 
the potentiometric data to obtain the protonation constant values. 
2.4.1.2. Spectrophotometric Titrations  
Spectrophotometric titrations with PE E   t              concentrations were 
carried out by varying  log[H3O
+
] from 4 to 3 with the addition of HCl and from 4 to 8.2 
with the addition of KOH. Both data sets were combined by normalizing the spectra 
against the absorbance of the PEMEA at pH 4. The combined data were analyzed by 
nonlinear least-squares fitting over the entire spectral range using the Specfit software 
package (36). 
2.4.2. Determination of Formal Potentials of Cu(II/I) Redox Couple 
Cyclic voltammograms were acquired in 10 mM PIPBS buffer, pH 5, containing 
0.1 M KClO4 as the electrolyte using a CH-Instruments potentiostat (model 600A). 
Experiments were carried out in a single compartment cell with a glassy carbon working 
electrode, a Pt counter electrode, and an aqueous Ag/AgCl reference electrode (1 M 
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KCl). The half-wave potentials were referenced to ferrocenium (0.40 vs. SHE (62)) or 
ferroin (1.112 vs. SHE  (8)) as external standards. Measurements were typically 























PEMEA - CuSO4 10 mM PIPBS, 
100 mM KClO4, 
pH 5 (Buffer A) 





14 mM HClO4, 
100 mM KClO4, 
pH 2 (Buffer B) 
100 µM 958 mM 
 
0 - 236 
µM 
MCL-1 - CuSO4 Buffer A 50 µM - 0 - 971 
µM 
 PEMEA Cu(I)-MCL-1 Buffer A 200   
978 µM 
96 µM 200 µM 





Buffer A 100 µM 0 - 227 µM 40 µM 
MCL-2 BCA Cu(I)-MCL-2 50 mM PIPES, 
60 mM KClO4, 
pH 7 (Buffer C) 
0.04   
4.97 mM 
100 µM 40 µM 
DHEAMP - CuSO4 10 mM HClO4, 
100 mM KClO4, 
pH 2.11 (Buffer 
D) 




      
 90 


















DHEAMP CuSO4 10 mM MES, 
100 mM KClO4, 
pH 6 (Buffer E) 
300 µM 300 µM 0 - 390 
µM 
 MCL-1 Cu(I)-MCL-1 10 mM PIPES, 
100 mM KClO4, 
pH 7 (Buffer F) 
100 µM 50 - 978 µM 50 µM 
 MCL-1 Cu(I)-MCL-2 Buffer F 50 µM 0 - 391 µM 5 µM 
MCL-3 - CuSO4 Buffer A 100 µM - 0 - 198 
µM 
 BCA Cu(I)-MCL-3 Buffer A 100- 682 
µM 
200 µM 100 µM 
 BCS Cu(I)-MCL-3 Buffer A 0.05 -
1.02 mM 
100 µM 50 µM 
CusF 
Protein 
MCL-3 CuSO4 + 
ascorbate 
50 mM MOPS, 
150 mM NaCl, 
pH 7 (Buffer G) 
20 µM 0 - 283 µM 20 µM 
 BCA Cu(I)-
Acetonitrile 
Buffer G 0 -72 µM 50 µM 16 µM 
 BCA Cu(I)-
Acetonitrile 




2.4.3. Determination of Stability Constants of Copper Ligands 
Table 2.7 summarizes the details of the experimental conditions used in the 
measurement of stability constants of copper ligands, namely the composition of the 
titration medium; nature of the competing ligand and the copper source; individual 
concentrations of the components including ligand being measured, the competing ligand, 
and the copper.  
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As a general consideration, spectrophotometric titrations were carried out under 
anaerobic condition in a septum-fitted air tight cuvette. All solutions including buffers, 
acetonitrile, and deionized water were thoroughly degassed before use. Usually reagent 
solutions, especially preformed copper-complexes, were prepared fresh inside a nitrogen 
tent; in case an old stock solution of free ligand was used, it was degassed thoroughly. All 
solutions were added with air-tight syringes. 50-100 µM sodium ascorbate was added as 
a reducing agent for competition titrations with Cu
+
 ions where the apparent affinity of 
one of the ligands is low, e.g., PEMEA-acetonitrile titration. Concentrations of reagents 
were corrected for dilution before fitting the experimental data with the Specfit software. 
2.4.4. Expression and Purification of CusF 
E. coli BL21(DE3) cells containing the pASK-IBA3 plasmid (a gift from Dr. 
M.M. McEvoy) with the gene encoding CusF residues 6-88, were grown in LB media 
containing 100 mg/L ampicillin with shaking at 37 °C. The cells were grown to an optical 
density at 600 nm of 0.6 - 1.1, and then protein expression was induced with 0.8 mg/L 
anhydrotetracycline (AHT). After 5 hours, the cells were harvested by centrifugation and 
the pellet was stored at  80 °C. The cell pellet was thawed and resuspended in buffer G 
and  CusF was extracted by three rounds of freezing and thawing of the suspended cells 
followed by agitation for 1 h at 4 °C. The cell extract was centrifuged at 6000 g for 15 
min at 4 °C and the supernatant was stored at  80 °C. Before purification, the supernatant 
was concentrated with a 3K microsep centrifugal device (Pall Life Sciences) and applied 
to a Superdex 75 gel filtration column equilibrated with Buffer G for purification. 
Fractions containing CusF were pooled, concentrated, and applied to the Superdex 75 
column for another round of gel purification. Fractions containing pure protein were 
confirmed by Laemmli-SDS-PAGE, pooled, concentrated, and stored at  20 °C in the 
elution buffer. The protein was used within two days of purification. 
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2.4.5. Determination of Stability Constant of CusF 
Protein concentration of CusF was determined from the absorbance of the 




 as calculated by ExPASy 
software ProtParam (63). The concentration was verified from the mole-ratio titration of 
CusF with Cu(I) generated in situ by the reduction of CuSO4 with sodium ascorbate. 
Concentrations of BCA and Cu(I) were verified from a separate mole-ration titration 




 was used 
for Cu(I)(BCA)2 complex at 562 nm (10). The experimental conditions for the 
competition titrations between CusF and MCL-3 and CusF and BCA are compiled in 
Table 2.7. 
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IN-SITU VISUALIZATION OF BIOLOGICAL COPPER WITH A 
WATER SOLUBLE FLUORESCENT PROBE:  
IN-GEL DETECTION OF A COPPER CHAPERONE  
 
In this chapter, the thermodynamic properties of a water soluble, high contrast 
Cu(I)-selective fluorescent probe CTAP-2 were determined. This is the first fluorescent 
probe among Cu(I)-sensors found in the literature which dissolves completely in water 
without formation of colloidal nanoparticles. This probe was utilized to develop a novel 
in-gel detection method of a copper chaperone under non-denaturing conditions. This 
work was published in the Journal of the American Chemical Society (1).  
3.1. Background 
The identification of genes and proteins involved in copper homeostasis greatly 
facilitated our understanding of the mechanisms of copper regulation (2), however, the 
knowledge about cellular distribution of copper during normal physiological function and 
its alteration in diseases are still limited. For example, little is known about the 
subcellular organelles and biomolecules including proteins and small molecules that are 
involved in transiently storing copper ions prior to their incorporation into copper-
proteins. Many efforts have been directed towards developing highly sensitive analytical 
techniques and instruments which will be useful for the in situ analysis of copper ions as 
well as for the understanding of copper speciation in biomolecules within the native 
physiological environment. This section will provide a brief overview of the key 
achievements in the rapidly evolving research area of detecting biological copper and 




3.1.1. In-Situ Detection of Cellular Copper  
The analytical techniques that were developed to furnish information about 
cellular copper status can be broadly classified into three categories: a) bulk techniques, 
like ICP-MS and AAS, to examine the total copper ion content of a cell; b) imaging 
techniques, exemplified by XRF, LA-ICP-MS, and SIMS, that provide knowledge about 
spatial distribution of the copper ions; and c) histochemical dyes and Cu(I)-selective 
fluorescent probes which are useful to capture the kinetically labile copper ion pool. The 
three categories provide distinct, yet complementary, information regarding copper 
homeostasis. For example, quantification of the total copper ion content in a cell (as in a) 
can report the movement of the metal into or out of the cell under different physiological 
conditions. The analytical techniques that reveal the copper topography of a cell (as in b) 
does not distinguish between the protein-bound and labile copper and is therefore of 
particular value in elucidating the speciation of the total cellular copper pool. Conversely, 
copper indicators (as in c) rely on a competitive exchange of copper ions with native 
endogenous ligands and hence only the labile fraction of the total cellular copper can be 
probed by this method. 
3.1.1.1. Methods to Probe Bulk Copper Concentration 
Atomic absorption spectrometry (AAS) and inductively coupled plasma mass 
spectrometry (ICP-MS) are extensively employed for the determination of the total trace 
element concentration in biological samples. These methods are useful in those studies, 
where knowledge of the total trace element content is sufficient without the need for 
speciation. In most cases, trace elements are determined in the bulk of biological extracts 





a) Atomic Absorption Spectroscopy (AAS) 
Atomic-absorption spectroscopy (AAS) uses the absorption of light to measure 
the concentration of gas-phase atoms by following the Beer-Lambert law. The atoms 
absorb ultraviolet or visible light and make transitions to higher electronic energy levels. 
The amount of energy required and as such the wavelength of the absorbed radiation is 
specific to a particular electron transition in a particular element, which gives the 
technique its elemental selectivity. Concentration measurements are usually determined 
from a working curve after calibrating the instrument with standards of known analyte 
concentration. In order to analyze a liquid or solid sample for its atomic constituents, it 
has to be atomized. The techniques most widely used for this purpose include flames and 
electrothermal (graphite tube) atomizers.   
AAS has a wide range of applications in determining copper content in a variety 
of biological substances including human serum, urine, saliva, tooth samples, bone tissue, 
and hair sample (3). This technique has also been successfully used to investigate role of 
copper ions in various diseased conditions. For example, high urinary copper is a 
diagnostic feature of Wilson’s disease linked to liver malfunction (4, 5) and AAS is often 
employed to measure copper content of urine in clinical laboratories (6). Similarly, AAS 
revealed elevated copper concentration associated with other diseases, for example, 
breast cancer (7, 8), rheumatoid arthritis (9), bladder cancer (10), colorectal cancer (11), 
coronary heart disease (12),  and alcoholic liver disease (13). 
Atomic-absorption spectroscopy is a fast inexpensive detection method, and 
sample preparation and instrumentation are easy to handle without substantial technical 
training. However, the sensitivity of the technique is low with the detection limits 





b) Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
In ICP-MS, a high-temperature inductively coupled plasma source composed of 
ionized argon gas converts the atoms of the elements in the sample to ions. These ions are 
then separated and detected by the mass spectrometer. The ability to filter ions on their 
mass-to-charge ratio allows ICP-MS to supply isotopic information, since different 
isotopes of the same element have different masses. Because the ion signal received by 
the detector is proportional to the initial concentration in the sample, the technique can be 
used for quantitative trace element speciation through calibration with known standards. 
ICP-MS is one of the most widely used mass spectrometric techniques for the analysis of 
trace elements because of its isotope specificity, versatility, high sensitivity (detection 




) (15, 16).  
Although ICP-MS can be successfully used for trace element analysis in 
biological tissues and fluids (3, 17-19), the potential of this method is best harnessed as a 
hyphenated technique combined with chromatographic separation of 
metallobiomolecules including metalloproteins. One of the most favored methods for a 
rapid semi-quantitative screening for the presence of metal–protein complexes in 
biological samples has been the coupling of size exclusion chromatography (SEC) and 
ICP-MS. SEC allows the fractionation of the metalloproteins as a function of size prior to 
elemental detection. Several SEC-ICP-MS applications exploited the capability of ICP-
MS to detect a single or multiple metals in separated protein fractions (20-22). However, 
the chromatographic purity of such fractions is usually low and the identity of the metal-
binding species cannot be assigned by this method. 
ICP-MS is sometimes coupled with high-performance liquid chromatography 
(HPLC) to identify metal containing protein fractions. This is often used as a second 
separation step after size exclusion chromatography to achieve a higher degree of purity 
of the fractionated metal species. For example, SEC followed by anion exchange (AE) 
HPLC was performed to study the Cu accumulation and turnover in marine animals (23).  
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Capillary electrophoresis (CE) combined with ICP-MS is becoming increasingly 
popular to analyze metalloproteins as CE is less susceptible than HPLC to generate 
artifacts due to the metal exchange by interaction with the stationary phase. CE also 
offers additional advantages that are attractive for biological research, such as a small 
sample size and very high-resolution. However, CE-ICP-MS applications, thus far, 
mainly involved studies of metal-binding to metallothioneins (24). The reason is that the 
proteins with higher molecular mass increases the risk of adsorption on the capillary wall 
and thus preventing the analysis of such proteins (25). 
The major problem for the metal detection in biological systems is the low 
concentration of the trace metals present in a biological tissue. This is further complicated 
by the fact that these endogenous trace metals of already low concentrations are usually 
distributed among several biomolecules and thus demanding the development of 
instrumental techniques with high detection sensitivity. In that regard, inductively 
coupled plasma mass spectrometry coupled with a chromatographic separation mode is 
virtually the only technique for element-specific detection that is compatible with the 
trace element concentrations in bulk biological materials. The major limitation of these 
hyphenated techniques is the contamination from the adsorbed metal ion impurities on 
the stationary phase as they can exchange with the native metal ions in a protein or can be 
scavenged by ligands from the biological extract leading to ghost signals. Moreover, ICP-
MS does not allow the identification of the metal-containing species, hence the fractions 
separated by liquid chromatography have to be analyzed with mass spectrometry and the 
faithfulness of such identification depends on the purity of the separated fractions. 
3.1.1.2. Bioimaging to Reveal Copper Topography 
The characterization of the copper biochemistry of a cell is not complete with the 
studies of its genome and proteome, but it is critically dependent on the distribution of the 
metal among the different species in various cellular compartments. Therefore, 
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bioimaging of copper, which produces spatially resolved concentration maps of the metal 
in the cell, provides valuable information about the intracellular metal speciation and in 
some cases also characterizes the copper coordination sites in situ. Several 
microanalytical techniques, such as X-ray fluorescence, SIMS, LA-ICP-MS, offer micron 
to sub-micron spatial resolution and have detection limit around 0.1 to 100 µg g
-1
 and 
thus have been suitable to probe trace metal speciation in a cell (26). The 
instrumentations of these imaging modes are continually progressing in order to improve 
the spatial resolution and detection sensitivity of metal analysis.  
a) X-ray fluorescence (XRF) 
In XRF-based imaging, the inner shell electrons of atoms are excited and 
ultimately relax to the ground state with the emission of photons which correspond to a 
measurable X-ray fluoresceence. Because the emitted X-ray energy depends on the 
nuclear charge, each element has unique emission energy, so this technique allows for 
multi-element analysis of a single sample. XRF provides qualitative and quantitative 
information on the topography, concentration and oxidation state of copper ions (27). 
Another advantage of the XRF imaging is that the sample is not ablated during the 
measurement. Depending on the mode of excitation, XRF analytical techniques can be 
categorized into three different classes: electron probe X-ray microanalysis (EPXMA) 
which uses an electron beam to excite the sample, proton or particle induced X-ray 
emission (PIXE) where a proton beam is the excitation source, and synchrotron X-ray 
fluorescence (SXRF) which is based on excitation with X-ray.  
Among the above-mentioned X-ray-based techniques, SXRF has the highest 
elemental sensitivity and together with submicron resolution and high penetration depth 
this technique has been proven to be useful for analyzing biological samples (28, 29). 
SXRF microscopy can also provide information regarding the oxidation state and 
coordination environment of metals by scanning the incident X-ray energy across the 
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absorption edge of an element of interest and by measuring the photons transmitted 
through the sample, this method is known as X-ray absorption near-edge structure 
(XANES) spectroscopy. In a study where SXRF microscopy was employed to explore 
the subcellular localization of copper in NIH 3T3 mouse fibroblast cells supplemented 
with 150 µM CuCl2, XANES spectra showed a near-edge feature that is characteristic for 
low-coordinate monovalent copper ion, thus consistent with the reducing environment of 
the cytosol (30). 
Synchrotron X-ray fluorescence microscopy was also applied to compare the 
cellular copper topology and concentration in disease states with the normal 
physiological conditions. Farquharson et al. applied SXRF to investigate the quantity and 
spatial distribution of trace metals in breast cancer cells (31, 32). The studies revealed an 
increase in all measured metal concentrations, particularly for Zn and Cu, in the tumor 
areas of the studied samples. Further analysis with XANES spectroscopy indicated that 
Cu is present as a mixture of its monovalent and divalent oxidation states, for both 
normal and cancerous tissue.  
The major shortcoming of the SXRF technique is the radiation damage of the 
biological sample because of the use of the high energy excitation source. To control the 
effects of radiation damage which includes decrease in spatial resolution, freeze-drying is 
the method of choice to preserve the elemental content. However, this method is not 
optimum to preserve the innate three dimensional structure of the specimen or its 
substructure. Therefore, it is challenging to colocalize the elemental speciation with 
subcellular organelles which are typically visualized by organelle-specific fluorescent 
markers or immunofluorescence prior to the freeze-drying. In order to circumvent this 
problem, SXRF has to use appropriate organelle-specific markers labeled with a heavy 
xenobiotic element which could be directly measured by SXRF at the time of elemental 
analysis (33).  
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b) Secondary Ion Mass Spectrometry (SIMS) 
In this technique, the surface of the solid specimen is sputtered during 
bombardment with a focused primary ion beam. The secondary ions generated from the 
surface of the sample are separated using their mass to charge ratio measured with a mass 
spectrometer. Therefore, SIMS imaging is able to determine the elemental, isotopic, and 
molecular composition of the specimen surface. SIMS is multielemental with isotopic 
capability, characterized by detection limits of 0.1–1 μg/g, and spatial resolution of 50 
nm, and thus making it suitable for cellular imaging. For example, SIMS was used to 
develop an improved diagnostic tool for Wilson’s disease by detecting copper in micro-
scale biopsies (34). This study was done with a murine model of Wilson’s disease and as 
expected a 40–50 times higher Cu concentration was measured in the disease tissue as 
compared to the control mouse.  
Since the surface of the specimen is sputtered by a primary ion beam, SIMS is 
destructive to the specimen. SIMS experiments can also be difficult to perform because 
the technique requires specimens to be compatible with the use of ultra-high vacuum as 
encountered during the analysis. Furthermore, due to considerable matrix effects SIMS 
can only provide qualitative images of elements from the top atomic layer of biological 
tissues. 
c) Laser Ablation Inductively Coupled Plasma Mass Spectrometry (LA-ICPMS) 
In LA-ICP-MS, the sample material can be directly ablated from the surface by 
using a focused laser beam. The evaporated material is then transported with a carrier gas 
into an ICP-MS instrument for trace element analysis. Mass spectrometer separates ions 
by their mass-to-charge ratio and hence isotopic information can be attained by this 
method. Furthermore, since the laser ablates only one area at a time, this technique results 
in high positional precision. Because of high sensitivity of LA-ICP-MS, this technique is 
emerging as a method of choice for soft tissue analysis and it has been primarily used in 
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neurological research where metal speciation in brains from patients with neurological 
diseases are compared with healthy individuals. Centering around LA-ICP-MS imaging, 
Becker laboratory developed highly sophisticated analytical BrainMet techniques 
(BrainMet – Bioimaging of Metals in Brain and Metallomics) (35, 36), which have been 
routinely used to study the distribution and quantity of trace metals (e.g., Cu, Zn, Fe, Mo, 
Na, K, and Mg) in thin tissue sections of brain samples (37-42). These techniques were 
applied to understand change in metal speciation in various disease conditions, such as 
brain tumor (38, 40, 43, 44), Alzheimer’s disease (45), and Parkinson’s disease (37).  
Although new biological applications of LA-ICP-MS are evolving, this method is 
still not being used extensively. The limited application of LA-ICP-MS in biological and 
medical research can be explained by difficulties in the laser ablation of biological 
matrices, destructive nature of the technique unsuitable for live-cell imaging, the lack of 
convenient quantification procedures, and relatively high price of modern and powerful 
laser ablation systems with a good resolution power suitable for cellular imaging.  
3.1.1.3. Detection of Kinetically Labile Copper 
As discussed in Section 1.3, the intracellular environment is devoid of free copper 
ions of either valence state to protect cells from deleterious oxidative damage. However, 
the rapid exchange of cellular copper with the extracellular medium indicates that not all 
copper ions are strongly chelated by proteins. This kinetically labile pool is instrumental 
in visualizing the bioavailable copper as it can exchange between the endogenous protein 
ligands and synthetic copper indicators. Although the labile copper pool constitutes only 
a portion of the total cellular copper, the fluctuation in this pool may induce cellular 






a) Histochemical Dyes 
Historically, imaging of kinetically labile copper has been accomplished by 
histochemical techniques where thin sections of tissue or cultured cells were stained with 
chromogenic indicators for the in situ visualization of copper ions. One of the most 
widely used indicators for Cu is rubeanic acid (dithiooxamide), which was developed by 
Okamoto et al. (46) in 1938. In alcoholic solution, rubeanic acid forms a dark green 
precipitate of polymeric copper rubeanate with Cu(II) ions. With a detection limit of 
approximately 6 μM for Cu(II), rubeanic acid is not sufficiently sensitive for visualizing 
labile copper levels present in normal tissue; however, it has been successfully applied to 
demonstrate elevated copper levels in various tissues of Wilson’s disease patients, 
including the liver, central nervous system (CNS), and kidney (47-49). Over the times 
various research groups have explored the utility of additional stains for the detection of 
copper, including diphenylcarbazide and rhodanine (p-dimethylaminobenzylidene-
rhodanine) introduced by Okamoto et al.  (50, 51); sodium diethyldithiocarbamate 
(DEDTC) by Waterhouse et al. (52); and orcein by Shikata et al. (53). A brief review on 
the applications and the limitations of these histochemical dyes was provided by McRae 
et al. (28). 
Because chromogenic indicators lack the sensitivity for detecting the low 
concentrations of copper in normal biological samples, their applications are mostly 
limited to the diagnosis of pathological conditions typically associated with excess 
copper accumulations. Moreover, because these dyes need to compete with the 
endogenous biological ligands, they are only suitable for the visualization of the 
histologically reactive fraction of loosely bound labile copper ions.  
b) Cu(I)-Selective Fluorescent Probes 
Compared to chromogenic histochemical dyes, fluorescent probes offer much 
greater detection sensitivity, metal specificity, and spatial resolution. Due to their small 
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molecular size, fluorescent sensors may passively diffuse across cell membranes and are 
thus well suited for the noninvasive imaging of kinetically labile metal pools in living 
cells (54). However, compared to redox-inactive cations such as Mg (II), Ca(II) and 
Zn(II) (55, 56), the design of fluorescent probes for Cu(I) is more challenging due to 
interfering quenching pathways. In order to overcome the Cu(I)-induced quenching, 
Fahrni lab pioneered a design strategy that relies on PET switching mechanism (Section 
3.2.2) to develop the first Cu(I) turn-on sensor CTAP-1 (30) based on a 1,3-diaryl-2-
pyrazoline fluorophore platform. Imaging experiments with mouse fibroblast cells 
supplemented with copper revealed that CTAP-1 fluorescence was localized in the 
mitochondria and Golgi apparatus, indicating the presence of labile copper in these 
regions. The cellular staining pattern of CTAP-1 also qualitatively colocalized with the 
elemental copper distribution as visualized by X-ray fluorescence microscopy (micro-
XRF). However, the contrast ratio (fe) of CTAP-1 i.e., the fold increase in fluorescence 
emission upon saturation with Cu(I) is relatively low (fe = 4.6). This limits the 
applicability of this probe in bioimaging because it is difficult to distinguish between 
fluctuations of cellular Cu(I) availability and local variations in probe concentration.  
In addition to CTAP-1, Chang laboratory also developed several Cu(I) turn-on 
probes based on the PET mechanism. The coppersensor 1 (CS 1) (57, 58), which utilizes 
a BODIPY fluorophore, exhibits a contrast ratio of 10 in HEPES buffer at pH 7. 
Replacement of the fluoro substituents on the BODIPY dye with methoxy groups yielded 
CS3 (59), which exhibits a much improved fluorescence contrast over CS1 (fe = 75). 
Imaging studies with human embryonic kidney cells (HEK293T) revealed a decrease in 
the fluorescence intensity of CS3 in cells grown in media treated with the membrane-
impermeable copper chelator bathocuproine disulfonate (BCS) when compared to basal 
media. Furthermore, combined micro-XRF and fluorescence imaging studies with CS3 
indicated a calcium-dependent copper translocation in neuronal cells. Based on the same 
Cu(I)-binding moiety as CS1, a mitochondrial-targeted copper sensor, Mito-CS1, was 
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developed by conjugating a lipophilic triphenylphosphonium cation to the BODIPY 
fluorophore (60). Built upon a cyanine 7 (CY7) near-infrared (NIR) fluorophore 
platform, Chang group has recently reported a copper sensor CS790 with near-infrared 





 mice, a murine model of Wilson’s disease. A similar Cu(I)-responsive NIR 
probe was developed by Cao et al. where the CY7 NIR fluorophore was conjugated with 
a Cu(I)-binding moiety similar to CS1. Additionally, Lim et al. introduced a two-photon 
Cu(I) sensor, ACu1 (62), which showed  high photostability in visualizing labile copper 
distribution in live cells and tissues. 
3.1.2. In-Gel Detection of Copper Bound to Protein 
Recently, detection of metals in protein gels has attracted considerable attention, 
the principal techniques including autoradiography, synchrotron radiation XRF, and LA-
ICP-MS. However, it is worth mentioning that these techniques can only detect the 
presence of metal ions in a gel spot. The identification of proteins in a spot was 
accomplished after tryptic digestion followed by mass spectrometry (MS) which in most 
cases cannot detect the intact metal-protein complexes. This is even more complicated by 
the fact that several proteins can overlap in a single gel spot. Therefore, it is difficult to 
prove conclusively that the protein identified by MS was the same protein that was 
analyzed for the metal content. Accordingly, correlation of a metal with a particular 
protein has to be ultimately established by further experimentations with the purified 
protein. Another difficulty associated with in-gel metal imaging is the loss of the 
endogenous metal ion from the protein. This limitation is primarily attributed to several 
factors that influence the protein metallation state during gel electrophoresis, including 
native versus denaturing electrophoresis, choice of trailing ion in the running buffer, 




a) X-ray Fluorescence 
SXRF analysis is multielemental and quantitative; the surface of the fluorescence 
peaks is directly proportional to the concentration of the elements within the sample (64). 
The one-dimensional IEF protein separation under non-denaturing conditions followed 
by SXRF has been successfully applied for the differentiation of metalloprotein content 
between tumor cells and surrounding normal tissues from hepatocellular carcinoma 
patients (65). While the detected Cu-containing proteins were very similar to their 
surrounding tissues, a decrease of Fe and Zn metalloprotein content in tumors was 
suggested. Recently, Raimunda et al. utilized non-denaturing two-dimensional gel 
electrophoresis to separate proteins and to investigate the metalloproteome of two 
microbial systems, Shewanella oneidensis and Pseudomonas aeruginosa, by XRF (66). 
This group pioneered methods for the native 2D gel electrophoresis separation of 
complex biological samples that are compatible with XRF analysis. This is an important 
contribution in the study of metalloproteins by XRF because 2D gel traditionally provides 
better separation of protein spots compared to 1D gel. 
One of the unique features of X-ray based imaging is that it can provide 
information about coordination geometry and oxidation state of the metal site by 
combining XRF with XANES spectroscopy (See 3.1.1.2.a). Chevreux et al. (67) used 
XANES on IEF gels to determine the coordination environment of copper and zinc in 
bovine and human copper zinc superoxide dismutase. This study showed that zinc is 
present in its Zn(II) oxidation state in all analyzed isoforms of SOD as expected. Copper 
is present in the Cu(II) oxidation state in the main acidic isoform, while it is found in both 
Cu(II) and Cu(I) states in the main basic isoform. 
Synchrotron radiation based methods for metalloprotein studies offer the 
identification, quantification, and speciation of metals in protein bands simultaneously by 
combining SXRF and XANES on the same sample. However, the detection limit offered 
by SXRF, about 0.1 µg g
-1
, is worse than autoradiography and LA-ICP-MS, which means 
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that only highly expressed proteins can be identified. This method is also time-consuming 
as proteins separated on a gel often have to be transferred on a blot and dried before XRF 
measurements. Moreover, another obvious limitation of synchrotron radiation based 
methods is the access to a synchrotron facility.  
b)  LA-ICP-MS 
Laser-ablation ICP-MS offers an attractive tool for the in-gel scanning of the 
protein spots for the presence of metal ions. Because of its high positional accuracy, a 
plot is obtained in which the quantity of a given metal is related to its position in the gel. 
Detection by LA-ICP-MS is also high throughput, because no further treatment of the gel 
after protein separation is required, and the output signal is, theoretically, directly 
proportional to the quantity of the trace element in the gel.  
LA-ICP-MS has been used extensively by Becker et al. (68-75) to detect metal-
containing proteins in brain tissues, especially with respect to Cu, Zn, and Fe. The 
detection limits for P, S, Cu, and Zn were determined in singular protein spots with 
0.0013, 1.29, 0.029, and 0.063 mg g
-1
 respectively (76). Following LA-ICP-MS the 
individual protein spot containing metal ions can be excised and digested by trypsin 
enzyme to form peptide fragments in order to identify the protein by MALDI-MS and 
database search. 
The main advantage of LA-ICPMS for in-gel detection of metals is that the 
screening of separated protein spots in a two-dimensional gel and the qualitative 
measurements of a multitude of protein spots was performed in just a few hours. 
Moreover, LA-ICP-MS offers high sensitivity, multi-elemental capacity, and isotopic 
resolution. However, elemental analysis of the gels by LA-ICP-MS is far from routine, 
primarily because of its destructive mode of operation. LA-ICP-MS ablates a small spot 
of the protein gels which causes two problems, first, because of the small volume of the 
ablated spot less abundant proteins are difficult to analyze for their metal content, and 
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second, the remaining amount of protein on the gel after ablation may not be sufficient 
for MS analysis in case of proteins with low expression. Furthermore, quantification of 
metal content using LA-ICP-MS can sometimes be difficult due to matrix effects. 
c) Autoradiography 
A relatively new method in metalloproteomics involves in-gel autoradiographic 
detection of a radioactive metal ion to study the proteome associated with that particular 
ion (77). This method is known as Metal Isotope native RadioAutography in Gel 
Electrophoresis (MIRAGE), and this has been applied to investigate the soluble Cu, Zn, 






Fe respectively (78, 79). MIRAGE involves four steps: i) labelling of target proteins 
with a radioisotope by adding the radioactive metal in the culture medium; ii) separation 
of holo-proteins using two-dimensional gel electrophoresis, where native isoelectric 
focusing (1D) is combined with Blue Native PAGE (2D); iii) visualization and 
quantification of the radioactive metal using autoradiography; and iv) protein 
identification by mass spectrometry.  
The advantage of MIRAGE is that all the proteins that contain a particular metal 
ion can be visualized on a single native gel in a non-destructive manner. MIRAGE 
records the radioactive signal of a particular metal ion which is not the natural isotope 
found in the environment, hence this method is less susceptible to contamination. The 
radioactive signal can also be quantified easily against commercially available standards. 
However, unlike LA-ICP-MS and XRF, MIRAGE is not multielemental. Moreover, this 
technique requires short-lived radioisotopes which may be difficult to obtain and work 






3.2. Copper(I) Selective Fluorescent Probes 
Copper is mostly present in its monovalent oxidation state (Cu
+
) inside the 
reducing cellular environment. Therefore, copper(I) selective fluorescent probes can 
serve as an important analytical tool to detect cellular copper pool. Similar to other 
fluorescent sensors, they have several advantages in biological applications including 
high optical sensitivity, submicrometer spatial resolution, and non-invasive imaging 
modality. However, redox lability of Cu
+
 ion poses unique challenges in designing 
effective Cu(I)-selective fluorescent probes. This section will elaborate on the challenges 
and key strategies in developing fluorescent Cu(I) sensors.     
3.2.1. Challenges in Designing Copper(I) Selective Fluorescent Probes  
In order to comprehend the underlying challenges in designing Cu(I) selective 
fluorescent probes for biological applications, first we need to understand the key 
features of cellular copper regulation. The dietary copper predominantly exists in its +2 
oxidation state (Cu
2+
), but inside the reducing cytosolic environment (-260 mV) (80) 
copper is presumably present in form of Cu(I). However, free aqueous Cu
+
 is redox labile 
and hence is susceptible towards oxidation and disproportionation in presence of oxygen. 
Additionally, aqueous Cu
2+
 is also highly reactive toward the ubiquitous intracellular free 




 in millisecond time scale (54). 
Therefore, free aqueous copper ions of either oxidation state are incompatible with the 
intracellular environment, which typically contains high concentrations of glutathione 
and molecular oxygen. Furthermore, free Cu
+
 ions are capable to induce oxidative 
damages inside the cell and hence are toxic. In contrast to the detrimental free aqueous 
Cu
+
 ions, complexation of the metal with suitable ligands, that increase Cu(II)/Cu(I) 
reduction potential, can suppress disproportionation and oxidation of Cu(I). Therefore, it 
is not surprising that nature has evolved sophisticated copper homeostatic machinery 
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where cellular copper is chelated by high affinity ligands to control oxidative damage, 
while still maintaining a kinetically labile pool for physiological functions. 
In light of the picture portrayed in the preceding paragraph, it is now conceivable 
that a successful copper-selective fluorescent probe design not only involves the usual 
optimization of photophysical properties such as optical sensitivity, but it also has to meet 
the following criteria in order to use the probe to detect cellular copper. First, it is not 
sufficient for the fluorescent probe to selectively bind Cu(I) over all other biologically 
relevant metal ions, it is also imperative that the probe discriminates against Cu(II) to 
prevent redox cycling between the two oxidation states which would ultimately deplete 
the cellular reservoir of glutathione and other reductants. Second, due to the lack of the 
free intracellular aquated copper, the availability of the metal ion, that is required for the 
fluorescence response of the probe, is limited to the exchangeable copper pool. 
Therefore, the Cu(I) binding affinity of the probe should be tailored such that it can 
compete with the endogenous ligands for the metal ion without disturbing the normal 
cellular functions. Finally, the probe should offer a high fluorescence contrast between 
the free and Cu(I)-bound form to minimize undesirable background fluorescence.  
3.2.2. Design of Fluorescent Copper(I) Sensors: PET Switching Mechanism   
The basic framework of metal ion selective fluorescent probes is to combine a 
metal-binding moiety with a fluorophore that will respond to any fluctuation of the metal 
status. Because Cu(I) is an efficient fluorescence quencher (81, 82), the design of Cu(I)-
responsive fluorescent probes is challenging. In some instances, although this 
fluorescence quenching can be correlated with the copper ion concentration (83), the 
overpowering fluorescence from the unbound probe decreases the detection sensitivity. 
Therefore, Cu(I) sensors are largely turn-on probes where the intensity increases upon 










Figure 3.2. Simplified Jablonski Diagram Illustrating the PET Process. A) In absence of 
Cu
+
, electron transfer from the donor (D) to the excited fluorophore (A*) is 
thermodynamically favorable. The rate of electron transfer (ket) is faster than the rate of 
fluorescence (kfl), resulting in emission quenching (kfl < ket). B) Cu
+
-coordination to D 
decreases the driving force for PET, and slows down the electron transfer process. As a 




The fluorescence quenching due to Cu(I) can be reduced when the Cu(I)-binding 
site is decoupled from the fluorophore with a spacer. One way to obtain the metal 
induced turn-on response of the fluorophore of this architecture is to apply a 
photoinduced electron transfer (PET) switching mechanism. Generally, PET-based 
probes are composed of an acceptor-spacer-donor framework (Figure 3.1), where an 





























fluorophore (A*) as the acceptor (Figure 3.2). In the absence of Cu(I), following the  
excitation of the fluorophore, an  electron transfer occurs from the donor to the acceptor 




).  This undergoes a rapid non-radiative charge 
recombination process to return to the initial ground state resulting in fluorescence 
quenching. In the Cu(I)-bound form, the electron density of the donor is occupied to  
coordinate the metal ion, thus PET from the donor becomes thermodynamically less 
favorable. As a result, the fluorescence emission of the probe increases. CTAP-1 was the 
first probe reported to detect Cu(I) in aqueous solution which was developed by Fahrni 






Figure 3.3. Acceptor-Spacer-Donor Architecture of a PET-based Fluorophore CTAP-1. 
The nitrogen colored in purple is part of the Cu(I) binding site as well as the PET donor. 
 
 
3.2.3. Photophysics of Photoinduced Electron Transfer 
Typically, the cellular distribution of fluorescent probes is not homogeneous; it 
greatly depends on the chemical nature of the probe and the physiological environment of 
subcellular organelles. Thus, accumulation of free probe inside cellular compartments is 
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not unusual in bio-imaging. This can lead to staining artifacts especially when the 
fluorescence intensity of the free probe is very high and the enhancement upon metal 
binding is not sufficient to distinguish between background and copper-mediated 
response. Therefore, in detection of intracellular copper, the optimization of the 
fluorescence contrast between the free and the metal saturated probe is extremely 
important. This subsection will provide a background about photophysical parameters 
that drive the PET process as tuning of these properties will alter the fluorescence 
contrast (often given as fluorescence enhancement factor) of a probe.  
3.2.3.1. Relationship between Fluorescence Enhancement and PET Rate 
Since the copper ion does not directly interact with the fluorophore, in PET-based 
Cu(I) sensors, only the emission intensity but not the wavelength is altered upon metal 
binding. This change in intensity can be quantified by the fluorescence enhancement 
factor (fe) which is defined as the ratio of the quantum yield of the Cu(I)-bound probe 
( f
b) to that of the free probe ( f












Fluorescence quantum yield of a fluorophore is defined by the ratio of the number of 
emitted photons to the number of photons absorbed. Therefore, in presence of non-
radiative electron transfer process, the quantum yield of an unbound PET probe is given 
by, 
 f
    
 fl





where kfl = rate of fluorescence,  et
 
 = rate of the electron transfer process, and knr = rate of 
any other non-radiative deactivation pathways. Similar equation can be derived for the 
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quantum yield of the Cu(I)-bound probe where the rate of the electron transfer will be 
described by  et
b
. 
Therefore, in terms of the rate constants, the fluorescence enhancement factor (as 
in eqn. (3.1)) can be given by eqn. (3.3) under the assumption that the rate constants of 
fluorescence and non-radiative deactivations other than electron transfer do not change 
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3.2.3.2. Correlation between PET Rate Constant and Driving Force 
For PET probes based on acceptor-spacer-donor architecture, the electron donor is 
separated from the fluorophore by a sigma bond spacer, and hence this electron transfer 
process can be rationalized as a nonadiabatic reaction according to the concept illustrated 
in semiclassical Marcus theory (84, 85). According to this theoretical model, the rate 
constant (ket) and the thermodynamic driving force (ΔGet) of PET can be related by eqn. 
(3.4),  
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where h is Planck’s constant, kB is Boltzmann’s constant, T is the absolute temperature, λ 
is the reorganization energy, and HDA is the electronic coupling between the states before 





According to eqn. (3.4), it can be deduced that the rate of electron transfer (ket) 
increases with increasing PET driving force (more negative ΔGet) when (-ΔGet) < λ 
(“normal” region), the rate reaches maximum at (-ΔGet) = λ, and then decreases as the 





Figure 3.4. Graphical Representation of the Relationship between Rate of Electron 
Transfer and PET Driving Force. 
 
 
3.2.3.3. Calculation of PET Driving Force 
The driving force for the PET reaction (ΔGet) can be estimated based on the 
Rehm-Weller equation (86) as given by eqn. (3.5),  
 
  et    (D






) are the ground state reduction potentials of the electron 
donor and acceptor moieties, ΔE00 is the transition energy for the excitation of the 
fluorophore from the lowest vibrational state of S0 to that of S1, and wp is the Coulombic 




) formed upon electron transfer. In 
aqueous environment, wp is typically small due to solvation of the ion pair by 
surrounding water molecules.  
During the electron transfer process, the donor is oxidized and the acceptor is 
reduced. Therefore, a more positive value of E(D
+
/D) will disfavor the oxidation of the 
donor corresponding to weaker driving force for PET (as ΔGet becomes more positive). 
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On the other hand, a more positive value of E(A/A
-
) or increase in ΔE00 will result in a 
stronger PET driving force (as ΔGet becomes more negative). 
On the basis of the above discussion, it can be visualized that several factors can 
contribute to the tuning of fluorescence contrast of a PET probe by altering the PET 
driving force and in turn the rate of electron transfer. These photophysical parameters 
include the donor E(D
+
/D)  and acceptor E(A/A
-
) potentials, the excited state energy 
ΔE00, the electronic coupling (HAD), and the reorganization energy (λ). The influence of 
these parameters in contrast optimization of PET-based fluorescence turn-on probes were 
investigated with a series of compounds built upon a tunable 1,3,5-triarylpyrazoline 
fluorophore platform (87-90) same as in CTAP-1 (Figure 3.3).  
3.2.4. Problems Associated with Aggregation of Fluorescent Probes 
Fluorescent probes applied for cellular imaging are usually lipophilic and poorly 
water soluble to facilitate their diffusion across the lipid bilayer membrane (91). 
Therefore, it is a common practice in cellular applications to dissolve these probes in 
organic solvents like DMSO followed by dilution of the stock solution in buffer to 
prepare the working solution. However, a systematic dynamic light scattering study with 
a large library of drug-like molecules showed evidence of colloidal aggregation when the 
working solution of these compounds were prepared by the above-mentioned method 
(92). Moreover, there is ample evidence in the literature showing effects of aggregation 
on the photophysical properties of fluorophores including spectral shift, quenching, and 
fluorescence enhancement (93-95). Spectroscopic properties of poorly soluble fluorescent 
molecules can further change in the biological membranes depending on their 
hydrophobicity, charge, and aggregation state (96). Therefore, the problems associated 
with applications of colloid forming fluorescent probes in cellular imaging are much 




3.3. Results and Discussion 
In the last decade, Fahrni group was invested in tuning the electronic properties of 
Cu(I)-selective fluorescent probes to optimize the fluorescence contrast. These efforts 
culminated in the development of several high contrast Cu(I) probes with the maximum 
fluorescence enhancement being 50 (89). However, these compounds were characterized 
in methanol due to their low solubility. Therefore, the natural progression of this work 
was to develop water soluble high-contrast Cu(I) sensors which can be useful to image 
kinetically labile cellular copper. 
This work will discuss characterization of two such probes, CTAP-2 and 4.3 
(Chapter 4), and application of CTAP-2 towards in-gel detection of a copper chaperone in 
non-denaturing condition. Both probes were synthesized by Dr. M. T. Morgan and the 











3.3.1. Characterization of CTAP-2 
CTAP-2 is a highly water soluble Cu(I)-selective fluorescent probe designed on 
the triarylpyrazoline fluorophore platform (Figure 3.5). The turn-on response of this 
probe upon Cu(I) binding is based on photoinduced electron transfer (PET) switching 
mechanism as discussed in section 3.2.2. To solubilize this probe, the thioether-based 
Cu(I)-binding  moiety was functionalized with four hydroxymethyl groups along with a 
sulfonic acid group attached to the fluorophore. Because of its very low pKa the sulfonic 
acid primarily exists as a sulfonate ion, thus increasing the solubility of the probe as well 
as imparting the electron-withdrawing effect which is critical in designing high contrast 
probes (89). Although it had been previously shown that both 3,5-difluoro (89) and 4-
cyano (90) substitution on the 3-aryl ring provide a suitable platform for  electronic 
tuning to develop contrast optimized probes, the latter was chosen for CTAP-2 as 4-








Absorption maximum 396 nm 
Emission maximum 508 nm 
Quantum yield of the neutral free probe
 b
 0.0015 
Quantum yield of the acidic free probe
 c
 0.25 







 Data adapted with permission from Reference (1). © 2011 American Chemical Society; 
b
 10 mM 
MOPS/K
+
, pH 7.2; 
c
 5 mM HCl; 
d
 Saturated with Cu(I) at pH 7.2 (10 mM MOPS); 
e
 Fluorescence 
enhancement factor of Cu(I)-saturated probe relative to the analyte-free probe at neutral pH (λex = 380 
nm, integrated emission from λem−1  to λem + 10 nm); 
f




3.3.1.1. Photophysical Properties  
In aqueous buffer (10 mM MOPS/K
+
, pH 7.2), upon excitation at 380 nm the 
fluorescence emission of analyte-free CTAP-2 was very weak but showed a strong 
fluorescence response upon Cu(I)-binding with an emission maximum at 508 nm. The 
fluorescence enhancement factor of Cu(I)-saturated probe relative to the free probe was 
estimated to be 65-fold with a quantum yield of 0.083 for the copper-bound probe (Table 
3.1). 
3.3.1.2. Water Solubility: Comparison with Previously Reported Cu(I)-Probes 
The ammonium salt of CTAP-2 dissolves directly in water owing to the 
solubilization strategies employed in designing the probe. On the contrary, Cu(I) 
selective fluorescent probes usually tend to be lipophilic due to the thioether based cation 
binding sites typically employed to achieve selectivity for the soft Cu(I) cation. Because 
of their inadequate solubilities, the aqueous solutions of such probes cannot be prepared 
by direct dissolution in water. Instead, they are first dissolved in an organic solvent such 
as DMSO to form a concentrated stock solution, which is then diluted into water or 
aqueous buffer to give a final working concentration in the low micromolar range. 
However, as mentioned in section 3.2.4, the poorly soluble probes are prone to form 
colloidal aggregates under these conditions (92). Because the colloids are composed of 
nanoparticles with sizes below the diffraction limit, the aqueous solution remains 
optically clear. In absence of macroscopic precipitates, the UV-vis absorbance of such 
solutions usually changes linearly with the compound concentration. For this reason, UV-














Dynamic light scattering (DLS), on the other hand, has been proven to be useful 
in characterizing colloidal aggregates. DLS measures fluctuations in the intensity of the 
light scattered by nanoparticles by comparing the intensity at time t to the intensity at a 
later time (t + τ). This intensity fluctuation, known as the autocorrelation function (C(t) in 
Figure 3.7), is due to the Brownian motion of the particles in solution where the scattered 
light continuously undergoes either constructive or destructive interference by the 
surrounding particles. These fluctuations can be linked to the fluctuations in the dielectric 
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constant of the scattering medium, from which it is possible to derive the diffusion 
coefficient of particles in colloidal suspensions. In sufficiently dilute systems, assuming 
that the particles are spherical, the Stokes-Einstein relation gives the radius of these 
particles from the diffusion coefficient data utilizing eqn. (3.6) , 
 
    
  




where k = Boltzmann constant, T = temperature,   = viscosity of the medium, and D = 
diffusion coefficient. Therefore, large particles diffuse slower than the small particles and 





Figure 3.7. Autocorrelation Curves from Dynamic Light Scattering of Fluorescent Probe 
Colloids. Reproduced with permission from Reference (1). © 2011 American Chemical 




In order to examine the hypothesis of colloidal aggregation by lipophilic Cu(I)-




scattering (DLS). Although the colloidal aggregation of lipophilic Cu(I)-probes in 
aqueous solution is expected based on their molecular structures, prior to this work the 
aggregation behavior of these probes had not been experimentally determined. To mimic 
the aggregation state associated with the dilution of organic stock solutions of poorly 
soluble dyes into aqueous buffer, a commonly used procedure for preparing aqueous 
solutions of lipophilic dyes, each of these probes was first dissolved in DMSO to a 
concentration of 1 mM. The stock solutions were then diluted in aqueous buffer (10 mM 
MOPS/K
+
, pH 7.2) to prepare a working solution with a concentration of 5 µM. All of 
these probes formed clear homogeneous solutions when prepared this way, however, 
DLS experiments showed evidence of colloid formation. Following the light scattering 
principles laid out in the preceding paragraph, hydrodynamic radii of all compounds 
(Table 3.2) were determined from their autocorrelation curves (Figure 3.7). Increasing 
hydrodynamic radius resulted in slower diffusion and consequently decreased the rate of 




Table 3.2. Hydrdynamic Radii of Cu(I)-selective Fluorescent Probes Measured by 
Dynamic Light Scattering. 
Probe
 a




3.1 (90) 100 12 
CS1 (57) 49 6 
CS3 (59) 67 9 
CTAP-1 (30) 63 6 
a
 DMSO stock solution (1 mM) of the probe diluted into aqueous buffer (10 mM MOPS/K
+
, pH 7.2) to a 
final concentration of 5 μM. 
b
 Hydrodynamic radius;  
c
 Standard deviation. Data adapted with permission 






For the Cu(I)-responsive probes 3.1, CS1, and CS3, the lipophilic nature of these 
molecules was confirmed by the DLS measurements. Surprisingly, CTAP-1 which was 
functionalized with a carboxylic acid group to increase aqueous solubility also showed 
formation of colloidal aggregates with an average hydrodynamic radius comparable to 
CS3. In line with the concern of alteration of photophysical properties of fluorescent 
probes upon aggregation as expressed in section 3.2.4, a recent publication pointed 
towards potential misrepresentation of cellular imaging data acquired with copper sensor 
CS1. In this study, multiple evidences suggested that the fluorescence response of CS1 is 
not limited to the fluctuation in cellular copper, but this probe also responds to alteration 






Figure 3.8. Absorbance of CTAP-2 at 396 nm versus Concentration. Inset: Expansion 
showing linearity within the 0-5 μM concentration range; Dashed line: the expected 
linear scaling based on the first five data points in 0-5 µM range; Red curve: non-linear 
least squares fitting using dimerization model. Reproduced with permission from 




In contrast to other probes, CTAP-2 gave no more DLS signal than the 
background count rate of the buffer, thus confirming the absence of colloidal aggregates. 
Furthermore, the absorption and emission intensity of Cu(I)-bound CTAP-2 scaled 
linearly with concentrations from   to 5 μM. Similarly, the absorbance of the free probe 
increased linearly in the same concentration range (Figure 3.8). At concentrations above 
1  μM, deviation from linearity in the absorbance vs concentration plot is apparent, 
indicating the presence of self-association of CTAP-2. Nonlinear least-squares fitting of 
the experimental data assuming a simple dimerization equilibrium yielded an equilibrium 
constant of logK = 3.98 ± 0.06 for the CTAP-2 dimer (1). While the presence of dimer 
formation is evident from this experiment, considerable self-association of CTAP-2 only 
occurs at concentrations that are substantially higher than the working concentration 






Figure 3.9. Fluorescence Titration of CTAP-2 with Cu(I). Reproduced with permission 




3.3.1.3. Copper(I) Binding Stoichiometry   
To determine the Cu(I)-binding stoichiometry of CTAP-2, a 4.5 µM solution of 
the probe in deoxygenated buffer (5 mM MOPS-K
+
, pH 7.2) was titrated with Cu(I), 
supplied either from a 2.5 mM stock solution of [Cu(I)(CH3CN)4]PF6 in CH3CN or by in 
situ reduction of CuSO4 with sodium ascorbate. Consistent with a 1:1 copper 
coordination stoichiometry, the fluorescence emission showed a linear increase with a 
sharp saturation at 1 molar equivalent of Cu(I), irrespective of the nature of the copper 






Figure 3.10. Fluorescence Response of CTAP-2 to Various Cations. Black bars, CTAP-







μM for other cations); gray bars, addition of 5 μM Cu(I) to the solution of CTAP-2 and 
the indicated analyte. Cu(I) was supplied from 2.5 mM [Cu(CH3CN)4]PF6 solution in 
CH3CN. Reproduced with permission from Reference (1). © 2011 American Chemical 






3.3.1.4. Analyte Selectivity   
To determine the selectivity of CTAP-2 for Cu(I) over other metal ions typically 
present in cellular environment, the fluorescence response of the probe was determined in 
presence of various cations. Furthermore, to assess the interference of these ions with the 
probe’s response to Cu
+
 ion, addition of each of these biologically relevant ions was also 
recorded in presence of Cu(I). As shown in Figure 3.10, no cation other than Cu(I) gave a 
significant fluorescence turn-on response, and none of the cations inhibited the response 
to Cu(I). It is also worth mentioning that CTAP-2 can successfully distinguish between 
Cu(I) and Cu(II) ions, which is an essential requirement of Cu(I) sensors to prevent cells 
from oxidative damages (see section 3.2.1). 
3.3.1.5. Acid Dissociation Constant 
As discussed in section 2.1.3, Cu(I) binding affinity of a ligand is pH-dependent. 
Depending on the pKa value of the ligand, the ratio of the protonated and the 
deprotonated ligands changes with the variation of the pH. Consequently, apparent metal 
affinity of the ligand also varies as the extent of the competition between the protonation 
and the metal binding equilibria depends on the pH of the experimental medium. 
Furthermore, CTAP-2 gives a very strong fluorescence turn-on response upon 
protonation of the arylamine PET donor as implied by its relatively high fluorescence 
quantum yield under acidic conditions (Table 3.1). Therefore, the pKa of CTAP-2 is not 
only important for binding affinity determination, but also for the susceptibility of the 
Cu(I) response to interference from environmental pH. To determine the pKa, the 
fluorescence emission of CTAP-  was recorded over a −log [H3O
+
] range from 2.4 to 5.0, 
and the data were analyzed using Specfit to yield a value of 3.97±0.01 at 0.1 M ionic 











Figure 3.11. Fluorimetric pH Titration of CTAP-2. A) Fluorescence emission spectra as 
a function of proton concentration, –log [H3O
+
] ranging between 2.4 and 5.0. B) Curve fit 
of fluorescence intensity at 512 nm vs. –log [H3O
+
]. Average fitted value: pKa = 







3.3.1.6. Cu(I) Stability Constant  
Binding affinity of Cu(I)-responsive probes should ideally be tailored towards the 
bioavailability of the copper pools under study. An affinity that is too high will result in 
the probe sequestering copper ion from endogenous proteins perturbing the cellular 
homeostasis, while a probe with too low an affinity will not show any spectroscopic 
changes at physiological metal concentrations.  
From the mole-ratio plot of CTAP-2 versus Cu(I) (Figure 3.9), it is evident that  
the probe saturates at exactly one molar equivalent of the metal. Under such condition, 
the ratio of the bound probe to the metal ion added is near unity i.e., all copper ions are 
essentially bound to the probe up to the saturation point. Therefore, the Cu(I) stability 
constant of the probe cannot be determined by direct titration with the copper ion, as for 
accurate measurement of this value, the fractional saturation of the probe should lie 
between 0.2-0.8 (see section 2.1.4). The Cu(I) stability constant of CTAP-2 was instead 
derived from its Cu(II) binding equilibrium as the interaction of the probe with Cu(II) is 
much more weaker. The two binding constants are related by eqn. (3.7),  
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where ECu(II/I)L = formal potential of ligand bound Cu(II/I) couple; E
0
Cu(II/I)aq = standard 
reduction potential of the aqueous Cu(II/I) couple; F = Faraday constant; R = universal 
gas constant; T = temperature in Kelvin, KCu(II)L =  Cu(II) stability constant, and KCu(I)L = 






Figure 3.12. UV-vis Titration of CTAP-2 with Cu(II). Reproduced with permission from 






Figure 3.13. Cyclic Voltammogram of CTAP-2. Scan rate 50 mV s
-1
. Reproduced with 




The Cu(II)-binding of CTAP-2 was monitored by UV-vis spectroscopy where the 
probe was titrated with  CuSO4. The titration was done at pH 5 (10 mM PIPBS, 0.1 M 
KClO4) to inhibit the precipitation of hydroxycopper(II) species which occurs in alkaline 
medium. The titration data shown in Figure 3.12 were fitted over 250-500 nm wavelength 
range using the Specfit software package to yield a value of logKCu(II)L = 2.97±0.07 at pH 
5. In presence of Cu(II), the formal potential of the probe-bound Cu(II/I) redox couple 
was determined by cyclic voltammetry (CV) in the same buffer (Figure 3.13). CV data 
showed a quasi-reversible one-electron redox process with a half-wave potential of 0.626 
V (vs. SHE). On the basis of these data and a value of 0.13 V vs. SHE for E
0
Cu(II/I)aq (99), 
the Cu(I) stability constant of CTAP-2 was estimated as logKCu(I)L = 11.4±0.1 at pH 5. 
Given the low pKa of CTAP-2, these values are not significantly influenced by 
protonation under the conditions of measurement and thus are unchanged at pH 7. 
3.3.2. Applications of CTAP-2 
3.3.2.1. In-gel Detection of a Copper Chaperone 
Copper homeostatic machinery in living organisms consists of several proteins 
with a broad range of functions including copper trafficking proteins or chaperones, 
cuproenzymes where copper acts as a redox cofactor, and copper storage proteins or 
peptides. Although detection of copper in whole cells and isolated from protein samples 
is being done routinely, there is a lack of simple and inexpensive methods to detect 
copper bound to the metalloproteins in their native state. Available technologies, namely 
laser ablation – inductively coupled plasma mass spectrometry (LA-ICP-MS) (74), 
autoradiography (100), and synchrotron X-ray fluorescence (66), either suffer from 




Encouraged by the high fluorescence contrast and selectivity toward Cu(I), the 
utility of CTAP-2 was explored as a reagent for the in-gel detection of copper proteins.  
For this purpose, hAtox1 was chosen which is a copper chaperone mediating the delivery 
of Cu(I) to ATP7A or ATP7B in the trans-Golgi network. The protein sample was 
separated by non-denaturing polyacrylamide gel electrophoresis (Native-PAGE). The 
only other example of fluorescence-based in-gel detection of copper proteins found in the 
literature employed quenching of fluorescence of BCS by Cu
+
 ions (101). Besides 
copper-dependent turn-on fluorescence response as in CTAP-2 is more sensitive that 
quenching based detection methods, in-gel detection by BCS utilized glacial acetic acid 
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Figure 3.14. Native-PAGE showing Relative Mobility of Proteins. Lane 1: Thioredoxin, 
Lane 2: Superoxide Dismutase, Lane 3: Serum Albumin, Lane 4: Carbonic Anhydrase, 
Lane 5: hAtox1, Lane 6: Myoglobin, and Lane 7: Glyceraldehde-3-Phosphate 
Dehydrogenase. 36 µg of each of the proteins in native sample buffer were loaded on the 




Table 3.3. Molar Masses and Isoelectric Points of Proteins. 







1  Thioredoxin  Human 11.6  4.82  
2  Superoxide Dismutase 
(Homodimer) 
Bovine 31  5.86  
3  Serum Albumin  Bovine 66.4  5.60  
4  Carbonic Anhydrase  Bovine 29.0  6.40  
5  hAtox1  Human 7.4  6.71  
6  Myoglobin  Horse 16.9  7.36  
7  Glyceraldehde – 3 -  
Phosphate Dehydrogenase  
Rabbit 35.6  8.52  
a
.  Molar mass and pI were calculated from the amino acid sequence of respective proteins (UniProt) 




In native gel electrophoresis, proteins maintain their native conformations as the 
samples are treated with neither SDS nor β-mercaptoethanol. While in SDS-PAGE the 
electrophoretic mobility of a protein depends primarily on its molecular mass, in native 
PAGE, the mobility depends on both the protein's hydrodynamic size and effective 
charge. The effective charge of a protein is governed by the intrinsic charge on the 
protein at the pH of the running buffer which can be predicted from the isoelectric point 
(pI) of the protein. Although there is a correlation between the molar mass and the 
hydrodynamic radius of a protein, the latter is also influenced by the actual conformation 
of the protein in solution. Figure 3.14 shows separation of seven proteins on a 
representative native-PAGE, their molecular masses and pI’s are tabulated in Table 3.3. 
From these data it is evident that the relative mobility of proteins on a native gel is 
difficult to predict as this property is affected cumulatively by several factors including 
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hydrodynamic size, effective charge, conformation, presence of different isomers of the 
proteins, and the pH of the running buffer. However, unlike SDS-PAGE, native gel 
electrophoresis prevents the loss of metal ion from a metalloprotein as the protein 





Figure 3.15. In-gel Detection of a Copper Chaperone with CTAP-2: Response of the 
Fluorescent Probe with Increasing KCN. (A) Native gel incubated with a 5 μM aqueous 
solution of CTAP-2 followed by visualization at 365 nm excitation (emission 537/BP 35 
nm; UV transillumination mode). (B) Same gel after staining with Coomassie blue. Lane 
1: untreated hAtox1; Lane 2: hAtox1, TCEP, 7.5 mM KCN; Lane 3: hAtox1, TCEP, 15 
mM KCN; Lane 4: hAtox1, TCEP, 30 mM KCN; Lane 5: hAtox1, TCEP, 
[Cu(I)(CH3CN)4]PF6; Lane 6: hAtox1, TCEP, [Cu(I)(CH3CN)4]PF6, then 7.5 mM KCN; 
Lane 7: hAtox1, TCEP, [Cu(I)(CH3CN)4]PF6, then 15 mM KCN; and Lane 8: hAtox1, 
TCEP, [Cu(I)(CH3CN)4]PF6, then 30 mM KCN. 
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In order to evaluate the utility of CTAP-2 for the in-gel detection of copper 
proteins, hAtox1 was separated on a native gel with varying amount of apo:holo ratio of 
the protein (Figure 3.15). [Cu(I)(CH3CN)4]PF6 was used to metallate the protein, whereas 
KCN was used to remove copper from the protein. After the incubation of the gel with 
CTAP-2, fluorescence signal was observed for the untreated protein (Lane 1), which 
disappeared with the treatment of the protein with KCN (Lane 2-4) even at the lowest 
concentration used in the experiment. Fluorescence signal of CTAP-2 intensified when 
exogenous copper was added to the protein as this treatment will result in majority of the 
protein being copper-bound (Lane 5). In contrast to Lane 2-4, when KCN was added to 
the copper-bound protein, the CTAP-2 fluorescence signal steadily decreases with 
increasing amount of KCN (Lane 6-8) and disappeared at the highest concentration 
added. Post-staining of the gel with Coomassie blue revealed the presence of the proteins 
in each lane and confirmed the removal of Cu(I) from hAtox1, based on the different 
mobilities of the apo and holo forms (103). Therefore, this study revealed that CTAP-2 
can detect hAtox1 in a reversible copper-dependent manner.  
Next we set out to determine the specificity of copper-dependent fluorescence 
response of CTAP-2. Similar to Figure 3.15, incubation of the native gel containing 
hAtox1 with CTAP-2 showed fluorescence signal only for the holo form (Cu(I)-bound) 
of the protein and not for the metal-free apo form obtained by removal of the metal by 
cyanide (Figure 3.16). CTAP-2 did not respond to carbonic anhydrase, a zinc protein, as 
expected, but interestingly the probe did not give any signal to Cu/Zn superoxide 
dismutase, which contains a copper site buried inside the protein (Figure 3.17).  
Therefore, CTAP-2 was successful to detect copper bound to a metallochaperone when 
the metal is readily accessible (Figure 3.17), however the mechanism of this response is 
uncertain. Given the high Cu(I) affinity of Atox1 (logK = 17.4) (104), it is probable that 
CTAP-2 associates with the protein in a Cu(I)-dependent manner without actually 
removing the metal ion from the binding site. The hypothesis of the CTAP-2-Cu(I)-
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Atox1 ternary complex formation is also supported by the fact that the fluorescence 
signal does not disappear with brief washing of the gel after incubation with the dye as 






Figure 3.16. Comparison of Fluorescence Response of CTAP-2 in hAtox1, Carbonic 
Anhydrase, and Superoxide Dismutase. (A) Native gel incubated with a 5 μM aqueous 
solution of CTAP-2 followed by visualization at 365 nm excitation (emission 537/BP 35 
nm; UV transillumination mode). (B) Same gel after staining with Coomassie blue. Lane 
1: untreated hAtox1; Lane 2: hAtox1, TCEP, KCN; Lane 3: hAtox1, TCEP, 
[Cu(I)(CH3CN)4]PF6; Lane 4: hAtox1, TCEP, [Cu(I)(CH3CN)4]PF6, then KCN; Lane 5: 
carbonic anhydrase; and Lane 6:, superoxide dismutase (SOD1). Reproduced with 








Figure 3.17. Crystal Structures of Copper Proteins. Left: Human Atox1 (PDB Code 
1FEE (105)), Right: Bovine Superoxide Dismutase (PDB Code 1Q0E (106)), Red 




Similar experiments were performed with probe 3.1 and CS3 (Figure 3.6).  As 
illustrated in Figure 3.18, aqueous solution of probe 3.1, prepared by the dilution of a 
DMSO stock solution, failed to detect hAtox1 on a native gel. Identical result was 
obtained with the probe CS3 (data not shown). Furthermore, incubation of the native gel 
with either 3.1 or CS3 resulted in high fluorescence background which was unsuitable for 
the further imaging. Therefore, after the incubation of the gel with the dye, a washing 
step had to be included before the imaging to reduce the background. These results are 
consistent with the fact that all of these compounds form colloidal aggregates in aqueous 
buffer. Although these lipophilic dyes will be highly soluble in methanolic solutions, we 
found that methanol is not a suitable solvent for staining native gels. Besides protein 
denaturation, which would result in loss of metal ions, the gel turned opaque and was 
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Figure 3.18. Visualization of hAtox1 with Probe 3.1. (A) Native gel incubated with a 5 
μM aqueous solution of 3.1, prepared by the dilution of a DMSO stock solution, followed 
by visualization at 365 nm excitation (emission 537/BP 35 nm; UV transillumination 
mode). (B) Same gel after staining with Coomassie blue. Lane 1: untreated hAtox1; 
Lane 2: hAtox1, TCEP, KCN; Lane 3: hAtox1, TCEP, [Cu(I)(CH3CN)4]PF6; Lane 4: 
hAtox1, TCEP, [Cu(I)(CH3CN)4]PF6, then KCN. 
 
 
3.3.2.2. Preliminary Cellular Imaging 
Despite its hydrophilic nature and the presence of an anionic sulfonate group, 
CTAP-2 proved to be cell permeant. The dye produced a perinuclear staining pattern in 
live NIH 3T3 cells under copper-supplemented conditions (Figure 3.19), the pattern is 
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consistent with the total subcellular copper distribution previously observed by 
synchrotron X-ray fluorescence microscopy (30). Although these preliminary results 
appear promising, given the low Cu(I)-binding affinity of CTAP-2 (logKCu(I)L = 11.4), it 
is unlikely to compete with endogenous proteins with affinities higher by at least two 
orders of magnitude and hence the significance of the observed staining pattern is not yet 
certain. Nevertheless, this experiment demonstrates that it is possible to design a Cu(I)-






Figure 3.19. Fluorescence Micrographs of Live Copper-supplemented NIH 3T3 cells 
with and without CTAP-2. Left: Grayscale image of cells incubated with 5 µM CTAP-2 
for 1 hour at 37°C. Center: False color image of the same cells (LUT shown as stripe 
below scale bar). Right: Micrograph of control cells in absence of CTAP-2 showing the 
cellular autofluorescence background under identical imaging conditions. Scale bar 20 





This chapter elucidated the characterization of the thermodynamic properties, 
including Cu(I) stability constant, acid dissociation constant, and redox potential, of a 
highly water-soluble Cu(I)-probe CTAP-2. The probe which was developed by 
combining a polyhydroxylated thiazacrown ligand with a sulfonated triarylpyrazoline 
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fluorophore (by Dr. M. T. Morgan) did not exhibit any measurable aggregation effect at 
typical working concentrations of 1-5 µM in aqueous solution. In contrast, previously 
reported Cu(I)-selective fluorescence turn-on probes based on a thioether-rich Cu(I)-
binding moiety coupled to an uncharged fluorophore are expected to have a strong 
tendency to aggregate in aqueous solution which can presumably alter the photophysical 
properties. The first ever proof of the formation of nanoparticles in aqueous solutions of 
such lipophilic fluorescent probes was provided by the dynamic light scattering 
experiments in this work. The exceptional aqueous solubility and high contrast ratio of 
the Cu(I)-selective probe allowed CTAP-2 to be used for the in-gel detection of a copper 
chaperone containing a solvent exposed Cu(I) site. The photophysical properties of 
CTAP-2 and the resolution of native gel are not optimum to detect proteins with labile 
Cu(I)-binding site from a complex mixture of proteins such as cellular extract. 
Nevertheless, in-gel detection of hAtox1 by CTAP-2 demonstrated a novel role of metal-
responsive turn-on fluorescent probes that can be applied to identify labile metal-binding 
sites in a protein. This detection method also complements the existing techniques for in-
gel metal profiling, including laser ablation inductively coupled plasma mass 
spectrometry (LA-ICP-MS) and synchrotron-based X-ray fluorescence mapping (Section 
3.1.2), both of which measure the total metal content whereas the fluorescent probes can 
distinguish between the accessible metal-binding site and the one buried inside a protein. 
Furthermore, CTAP-2 proved to be cell permeant despite its hydrophilic nature. 





(104)), it is improbable that CTAP-2, with Cu(I)-affinity several orders of magnitude 
lower, can be engaged in copper exchange with the endogenous proteins. Therefore, the 
interpretation of the observed cellular staining patterns is uncertain at present and will 
require further study, ideally with future Cu(I)-probes featuring higher binding affinities 




3.5. Experimental Methods 
3.5.1. Dynamic Light Scattering Experiments 
To test for colloidal aggregate formation, the respective compounds were 
dissolved at a concentration of 1 mM in DMSO and directly diluted into aqueous buffer 
(MOPS/K
+
, pH 7. ) to a final concentration of 5 μM. The hydrodynamic radii (Rh) of the 
formed colloidal particles were determined by dynamic light scattering (DLS) at a 90° 
angle using a DynaPro Protein Solutions DLS instrument (Wyatt Technology 
Corporation, Santa Barbara, CA). Particle size measurements represent an average value 
of 20 measurements with a 60 sec acquisition time each. All data analyses were 
performed using the Dynamic v.5.26 software (Wyatt Technology Corporation, Santa 
Barbara, CA). The Rh of the formed nanoparticles were determined from their respective 
diffusion coefficients according to the Stokes-Einstein relation. 
3.5.2. Acid Dissociation Constant 
Fluorescence spectra were acquired in 0.1 M KCl as ionic background. The 
excitation wavelength was set at 380 nm and the emission scan ranged from 410–700 nm. 
All solutions were filtered through  .  μm membrane filters to remove interfering dust 
particles or fibers. Three independent pKa titrations were carried out at  .  μM 
concentration of CTAP-2 by adding HCl such that pH interval is 0.1 at each step. The 
data were analyzed by non-linear least-squares fitting using the Specfit software package 
(107).  
3.5.3. Cu(II) Stability Constant  
UV-vis absorption spectra were measured in 10 mM PIPBS buffer, pH 5, 
containing 0.1 M KClO4. All solutions were filtered through  .  μm membrane filters to 
remove interfering dust particles or fibers. UV-Vis titrations with Cu(II) were carried out 
at 7 μM concentration of CTAP-2 (ammonium salt) by adding 1   μM aqueous 
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copper(II) sulfate in each step. The data were analyzed by non-linear leastsquares fitting 
using the Specfit software package (107). 
3.5.4. Electrochemistry 
The cyclic voltammograms were acquired in 10 mM PIPBS buffer, pH 5, 
containing 0.1M KClO4 as the electrolyte using a CH-Instruments potentiostat (model 
600A). The ammonium salt of CTAP-2 was measured at 1  μM concentration in a single 
compartment cell with a glassy carbon working electrode and a Pt counter electrode. An 
aqueous Ag/AgCl reference electrode (1 M KCl) was used. The half-wave potentials 
were referenced to ferrocenium as the external standard. Measurements were typically 
performed with a scan rate of 50 mV s
–1
 or 100 mV s
–1
. 
3.5.5. Cu(I) Stability Constant  
The stability constant for binding of Cu(I) to CTAP-2 was estimated based on the 
Nernst equation (eqn. 3.7). The formal potential of the aqueous Cu(II/I) redox couple 
(E
0
Cu(II/I)aq) was previously reported as 0.13 V (108). This value corresponds to a “formal 
concentration potential” which was obtained from the standard potential of the 
aquocopper(II) redox couple (E
0
 = 0.153 V) by correcting for the activity of the aquated 
ions at an ionic strength of 0.10 M using the extended Debye-Hückel equation. This 
correction alters the calculated ratio of Cu(I) stability constants by a factor of 2. A 
reference potential of 0.40 V vs SHE was used for the Fc
+/0
 redox couple in aqueous 
solution (109). 
3.5.6. Atox1 Expression and Purification 
E. coli BL21(DE3) cells containing pET11d with the gene encoding hATOX1 
were grown at 37 °C to an optical density at 600 nm of 0.8-1.1, and then protein 
expression was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG, 0.5 mM total 
concentration). After 4 hours, the cells were harvested and the pellet was stored at –80 
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°C. The cell pellet was thawed and resuspended in a buffer containing 20 mM MES, pH 
6.0, 1 mM EDTA, and 5 mM DTT (added just before use) before purification. 
Purification of Atox1 was initiated by three rounds of freezing and thawing of the 
suspended cells followed by extraction for 1 h at 4 °C. The cell extract was centrifuged at 
6000 x g for 15 min at 4 °C. The supernatant was then concentrated with a 3K microsep 
centrifugal device (Pall Life Sciences) and applied to a Superdex 75 gel filtration column 
equilibrated with 50 mM HEPES, pH 7.5, 200 mM NaCl for purification. Fractions 
containing pure protein were confirmed by Laemmli-SDS-PAGE, pooled, and stored at   
–80 °C in the elution buffer. Protein concentrations were quantified using Bradford 
protein assays using BSA as a standard (Pierce). 
3.5.7. Electrophoresis of Purified Metalloproteins 
Bovine superoxide dismutase (SOD1) and bovine carbonic anhydrase (CA) were 
purchased from Sigma-Aldrich. These proteins were subjected to native polyacrylamide 
gel electrophoresis (native-PAGE) without any prior treatment. In all experiments, a 
solution of hAtox1 (0.3 mM) in HEPES buffer (50 mM, pH 7.5, 0.2 M NaCl) was treated 
with tris(2-carboxyethyl)phosphine (TCEP, 3 mM final concentration) followed by 
addition of [Cu(I)(CH3CN)4]PF6 (1.2 mM, diluted from a 25 mM stock solution in 
acetonitrile) to prepare Cu-Atox1. In combination with TCEP (3 mM final 
concentration), KCN (30 mM final concentration) was used to prepare reduced apo-
Atox1 in experiments described in Figure 3.16 and Figure 3.18; variable concentrations 
of KCN were used as indicated as indicated in the legend of Figure 3.15 for each lane. A 
total amount of  5 μg protein in Tris-HCl sample buffer (pH 6.8) was loaded in each lane 
of a 4% stacking - 10% resolving Tris-HCl Native Gel, which was then subjected to 
electrophoresis at 200 V for 45 min using a Tris-glycine running buffer (25 mM Tris, 192 




3.5.8. In-gel Visualization of Proteins with CTAP-2 
After the electrophoresis run, the gel was immersed in a 5 μM aqueous solution of 
CTAP-2 for 15 minutes. Images were acquired with Alpha Imager (Cell Biosciences) 
using the UV transilluminator (excitation 365 nm) and Green Filter (537 nm, 35 nm Band 
Pass). Subsequently, protein content of the same gel was visualized by coomassie dye 
(GelCode Blue Stain Reagent, Pierce). 
3.5.9. In-gel Visualization of Proteins with Probe 3.1 
After the electrophoresis run, the gel was immersed in a 5 μM a ueous solution of 
3.1 (prepared by dilution from a DMSO stock solution) for 15 minutes. The gel has to be 
washed for 5 minutes before the imaging to reduce the undesired fluorescence 
background. Images were acquired with Alpha Imager (Cell Biosciences) using the UV 
transilluminator (excitation 365 nm) and Green Filter (537 nm, 35 nm Band Pass). 
Subsequently, protein content of the same gel was visualized by coomassie dye (GelCode 
Blue Stain Reagent, Pierce). 
3.5.10.  Cell Permeability 
NIH 3T3 mouse fibroblast cells were cultured at 37 ⁰C (5% CO2) in Dulbecco’s 
modified Eagle’s medium (DMEM, Invitrogen) supplemented with 10% bovine serum, 4 
mM L-glutamine,     unit/ml penicillin, and     μg/ml streptomycin. For staining 
experiments cells were directly grown on cover slips in basal medium supplemented with 
5  μM copper(II) chloride over a period of 1  hours. After removing the growth medium, 
the cells were gently washed with DMEM (prewarmed at 37 °C) and then incubated with 
CTAP-  (5 μM in serum-free DMEM) for 1 hour at 37 °C (5% CO2). After washing with 
prewarmed DMEM (supplemented with 25 mM HEPES), the cover slips were mounted 
on slides using Fluoromount-G (Southern Biotech). Fluorescence micrographs were 
acquired with a Zeiss inverted fluorescence microscope (Axiovert 200) equipped with a 
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cooled CCD camera (CoolSnap HQ, Photometrics) using a mercury lamp as excitation 
source combined with a 370-390 BP excitation filter, 400 nm dichroic mirror, and a 420 
LP emission filter. 
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DESIGNING HIGH CONTRAST COPPER(I)-SELECTIVE 
AQUEOUS FLUORESCENT PROBES: IMPORTANCE OF LIGAND 
DONOR STRENGTH AND EXCITED STATE PROTON TRANSFER 
 
In this chapter, coordination properties of a water soluble, high contrast Cu(I)-
selective fluorescent probe 4.3 were determined. With the ultimate goal of designing a 
fluorescent probe suitable for biological applications, this probe was originally developed 
to improve the photophysical parameters of CTAP-2 by modifying the ligand design. 
However, this work eventually provided plausible mechanisms for the incomplete 
fluorescence recovery and the low intrinsic fluorophore quantum yield often observed for 
the triarylpyrazoline-based aqueous Cu(I)-probes. This work was published in the Dalton 
Transactions (1). 
4.1. Background 
CTAP-1 was the first synthetic fluorescence turn-on probe reported for the 
detection of aqueous Cu(I) ions (2). This probe was designed on a 1,3-diaryl-2-pyrazoline 
fluorophore platform (Figure 3.3) using PET switching mechanism. Although CTAP-1 
was used in detection of cellular copper, the contrast ratio (fe) of the probe was relatively 
low (fe = 4.6) limiting its applicability in bioimaging. Moreover, aqueous solution of 
CTAP-1, even with an ionizable carboxylic acid moiety attached to the fluorophore, 
showed evidence of colloid formation by dynamic light scattering. In contrast, CTAP-2 
with an improved contrast ration of 65, was highly water soluble and at the same time 
cell permeable. The fluorescence quantum yield of Cu(I)-saturated CTAP-2, however, 
remained relatively low at 8.3% which was even lower than CTAP-1 (14%). 
Interestingly, protonation of the metal-free N-arylthiazacrown PET donor of CTAP-2 
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under acidic conditions increased the quantum yield by 3-fold to 25% (Table 3.1). 
Similar behavior was previously observed for the N-arylthiazacrown-based methanolic 
Cu(I)-probes 4.1a-d (Figure 4.1). For example, probe 4.1b (where R = 2,5-F2) (Table 
4.1), which provided the highest contrast ratio of 29, gave a fluorescence quantum yield 
of only 9.5% upon saturation with Cu(I). However, protonation of the aniline nitrogen of 










There could be potentially two contributing factors that can explain this 
incomplete fluorescence recovery of the PET probes. First, protonation of the aniline 
nitrogen renders it inactive towards oxidation, thereby completely blocking the PET 
process. In contrast, coordination to a soft cation like Cu
+
 will increase the E(D
+
/D) to a 
smaller extent, thus under this condition the PET-induced fluorescence quenching 
observed for the free probe is not entirely inhibited.  This residual fluorescence 
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quenching of the Cu(I)-bound form will decrease its quantum yield and hence reduce the 




Table 4.1. Comparison of Fluorescence Recoveries upon Cu(I) Binding and Protonation 

























4.1a 3-F 0.0072 0.53 0.15 74 21 
4.1b 2,5-F2 0.0033 0.54 0.095 164 29 
4.1c 2,3,5-F3 0.0024 0.6 0.048 250 20 
4.1d 2,3,5,6-F4 0.0010 0.55 0.02 550 20 
 
a 
Data adapted with permission from Reference (3). © 2010 American Chemical Society; 
b 
fe = Φf 
/Φf(neutral);  
c 
Probe in methanol alone; 
d 
180 mM TFA in methanol; 
e 
10 µM [Cu(I)(CH3CN)4]PF6 in 




Second, it can be presumed that a competing photoinduced electron transfer from 
the probe-bound Cu(I) to form a Cu(II) complex can contribute towards incomplete 
fluorescence recovery.  However, femtosecond time-resolved pump-probe experiments 
with the probe 4.1a (where R = 3F) provided no evidence of the formation of a Cu(II) 
complex thus negating the above possibility (3). On the other hand, this data along with 
the time-resolved fluorescence decay measurements of the same probe showed evidence 
of at least three distinct emissive species. Furthermore, variable temperature NMR 
studies in deuterated methanol revealed a dynamic equilibrium between two types of 
Cu(I) coordinated species. One is the expected tetradentate NS3-coordinated Cu(I)-
complex and the other is a ternary complex formed by Cu(I)-coordination of a solvent 
molecule replacing the Cu-N bond. Because the ternary complex with the solvent 
weakens the interaction between Cu(I) and the aniline nitrogen, the photoinduced 
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electron transfer by the arylamine donor is not completely inhibited upon Cu(I) binding 
leading to incomplete fluorescence recovery. 
The weakening of the Cu-N bond and the ternary complex formation with solvent 
molecule can be reasoned as an effect of steric hindrance between the ortho-hydrogens of 
the N-aryl ring and the thiaza crown backbone upon Cu(I) binding to the probes 4.1. 
Binding to the solvent molecule reduces this strain and thus driving the equilibrium 
towards thermodynamically stable ternary complexes. This hypothesis was indeed 
confirmed with probe 4.2 where the aniline ring was fused with the ligand backbone to 
reduce the unfavorable steric interactions. Upon saturation with Cu(I), probe 4.2 offered a 






Figure 4.2. Design Strategy of Water Soluble Cu(I)-probe 4.3.  Part of the fluorophore 










4.2. Results and Discussion 
This work will discuss characterization of thermodynamic properties of probe 4.3 
which was synthesized by Dr. M. T. Morgan. The detail of the synthetic procedures can 
be found elsewhere (1). 
With the objective of improving the fluorescence quantum yield of CTAP-2 
utilizing a similar design strategy described for 4.2, the probe 4.3 was conceived where 
the arylamine ring was integrated with the ligand backbone, the solubilization groups 
were similar to CTAP-2 including functionalization of the thioether-based Cu(I)-binding  





Table 4.2. Comparison of Photophysical Properties of CTAP-2 and Probe 4.3 
Compound
a,d 







 394 506 0.0014 
4.3 0.1 M HCl 391 504 0.070 
4.3-Cu(I) pH 7.2
 b
 388 506 0.074 
CTAP-2 pH 7.2
 b
 396 512 0.0015 
CTAP-2 5 mM HCl 388 512 0.25 
CTAP-2-Cu(I) pH 7.2
 b









, pH 7.2; 
c
 65-fold enhancement over Cu(I)-free CTAP-2 at 380 nm; 
d
 Data 










Figure 4.3. Fluorescence Titration of Probe 4.3 with Cu(I). Fluorescence response of 
probe 4.3 (4.6 μM) to Cu(I) (provided by in-situ reduction of Cu(II) with 100 µM 
ascorbate) in aqueous buffer at pH 7.2 (10 mM MOPS/K
+
, 22 °C, λex = 380 nm). 
Reproduced with permission from Reference (1). © 2012, Royal Society of Chemistry. 




4.2.1. Photophysical Characterization  
Similar to CTAP-2, the ammonium salt of probe 4.3 was found to dissolve in 
water at millimolar concentrations. In aqueous buffer (10 mM MOPS/K
+
, pH 7.2), upon 
excitation at 380 nm 4.3 gave a strong fluorescence turn-on response to Cu(I) with an 
emission maximum at 506 nm. As expected for a 1:1 metal-ligand binding, the 
fluorescence emission saturated sharply at 1 molar equivalent of the metal under 
deoxygenated conditions (Figure 4.3). However, contrary to our expectations, the 
fluorescence quantum yield (Φf = 0.074) and contrast ratio (fe = 57) of 4.3 upon 
saturation with Cu(I) did not show an improvement over CTAP-2, which gave a 
fluorescence quantum yield and contrast ratio of 0.083 and 65, respectively (Table 4.2). 
The response of 4.3 to acidification was also surprisingly weak, reaching a maximum 
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fluorescence quantum yield of only 0.070 at 100 mM HCl versus 0.25 at 5 mM HCl for 
CTAP-2. Altogether these photophysical data pointed towards the possibility of 
additional fluorescence quenching pathways in probe 4.3 which would be responsible for 
lowering the intrinsic quantum yield of the probe. 
4.2.2. Analyte Selectivity   
The fluorescence response of probe 4.3 showed high selectivity for Cu(I) over all 
other cations tested, including Cu(II), Cd(II), and Hg(II) (Figure 4.4). Furthermore, 
identical fluorescence enhancements were obtained for Cu(I) regardless of whether 
supplied as the acetonitrile complex (*) or by in situ reduction of Cu(II) with excess 











SO4 reduced in situ with 150 µM ascorbate. Reproduced with permission from 






Figure 4.5. Determination of Acid Dissociation Constant of Probe 4.3. A) UV-vis spectra 
acquired for c(HCl) ranging between 1 mM to 100 mM. The red trace corresponds to the 
UV-vis absorption spectrum at –log[H3O]
+
 = 3.0. B) Absorbance change (red points) and 
curve fit (solid trace) for the titration (A) at a wavelength of 419 nm (pKa = 1.0±0.05). 




4.2.3. Incomplete Fluorescence Recovery: Clues from Cu(I)-coordination Study 
4.2.3.1. Acid Dissociation Constant 
Initial experiments to understand the influence of acidification of the probe 4.3 on 
its spectral properties revealed an estimation of pKa near 1. Protonation of the arylamine 
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nitrogen presumably results in spectral shift as observed previously with the absorption 
maximum of CTAP-2 which shifted from 396 to 388 nm upon protonation with 5 mM 
HCl (Table 4.2). Similarly, upon acidification probe 4.3 showed a significant shift in 
absorption maximum from 394 nm in 1 M KCl to 388 nm in 1M HCl. In 100 mM HCl, 
probe 4.3 gave an absorption maximum of 391 nm, exactly halfway between the values 
observed in 1 M HCl and neutral solution, suggesting a pKa near 1 for protonation of the 






Figure 4.6. Determination of Formal Potential of 4.3. Cyclic voltammogram of 4.3 (70 
μM) in the presence of 30 µM [Cu(I)(CH3CN)4]PF6 at pH 5.0 under deoxygenated 
condition (10 mM PIPBS, 0.1 M KClO4, glassy carbon working electrode, Pt counter 
electrode, aqueous Ag/AgCl/1 M KCl reference electrode, scan rate 50 mV/s, direction 
indicated by black arrows). The voltammogram was referenced against the external Fc
+/0
 
potential measured under the same conditions. Reproduced with permission from 




With this initial estimation of pKa, spectrophotometric titrations with probe 4.3 
were carried out by varying –log[H3O
+





] range from 2 to 1, aqueous HCl-KCl mixtures of varying [H3O
+
] but constant 
ionic strength were used. The data were analyzed by non-linear least-squares fitting using 
the Specfit software package (5), yielding an extrapolated pKa value of 1.0 at 0.1 M ionic 
background (Figure 4.5).  
4.2.3.2. Cu(I) Stability Constant   
Unlike CTAP-2, Cu(I) stability constant of probe 4.3 could not be determined 
from its Cu(II) affinity and redox potential of probe bound Cu(II/I) couple using Nernst 
eqn. (eqn. 3.7). One of the problems was a slow redox reaction between Cu(II) and the 
probe itself prohibiting the determination of its Cu(II)-affinity. Because of this additional 
redox process, with addition of each aliquot of CuSO4, the absorption spectrum of the 
probe continued to change in a time-dependent fashion without reaching equilibrium.  
Furthermore, cyclic voltammetry experiments with Cu(I)-saturated 4.3 at pH 5 (50 mV/s 
scan rate) revealed a one-electron process with a peak separation of 266 mV and a formal 
potential of 0.480 V vs. SHE (Figure 4.6). Such a large peak separation indicates that 
large structural changes are associated with the conversion from Cu(I) to Cu(II). Given 
the large peak separation, the measured potential is not suitable to determine a reliable 
Cu(I) affinity based on eqn. 3.7.  
Instead, the Cu(I)-affinity of 4.3  was determined via direct fluorescence titration 
using acetonitrile (2, 6). This gave a uniform apparent Cu(I) affinity of logKCu(I)L = 
9.72±0.03 at pH 7.2, irrespective of whether the titration was conducted by varying the 
Cu(I) concentration and keeping acetonitrile constant (Figure 4.7) or vice versa (Figure 
4.8). This binding affinity is 50 fold weaker than that of CTAP-2 (logKCu(I)L = 11.4) (7). 
This weak copper binding to the probe 4.3  is consistent with the unusually low pKa of 
the arylamine nitrogen of the probe (Section 4.2.3.1), which is nearly 1000-fold lower 
than that of CTAP-2 (pKa = 3.97) (7). Such a poorly basic nitrogen in the Cu(I)-binding 
moiety is expected to coordinate Cu(I) very feebly. Therefore, the low acid dissociation 
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constant together with a small value of Cu(I) binding affinity confirm an unusually low 
donor ability of the arylamine nitrogen compromising the fluorescence enhancement of 





Figure 4.7. Determination of Cu(I) Stability Constant of 4.3: Titration with Cu(I). 
Fluorescence titration of pyrazoline 4.3 (5 μM) with CuSO4 in the presence of  100 μM 
sodium ascorbate and constant CH3CN concentration of 0.70 M under deoxygenated 
condition in PIPBS buffer (50 mM, pH 5.0, 60 mM KClO4, 22 °C). A) Fluroescence 
spectra acquired for c(Cu(II)) ranging between 0.56 to 8.56 μM. B) Fluorescence 
intensity change (red points) and curve fit (solid trace) for the titration (A) at a 
wavelength of 508 nm (logK
Cu(I)
 = 9.74±0.03). Reproduced with permission from 






Figure 4.8. Determination of Cu(I) Stability Constant of 4.3: Titration with Acetonitrile. 
Fluorescence titration of pyrazoline 4.3 (5µM) with CH3CN in the presence of 3.6 μM 
CuSO4 and 50 μM sodium ascorbate under deoxygenated condition in PIPBS buffer (50 
mM, pH 5.0, 60 mM KClO4, 22 °C). A) Fluorescence spectra acquired for c(CH3CN) 
ranging between 0 to 1.60 M. The red trace corresponds to the emission spectrum prior to 
addition of CH3CN. B) Fluorescence intensity change (red points) and curve fit (solid 
trace) for the titration (A) at a wavelength of 508 nm (logK
Cu(I)
 = 9.71±0.02).Reproduced 
with permission from Reference (1). © 2012, Royal Society of Chemistry.  
 
 
4.2.4. Incomplete Fluorescence Recovery: Clues from Photophysical Study 
Photophysical studies done by Dr. M. T. Morgan uncovered possible factors that 
would be responsible for the incomplete fluorescence recovery of the probe 4.3 and 





Figure 4.9. Fluorescence Decay Profile of CTAP-2 and 4.3 Saturated with Cu(I) in 
Aqueous Buffer at pH 7.2 (10 mM MOPS/K
+
, 22 °C). Each sample was excited at 372 nm 
(80 ps fwhm), and the emission signal was detected at 506 nm by single photon counting. 
Non-linear least squares fitted traces are shown as solid lines (see Table 4.3 for the data; 
IRF = instrument response function).Reproduced with permission from Reference (1). © 




Table 4.3. Time-resolved Fluorescence Decay Data in Aqueous Solution at 22 °C. 
Compound
e





















 Deoxygenated conditions. 
b
 Air saturated conditions. 
c
 Deoxygenation had no effect on the observed 
lifetime within experimental error. 
d
 Normalized pre-exponential factors from fitted biexponential decay 
function. 
e 
Data acquired by Dr. M. T. Morgan. Reproduced with permission from Reference (1). © 2012, 





Time-resolved fluorescence spectroscopy data (Figure 4.9) showed that both 
CTAP-2-Cu(I) and 4.3-Cu(I) gave multiexponential fluorescence decay profiles that were 
consistent with the presence of multiple coordination species. In contrast, the reference 
compound which was known to be composed of a single emissive species gave clean 
monoexponential decay. Deconvolution of the decay profiles of CTAP-2 and 4.3 with a 
biexponential model produced the lifetime components tabulated in Table 4.3. In contrast 
to CTAP-2 which showed two lifetime components of 0.82 ns (67%) and 1.36 ns (33%), 
the probe 4.3 exhibited a short-lived (0.72 ns) dominant component (93%) and a minor 
one (7%) with a longer lifetime (1.44 ns). The predominance of a single component in the 
decay profile of 4.3-Cu(I) suggested that the modified ligand design of 4.3 effectively 
inhibited the formation of multiple coordination species which was the original aim of 
this work in order to improve the performance of CTAP-2. However, the rather short 
fluorescence lifetime (0.72 ns) of the Cu(I)-probe coupled with a low quantum yield 
(7.4%) implies a weak or absent interaction between the arylamine nitrogen and the 
Cu(I)-center as also inferred from the coordination properties of the probe (Section 
4.2.3). Furthermore, concluding from the solvent isotope effects on the fluorescence 
quantum yield and lifetime of the Cu(I)-probes and the responses of the free probes to 
acidification (data not shown), it can be derived that two distinct excited state proton 
transfer (ESPT) pathways are operative under neutral and acidic conditions that reduce 
the intrinsic fluorophore quantum yield of the probe 4.3 and also CTAP-2.  
4.3. Conclusion 
In an attempt to design a Cu(I)-selective fluorescent probe with quantum yield 
and contrast ratio improved over CTAP-2 (Chapter 3), aqueous solubilization strategy of 
CTAP-2 was combined with a new ligand design where the PET donor aryl ring  was 
integration into the ligand backbone. Based on previous results obtained in methanolic 
solution (4), we expected that the new ligand design would  improve the fluorescence 
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performance of the new probe by eliminating the propensity of the ternary complex 
formation between the copper-bound probe and the solvent molecule which was proven 
to be responsible for incomplete fluorescence recovery of the triarylpyrazoline probes.  
The new probe 4.3 gave a strong fluorescence turn-on response with high 
selectivity for Cu(I),  however, the contrast ratio and quantum yield did not improve over 
CTAP-2. Further studies on the thermodynamic and photophysical properties of the probe 
uncovered two separate effects that limit the fluorescence contrast of the Cu(I)-probe as 
well as the intrinsic fluorophore quantum yield. One of the effects is the inadequate 
coordination of Cu(I) to the weakly basic arylamine nitrogen as concluded from the 
coordination properties and the fluorescence decay profile of the probes. The other effect 
is the fluorescence quenching via two distinct excited state proton transfer pathways 
operating under neutral and acidic conditions as deduced from the solvent isotope effects 
and responses of the probe to acidification.  
4.4. Experimental Methods 
4.4.1. Acid Dissociation Constant 
To determine the pKa of probe 4.3, spectrophotometric titrations (10 cm path 
length) were carried out at a 2.8 μM ligand concentration and 0.1 M KCl as ionic 
background by varying  –log[H3O+] from 3 to 2 with the addition of 0.1M HCl. In the –
log[H3O+] range from 2 to 1, the amount of KCl present was adjusted downward such that 
the ionic strength of the solution remained constant at 0.1 M. The data were analyzed by 
nonlinear least-squares fitting using the Specfit software package (5).  
4.4.2. Cu(I) Stability Constant 
For the determination of the Cu(I) stability constant of probe 4.3 we used 
acetonitrile as competing ligand. Titrations were carried out at 5 μM concentration of 4.3 
in deoxygenated PIPBS buffer (50 mM, 60 pH 5.0, 60 mM KClO4 ionic background) by 
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either (a) adding aliquots of 0.25 μM CuSO4 at constant acetonitrile concentration (0.7 
M) and 100 μM sodium ascorbate (for in situ reduction to Cu(I)) or (b) varying the 
acetonitrile concentration from 0 to 1.6 M while keeping the Cu(I) concentration constant 
at 3.6 μM 65 (formed again by in situ by reduction of copper(II) sulfate with 50 μM 
sodium ascorbate). The data were analyzed by non-linear least squares fitting with 
Specfit using published Cu(I)/CH3CN stability constants (logβ1 = 2.63, logβ2 = 4.02, and 
logβ3 = 4.29) (8). In method (b), the data were corrected for volume changes with each 
acetonitrile addition. 
4.4.3. Electrochemistry 
Cyclic voltammograms were acquired in deoxygenated 10 mM PIPBS buffer, pH 
5, containing 0.1M KClO4 as the electrolyte using a CH-Instruments potentiostat. 
Compound 4.3 was analyzed at a concentration of 70 μM in a single compartment cell 
with a glassy carbon working electrode, a Pt counter electrode, and an aqueous Ag/AgCl 
reference electrode (1 M KCl). The potentials were referenced to ferrocenium (0.40 vs. 
SHE) (9) or ferroin (1.112 vs. SHE) (10) as external standards. Measurements were 
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PROTEOMIC IDENTIFICATION OF COPPER PROTEINS BY 
SELECTIVE LABELING OF COPPER(I) BINDING CYSTEINES  
 
Proteomic profiling is gaining increased attention in cancer research as this 
method offers not only better understanding of the disease states, but also provides 
valuable insights in detecting putative biomarkers and in improving treatments (1-4). In 
contrast, despite copper imbalance being related to various diseases including Menkes 
disease, Wilson’s disease, Parkinson’s disease, and Alzheimer’s disease (5, 6), the 
changes in copper proteome in these disease states are still poorly understood. In 
metalloproteins, cysteine is a ubiquitous ligand for Cu(I) coordination (7). Therefore, to 
develop methods for systematic proteomic profiling suitable for the copper proteome, 
several proteomics-based methods were developed in this chapter to identify copper(I) 
binding proteins in which the amino acid cysteine serves as the metal binding site. 
Moreover, this work will also lay a foundation for the identification of new copper 
proteins that are yet to be discovered.  
5.1. Background 
Copper is an essential trace element and required for various biological processes 
such as cellular respiration, connective tissue cross-linking, pigment formation, and 
antioxidant defense (8). Several copper binding proteins are an integral part of the copper 
homeostatic machinery and work in conjunction to regulate copper uptake, distribution, 
and excretion (9). However, identification of these copper binding proteins is often 
challenging due to lack of specification associated with copper-induced genetic 
screening, limitation of bioinformatics approach, and a dearth of reliable biochemical 
data.  
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5.1.1. Identification of Copper-binding Proteins 
This subsection offers a brief overview of previously developed methods utilized 
to discover the proteins in mammalian copper proteome that regulate copper transport 
inside the cell.  
5.1.1.1. Genetics-based Methods 
Copper-dependent genetic screening, which is done by either copper overload or 
starvation, is not specific to genes involved in copper metabolism. Such screening will 
also identify genes involved in different cellular processes like copper-induced oxidative 
stress, which are under the influence of change in cellular copper status, even though they 
are not directly connected to copper metabolism.  For example, a study for gene 
expression profiling in liver cells of copper-treated mice revealed significant upregulation 
of a set of 22 genes involved in immunity, iron, and cholesterol metabolism (10). 
The yeast complementation assay provides a different approach in the 
identification of genes encoding proteins associated with copper metabolism. The human 
homolog of Cox17 (11), hAtox1 (12), hCTR1 (13), and CCS (14) are examples of 
proteins identified or functionally characterized by this method. The assay analyzes the 
rescue of the phenotypes of a yeast deletion mutant in the presence of a functionally 
conserved gene cloned from higher eukaryotes.  Some of the properties that make yeast 
particularly suitable for biological studies include rapid growth, the ease of mutant 
isolation, and a well-defined genetic system. These properties allow the rapid 
identification of the phenotypic consequences of a mutation in any cloned gene, a 
technique generally unavailable in higher eukaryotes. However, successful recovery of 
the activities in yeast can be prevented even if the cloned gene has a conserved function. 
For example, the expressed protein may need to be part of a multi-protein complex to 
function properly but the key components of such a complex might not be present in 
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yeast, or the endogenous structure of the expressed protein may differ from the inherent 
one to render the resultant protein functionally inactive. 
Furthermore, some copper transport proteins were discovered from their 
respective genes which were isolated by studying the disease phenotypes caused by the 
mutations of these genes. This is a rigorous genetic approach that led to the identification 
of genes encoding ATP7A (15-17), ATP7B (18-20), Sco1, and Sco2 proteins. However, 
some genes are indispensable to embryonic function, so that their deleterious mutations 
result in embryonic lethality precluding further studies.  For example, the copper importer 




 mice die in utero 
mid-way through gestation (21, 22). A similar effect was observed with mice lacking 
copper chaperone Cox17 (23). In other cases, abolition of a gene function may not have 
any prominent effect on the phenotype because of genetic redundancy where other 
nonallelic genes supply the same function (24), as a result, such genes are difficult to 
identify from disease states.   
5.1.1.2. Bioinformatics- based Methods  
The striking similarities between yeast and mammalian copper homeostasis have 
permitted the characterization of mammalian orthologues using S. cerevisiae gene 
sequences (12, 14), hence underscoring the importance of this genetically tractable 
organism in order to understand copper metabolism in mammals (25). Advances in 
genome sequencing led to the discovery of copper-binding proteins based on sequence 
homology. For example, the human CTR1 sequence has been used for homology 
screening, giving rise to a putative copper importer hCTR2 (13). However, identification 
of a gene encoding a putative copper-binding protein should be confirmed by 
biochemical studies proving the dependence of the function of the proteins of interest on 
the presence of the metal. 
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In recent years, development of several protein data repositories including PDB, 
UniProt, Pfam, and InterPro has opened another avenue for identifying novel copper 
proteins based on their amino acid sequences and three dimensional structures. For 
example, human COMMD proteins, a family of proteins structurally and functionally 
related to MURR1, were identified by searching human protein databases for sequences 
homologous to MURR1 (26). The function of MURR1  is to regulate the transcription 
factor NF-kappa-B and presumably to control copper metabolism (27).  
Protein-based bioinformatics can also be utilized to identify novel copper proteins 
that are yet to be characterized, based on already known copper-binding motifs. In this 
approach, metalloproteins are identified through the searches of the whole ensemble of 
the sequences of proteins in the PDB using local sequence similarity to either known 
copper binding motif (28) or known copper-binding domains (29). Besides finding 
putative Cu-binding proteins, these studies also provide valuable information about the 
correlations between the copper coordination sphere and protein function. However, the 
bioinformatic approaches rely on the data stored in the protein databases which is largely 
gathered by experimental characterization of proteins, thus limiting the searchable 
number of potential candidates.  Moreover, the predicted copper proteome suffers from 
other limitations questioning the reliability of the method. First, the searches based on 
known copper binding motifs often retrieve a significant number of metalloproteins 
which are known to bind metals other than copper to carry out their physiological 
functions (28). Second, the analysis done using copper-binding domains as an input 
suffer from the opposite problem, i.e., underestimation of the copper proteome, because 
there are a number of domains that are not yet recognized as copper-binding sites because 
of the lack of experimental data (29).  
Both genetics and bioinformatics-based methods are high-throughput and hence 
can provide valuable support to experimental methods which often can be quite 
challenging. However, such screening results can be anomalous in assigning a metal to 
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the functionality of a protein, even though the protein does not bind the metal ion. For 
instance, Dancis et al. (30, 31) identified the copper importer CTRl by a genetic selection 
for mutants defective in iron uptake in yeast cells. Surprisingly, this protein had no 
affinity for iron, but rather transported copper. Accordingly, development of 
experimental analytical methods is required to verify the results of bioinformatics studies. 
Furthermore, copper sensing in mammals primarily occurs post-translationally, by 
adjusting intracellular protein trafficking or degradation (8, 32, 33). For example, copper-
responsive degradation is presumably a strategy to regulate intracellular copper 
concentration that applies to the copper chaperone CCS (34, 35) and to the copper 
importer CTR1 (36, 37). Another mechanism adopted by copper-homeostasis proteins is 
metal dependent trafficking (38). This phenomenon was first observed for copper-
transporting P-type ATPase ATP7A, which redistributes from trans-Golgi membranes to 
the plasma membrane when exposed to high cellular copper concentrations (39). Under 
basal conditions ATP7A supplies metal to copper proteins in the biosynthetic pathways 
inside trans-Golgi network, whereas under high-copper conditions it facilitates efflux of 
the metal. An analogous protein (ATP7B) is expressed primarily in the liver, where it 
relocates to apical hepatocyte membranes under high-copper conditions to aid biliary 
excretion of the metal (40). These post-translational modifications cannot be captured by 
genetic or transcriptional analysis as demonstrated by a study where CCS protein, but not 
its mRNA, was shown to be consistently elevated in copper deficiency (41). Therefore, 
development of proteomics-based methods not only complements the genetics and 
bioinformatics studies, but this area of research is imperative to fully comprehend the 
copper homeostasis at a molecular level.  
5.1.2. Copper-proteomics: Detection of Proteins that Bind Copper 
Copper-proteomics is a collection of bioanalytical approaches for the 
identification and quantification of copper-binding proteins as well as protein-bound 
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metal ions. The general workflow, which is usually known as top-down proteomics, 
follows two key steps:  a) fractionation of samples, by sequential chromatographic or 2D 
gel separations, and b) metal and protein identification in individual fractions by different 
techniques. Detection of protein-bound copper ions was covered in chapter 2 and this 
subsection will, therefore, focus on the current methodological approaches undertaken in 
protein fractionation in connection with copper proteome and overall limitations of top-
down technologies. 
The major challenge in copper-proteomics is the preservation of the native metal-
ligand interactions during sample preparation. In that regard, the first and foremost 
consideration is to avoid denaturation of the protein, as unfolding of protein usually leads 
to loss of the metal ions (42-44). Second, exposure to oxidizing environment should be 
limited because both copper ions and thiols of cysteine ligands are susceptible towards 
oxidation resulting in disruption of the metal binding. Third, copper-ligand interactions in 
proteins are pH-sensitive because metal ions and protons, both being positively charged, 
compete for the same binding sites (45). Accordingly, to identify copper binding proteins 
that are yet to be characterized or to verify metal binding capacity of a putative protein 
outside cellular environment as often encountered in working with cell lysates, the 
experimental setup should mimic the native physiological conditions as close as possible.   
5.1.2.1. Two-dimensional (2D) Gel Electrophoresis 
In two-dimensional (2D) gel electrophoresis, proteins are separated in the first 
dimension by isoelectric focusing (IEF) which takes advantage of varied net charges of 
the proteins determined by their isoelectric points (pI). In the second dimension, the 
mobility of a protein is determined solely by their molecular mass in denaturing SDS-
PAGE, or mass and effective charge in non-denaturing native-PAGE. The protein spots 
are then analyzed for their metal content by a suitable technique, such as LA-ICP-MS 
(Laser Ablation Inductively Coupled Plasma Mass Spectrometry) (46), autoradiography 
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(47), or X-ray fluorescence (48). Subsequently, the protein spots are excised and in-gel 
digestion is carried out with a site-specific cleavage enzyme, normally trypsin, into 
peptide fragments. The resulting products are then identified by peptide mass 
fingerprinting using MALDI-MS (Matrix-Assisted Laser-Desorption Ionization-Mass 
Spectrometry) and peptide sequencing with tandem mass spectrometry. As mentioned in 
the preceding paragraph, to identify copper-proteins where the metal ion is non-
covalently bound to the ligand, 2D gel electrophoresis has to be performed under non-
denaturing condition. The problem with unfolding of metalloproteins during gel 
electrophoresis is not only limited to loss of the endogenous metal ion and thereby 
missing the putative metal-binding protein in the analysis (42-44), but the liberated metal 
coordination site of the protein can bind to other metals adventitiously which are not 
physiologically relevant. For example, a study was conducted with proteins from yeast 
mitochondria where metal ions bound to proteins were probed by Laser Ablation 
Inductively Coupled Plasma Mass Spectrometry (LA-ICP-MS). In this work, the proteins 
were first separated by blue-native gel electrophoresis (BN-PAGE) followed by SDS-
PAGE and thereby revealing nonspecific accumulation of metal ions by LA-ICPMS (49). 
Consequently, this precludes the use of chaotropic agents, such as urea and thiourea, and 
detergents including CHAPS and SDS in 2D gel electrophoresis, all of which increases 
the solubility of the proteins during isoelectric focusing as the proteins tend to precipitate 
at isoelectric points.  As a result, non-denaturing gels preserve the native metal-protein 
interactions but at the expense of resolution of the separated protein spots (48).  
Isoelectric focusing is sometimes combined with blue-native gel electrophoresis 
(BN-PAGE) to separate proteins in the second dimension (47, 50). This technique 
involves addition of the anionic dye Coomassie blue G-250 to the protein sample prior to 
electrophoretic separation. Binding a large number of dye molecules imposes an overall 
negative charge even for basic proteins such that they migrate to the anode during 
electrophoresis according to their size (51). Although there is evidence in the literature 
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that shows loss of protein-bound metal during the post-separation staining of a gel by 
Coomassie blue (44), Jimenez et al. successfully used blue-native PAGE to identify Cu 
and Zn-binding proteins in the plankton extracts after LA–ICP–MS measurements (43). 
However, blue-native PAGE also suffers from poor resolution of the protein bands. 
The major drawback of 2D gel electrophoresis is the limited dynamic range 
associated with the detection of copper and protein as individual 2D gel spot may only 
contain very small amounts of protein especially for the ones with low abundance. In 
order to improve the sensitivity of the method Pioselli et al. (52) explored the 
compatibility of a pre-fractionation technique, microsolution isoelectric focusing, with 
downstream proteome analysis. Pre-fractionation is a typical strategy for enriching low 
abundance proteins in biological samples. Following the same principle of isoelectric 
focusing, solution IEF (sIEF) traps the proteins at their pI values in liquid phase. In this 
study, metal retention of proteins including Cu/Zn-superoxide dismutase was evaluated 
under denaturing and non-denaturing conditions.  While non-denaturing sIEF preserved 
the endogenous metal-protein interaction, precipitation of proteins under this condition 
resulted in low recovery, thus decreasing the overall utility of the method. 
In summary, 2D gel electrophoresis is capable of resolving a large number of 
proteins in a single experiment However, because of time-consuming processes in gel 
electrophoresis and subsequent in-gel enzymatic digestion, 2D gel electrophoresis 
coupled with MS is a fairly low-throughput detection method. It also requires relatively 
large amount of biological samples in order to increase the detection sensitivity, 
especially for low abundance proteins. Furthermore, this technique is often unsuitable for 
proteins that are highly acidic or basic and large membrane proteins as they are more 
likely to precipitate during isoelectric focussing. This problem poses difficulties to detect 
membrane associated copper-proteins as exemplified by the ATPases, ATP7A and 
ATP7B. 
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5.1.2.2. Liquid Chromatography 
The shortcomings of 2D gel electrophoresis have paved the path for developing 
gel-free technologies for proteomics analysis. In principle, biological samples can be 
separated using multidimensional liquid chromatography followed by identification and 
quantification of proteins by MALDI-MS and ESI-MS (Electrospray Ionization Mass 
Spectrometry), and metals by ICP-MS (Inductively Coupled Plasma Mass Spectrometry) 
and AAS (atomic absorption spectrometry). In the literature, several examples can be 
found where fractionation of biological samples were performed to identify copper-
binding proteins using liquid chromatographic techniques including reversed-phase high-
performance liquid chromatography (RP-HPLC) (53), ion-exchange (IE) chromatography 
(54), size-exclusion chromatography (SEC) (54, 55), capillary liquid chromatography 
(56), and capillary electrophoresis (57). RP-HPLC seems to be superior to SE and IE 
chromatography for the separation of metal–protein complexes because the stationary 
phase of the column is devoid of free ligands that can potentially bind metal ions. 
However, use of HPLC is largely limited to small proteins, such as metallothioneins, 
leaving a still unexplored potential for the separation of metalloproteins with high 
molecular weight. Recently, multi-step liquid chromatography has been used to 
fractionate microbial metalloproteomes (58). Although this work was not directed 
towards the copper proteome, the large scale sample preparation in this detailed study 
brought out many advantages and disadvantages associated with liquid chromatographic 
separations followed by metal speciation.  
The main advantage of this approach is that the careful selection of appropriate 
separation conditions enables the isolation of metalloproteins in near-native environment. 
The metal-containing fraction can be readily collected for further proteomics analysis to 
identify the metal-containing protein. Moreover, chromatographic separation can be 
performed in shorter time compared to gel electrophoresis and this can be combined 
efficiently with metal-detection devices such as ICP-MS or protein-detection instrument 
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like ESI-MS offering the most promising tool for the identification of metal–protein 
complexes at the sub-nanomolar levels. A major disadvantage of the liquid 
chromatographic approach is the very low resolution; often one separated fraction 
contains multiple proteins with varied metal contents. Further resolution up to the level of 
one protein per fraction can be achieved by multi-step fractionations as demonstrated by 
Cvetkovic et al. (58), but the yield of the protein is seriously compromised during the 
process. Additionally, loss of endogenous metal-protein interaction and misincorporation 
of non-native metal ions in proteins are a few potential problems with  liquid 
chromatographic separations. 
5.1.2.3. Immobilized Metal-affinity Chromatography 
Immobilized-metal affinity chromatography (IMAC) is another fractionation 
technique in metalloproteomics which is based on the differential binding affinities of the 
surface exposed amino acids towards immobilized metal ion (59). In application to 
copper-proteomics, usually unfolded metal depleted samples are loaded on an IMAC 
column saturated with CuSO4, and proteins with affinity to Cu
2+
 ion are recovered and 
subsequently analyzed by 2D gels coupled with MALDI-MS (60, 61) or surface 
enhanced laser desorption ionization (SELDI) MS (62). 
IMAC detects proteins with copper-binding affinity in the sample but does not 
provide information on the presence of such copper–protein complexes in vivo. 
Moreover, the reliability of IMAC in detection of copper-proteins is dubious primarily 
due to the use of Cu(II) as the immobilized metal ion. As presented in chapter 1, majority 
of the proteins involved in copper-trafficking bind to Cu(I) by sulfur ligands as found in 
cysteine and methionine residues, whereas the enzymes where copper being used as a 
redox cofactor, the metal is bound to histidine residues. Following the hard soft acid base 
principle, soft ligands like sulfur preferentially bind to Cu
+
 ions and hard acids like Cu
2+
 
ion is primarily bound to bases like nitrogen of an imidazole group. Therefore, it is not 
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surprising that Cu-IMAC separation often results in enrichment of proteins containing 
histidine groups, because the amino acid residues that bind to the Cu-IMAC column 
follow the order of histidine > methionine > cysteine. Accordingly, IMAC is insufficient 
to detect a major group of copper-binding proteins containing CXXC motifs. Moreover, 
non-native metal-protein interaction and non-specific adsorption of proteins in the 
column matrix resulting in false-positive is another inevitable problem when isolating 
copper-proteins by IMAC. 
In summary, the necessity for the development of proteomics-based methods in 
characterizing copper-proteome is two-fold: one is to identify novel putative copper-
binding proteins for complete understanding of copper trafficking pathways, and the 
other is to compare protein expressions between normal physiology and disease states 
resulting from impaired copper metabolism in order to develop biomarkers and targeted 
therapy for various diseases. Evaluation of the current methodologies in this field reveals 
one common problem which is the loss of the copper ion during sample preparation and 
protein separation. Although native gel electrophoresis has been shown to maintain the 
integrity of the endogenous copper-protein complex, it is also noteworthy that there is 
evidence in the literature which shows the influence of other factors that can cause 
release of metal ions from proteins even under non-denaturing conditions. These factors 
include components of protein extraction, e.g., buffer composition, presence of protease 
inhibitor and reducing agents (43); choice of trailing ions, for example, tricine vs. 
glycine, and the current applied in the electrophoretic methods (63); and choice of mobile 
phase buffers in chromatographic separation (64). Another important problem is the 
contamination of non-native metal ions in protein samples during protein separation or 
metal analysis. This is often due to the loss of the endogenous copper ion from the 
protein followed by adventitious metal binding to the liberated coordination sites. 
Therefore, an ideal protocol for the detection of copper-binding proteins should involve a 
“metal-free” method where copper coordination to a protein will be translated to a 
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measurable response without the metal being actually present during the assay. The aim 
of this work was to develop such proteomics methods for copper-binding proteins 
rendering them suitable for identification of the copper-proteome.  





Scheme 5.1. Key Steps of the Two-dimensional Diagonal Polyacrylamide Gel 
Electrophoresis (shown for SDS–PAGE; see text for details). Reproduced with 




5.2.1. Two-dimensional Diagonal Native PAGE: Mobility Shift assay 
Metalloproteins can exhibit different electrophoretic mobilities in the presence 
and absence of metal ion cofactors when the binding of the metal ions induces changes in 
conformations or effective charges of the proteins. This property was exploited to 
develop mobility shift assay, which is based on two-dimensional (2D) polyacrylamide gel 
electrophoresis (PAGE), to identify metalloproteins from cellular extracts. The method 
was originally developed to detect calcium-binding proteins (65, 66) on SDS-PAGE; the 
major steps of this assay are shown in Scheme 5.1.  
The general protocol of the mobility shift assay is as follows: (A) proteins isolated 
from cellular extract are separated by gel electrophoresis. Following the electrophoresis, 
the lane of the gel containing the protein sample is cut out longitudinally. The gel strip is 
then soaked in an appropriate equilibration buffer whose role is to alter the mobilities of 
the proteins in the second dimension. For metalloproteins, this can be achieved either by 
the addition of a ligand in the equilibration buffer in order to remove the metal ion under 
study from the holo-protein, or addition of the specific metal ion to the apo-protein before 
the second dimension electrophoresis. (B) Afterwards, the gel strip is placed horizontally 
on top of another gel and a second electrophoresis is carried out. (C) Finally, the gel is 
stained to visualize the proteins. 
Scheme 5.2 shows the diagram of a representative 2D diagonal gel. Proteins, 
whose electrophoretic mobilities are the same in both dimensions, align along a diagonal, 
and hence the name “diagonal” gel is given by the author of this work to differentiate this 
method from the traditional 2D gel electrophoresis. Proteins containing a specific metal 
ion under study might migrate differently compared to their apo-forms owing to metal-
induced changes in their conformations or effective charges. These proteins of interest 
constitute the off-diagonal spots. Moreover, an off-diagonal spot left to the diagonal 
(shown in red) means that the protein migrated less in the second dimension, whereas an 
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off-diagonal spot right to the diagonal (shown in black) means that the protein migrated 










In order to screen for periplasmic proteins with readily exchangeable copper sites 
of the cyanobacterium Synechocystis PCC 6803, Waldron et al. showed that the mobility 
shift assay can also be adapted to proteins separated under non-denaturing conditions 
(67). In 2D diagonal SDS-PAGE, the anionic surfactant SDS denatures the proteins and 
thus exposes even those metal-binding sites that are buried in the core of the proteins, 
whereas 2D diagonal native-PAGE is only applicable for proteins with solvent exposed 
metal-binding sites. Besides, as delineated in section 5.1.2, addition of SDS to protein 
samples will most likely result in loss of the endogenous non-covalently bound metal 
ions, while native-PAGE will preserve the innate metal-protein binding. Therefore, in an 
attempt to identify copper-binding proteins present in mammalian cells, the native 2D 
diagonal PAGE was adopted in this work.  The previously published method by Waldron 
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et al. utilized acrylamide tube gels, frequently used in isoelectric focusing, for the first 
dimension, whereas the author of this work standardized the original protocol shown in 
Scheme 5.1 for copper-binding proteins. This is because, in our hands, the reproducibility 
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Figure 5.1. Differential Mobility of hAtox1 under Non-denaturing Condition. Lane 1: 
untreated hAtox1; Lane 2: hAtox1 and reducing agent TCEP; Lane 3: hAtox1, TCEP, 
and copper chelator BCS; Lane 4: hAtox1, TCEP, and [Cu(I)(CH3CN)4]PF6. 24 µg of the 
protein in native sample buffer was loaded in each lane of the gel, pH of the running 




hAtox1 is a copper chaperone with solvent exposed metal-binding site (12, 68) 
and it binds Cu(I) with a cysteine-containing motif, CXXC. This protein has been shown 
to migrate differently during gel electrophoresis under non-denaturing conditions 
depending on the copper status (69, 70). This is presumably due to copper-dependent 
dimerization of the protein (71) or the change in overall charge of the protein upon 
copper-binding.  As shown in Figure 5.1, untreated purified hAtox1 (Lane 1), probably a 
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combination of the oxidized apo-protein and Cu(I)-bound (holo) form, migrates 
differently than the protein reduced by tris(2-carboxyethyl) phosphine (TCEP) (Lane 2), 
or the metal-free (apo) form prepared by adding the copper chelator BCS (Lane 3). Holo-
protein formed by addition of exogenous Cu(I) (Lane 4) migrates similar compared to 
untreated hAtox1 (Lane 1), but the Coomassie stained band in lane 4 is much more 
intense showing that the majority of the protein is concentrated in that region.  
Encouraged by the copper-dependent differential mobility of purified hAtox1, the 
standardization of the native 2D diagonal PAGE for this work was accomplished with E. 
coli extract overexpressing hAtox1 (the expression of the correct protein was confirmed 
by Western blot using hAtox1 antibody, data not shown). The E. coli extract was used to 
provide a number of proteins whose mobilities will not be altered in a copper-dependent 
manner and hence these proteins will form the diagonal. 
Native (without SDS and β-mercaptoethanol) polyacrylamide gel electrophoresis 
(PAGE) was performed according to the method of Laemmli (72). Slab gels were 
prepared consisting of a 10% acrylamide resolving gel and a 4% stacking gel. The protein 
samples were equilibrated in appropriate solutions (1
st
 equilibration, Figure 5.2) before 
they were resolved by electrophoresis in tris/glycine buffer. Following the first dimension 
electrophoresis, the lane of the gel containing the protein sample was cut out 
longitudinally (Scheme 5.1). The gel strip was then soaked in the 2
nd
 equilibration buffer 
(native sample buffer containing additives where necessary, Figure 5.2) at room 
temperature for 1 hour. Then the gel strip was placed horizontally on top of another slab 
gel (composition same as above) and electrophoresis in the second dimension was 
performed (Scheme 5.1). In experiments A and C, the resolving gels and the running 





Figure 5.2. Two-dimensional Diagonal Native Polyacrylamide Gel Electrophoresis 
under Different Copper Conditions. Proteins were visualized by Coomassie staining; the 
gels were shown as inverted images for better visualization. See text for the experimental 










A: Experimental Gel  B: Control  Gel   
2mM TCEP + 
0.2 mM Cu(I) 
2 mM BCS 
 
2mM TCEP + 






C: Experimental Gel   D: Control  Gel   
2mM TCEP + 
0.2 mM Cu(I) 
2mM TCEP + 
2 mM BCS 
2mM TCEP + 








In experiment A (Figure 5.2), first the protein sample was equilibrated with the 
reducing agent TCEP to reduce the Cu(I)-binding cysteines and with 
[Cu(I)(CH3CN)4]PF6 to supply the metal ion to the Cu(I)-proteins (1
st
 equilibration). In 
the second dimension, the equilibration buffer contained the copper chelator BCS (2
nd
 
equilibration). Therefore, the copper-proteins that were metal-bound in the first 
dimension lost their metal ion in the second and hence were expected to migrate 
differently during the second electrophoresis step. Four distinct off-diagonal protein 
spots, 1, 2, 4, and 5, were identified which showed differential electrophoretic mobilities 
in experiment A.  
It is noteworthy at this point, that the mobility shift assay can capture changes in 
electrophoretic migrations of proteins due to any factor that is different in the second 
dimension compared to the first one. These factors are not limited to the metal ion loss, 
for example, change in oxidation state can also cause a protein to migrate differently. 
Therefore, to identify the subset of proteins whose mobility shifts are caused only due to 
copper removal by BCS, a control gel was run. In control gel B, the same equilibration 
condition (TCEP + Cu(I)) was used in the first dimension as in experiment A, but no 
BCS was added in the second dimension. Consequently, copper proteins will remain 
metal-bound in both dimensions and thus were expected to have same electrophoretic 
mobilities. When control gel B was compared with the gel A, protein spot 1 was indeed 
found to lie on the diagonal. Interestingly, off-diagonal protein spot 4 disappeared from 
the control gel, while the intensity of the Coomassie stained spot 3 increased. However, 
two off-diagonal protein spots, 2 and 5, were still present in the control gel B at the same 
position as in gel A. Therefore, the cause of the mobility shift of these proteins was not 
due to the copper removal by BCS, but it had originated from a different source. 
The equilibration buffers used in the experiments A and B were very similar to 
those previously reported in the literature (67), where a mobility shift assay was used to 
screen proteins with readily exchangeable copper sites in the cyanobacterium 
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Synechocystis PCC 6803, and this protocol was used as a starting point for this work. 
Nevertheless, the reducing agent TCEP was used only in the first dimension both for the 
experimental gel A and control B. Therefore, it could be possible that in the equilibration 
step following the first dimension electrophoresis, the reduced proteins were air-oxidized 
in absence of a reductant, resulting in the differential migrations of the proteins in the 
second dimension. In order to investigate further whether this is indeed the reason for the 
mobility shifts of protein spots, 2 and 5, another set of experiments (C and D) were 
designed.  
In experiment C, the sample was first equilibrated in the same solution as in 
experiment A, i.e., TCEP and Cu(I). However, during the second equilibration, the buffer 
contained both BCS and TCEP. Because TCEP was added in both dimensions, it was 
expected that the proteins, which do not bind Cu(I), will remain in the reduced states. In 
control D, the same condition as in experiment C was used except that the copper 
chelator BCS was omitted. Interestingly, protein spots 2 and 5 did not disappear in either 
experiment C or control D and thus it can be concluded that the redox reversibility was 
not causing the differential electrophoretic mobilities in these spots. Moreover, there was 
no significant difference observed between the results of two experimental gels A and B 
and control gels C and D.  
In the above experiments the occurrence and position of spots 3 and 4 were 
particularly interesting. In control gels B and D, the sample was treated with Cu(I) during 
the first equilibration and BCS was not added during the second equilibration such that 
the proteins that bind copper will be metal-bound in both dimensions. Under this 
condition the spot 3  was observed on the diagonal as expected for proteins with 
unchanged electrophoretic mobilities. However, in case of the experimental gels A and 
C, where the sample was treated with Cu(I) in the first dimension and BCS was added to 
remove the metal ion in the second  dimension, spot 3  mostly disappeared and a new 
spot 4 was observed, shifted to the right of the diagonal. As explained with Scheme 5.2, 
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this means that the protein constituting spot 4 has a higher electrophoretic mobility in the 
second dimension than in the first. The differences in spots 3 and 4 between the 
experimental and control gels in Figure 5.2 can be explained on the basis of the native 
PAGE in Figure 5.1. It is evident from Figure 5.1, that the migration of the reduced apo-
hAtox1 (lane 3) was increased compared to the copper-bound protein (lane 4). 
Accordingly, the spot 3 might be the copper bound form of a protein which lost its metal 
ion to BCS in the second dimension to form the corresponding reduced apo-protein. This 
resulted in higher mobility during the second dimension and thus the spot 4 appeared on 
the right side of the diagonal with concomitant decrease in the intensity of the spot 3. 
Because of the diffuse spot appearance and insufficient quantities of the proteins in spots 
3 and 4, in-gel digestion followed by peptide mass fingerprinting to identify the proteins 
was not attempted. Nevertheless, a similar 2D diagonal gel with purified hAtox1 showed 
the same differential migration pattern and thus it is possible that the spots 3 and 4 were 
associated with hAtox1. 
Although the mobility shift assay showed promises in identifying proteins with 
solvent-exposed copper-binding sites as exemplified with hAtox1 in this work, the 
method suffers from the low resolution in protein separation, an inherent limitation of 
native gel electrophoresis, and hence is not suitable to analyze complex protein mixtures. 
Moreover, the amount of protein that can be loaded on the gel was limiting as any 
overload in the first dimension resulted in non-specific diffusion of protein spots from the 













Scheme 5.3. Key Steps of the Metal-dependent Labeling of Cu(I)-binding Cysteines with 
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As discussed in Section 1.2, the amino acid cysteine dominates the Cu(I) binding 
sites in proteins (Table 1.2). Cysteine thiols in their reduced form are chemically reactive 
towards maleimide and iodoacetamide derivatives, and this technique is routinely used 
for covalent labeling of antibodies with fluorescent dyes (73). However, upon Cu(I) 
binding these thiols become less reactive as they are occupied in coordinating the metal 
ions. Therefore, thiol-specific labeling strategies can be employed to differentiate 
between the metal-free apo and the bound holo forms of copper-binding proteins. This 
metal-dependent labeling of copper-coordinating cysteines was exploited by Walker et al. 
(74) to monitor copper transfer from holo-WNDP (Wilson’s disease protein) to apo-
Atox1. In this study, the accessible cysteines in WNDP after the removal of copper by 
apo-Atox1 were labeled with the residue specific fluorescent reagent 7-diethylamino-3-
(4′-maleimidylphenyl)-4-methylcoumarin (CPM). The addition of the increasing amounts 
of apo-Atox1 to copper-bound WNDP facilitated the copper transfer from holo-WNDP to 
apo-Atox1 which was observed by the increasing amount of fluorescent labeling of 
WNDP. 
Labeling of cysteines with biotin-conjugated iodoacetamide (BIAM) was used to 
identify proteins containing redox active cysteine residues (75). Similar to loss of thiol 
reactivity upon Cu(I) binding, oxidized cysteins are also unable to react to iodoacetamide 
derivatives. The previously published protocol was modified for the copper-binding 
proteins in this work as shown in Scheme 5.3.  
The method in Scheme 5.3 is described for a hypothetical protein with a CXXC 
motif that binds Cu(I) ion plus a third cysteine that does not bind the metal ion as 
encountered in the copper chaperone hAtox1. The third cysteine also represents the large 
population of cysteine-containing proteins that do not bind copper ions under normal 
physiological conditions, e.g., thioredoxin, zinc finger proteins, etc. First, exogenous 
Cu(I) was added to the TCEP-reduced apo protein to metallate the CXXC motif.  Second, 
the free accessible cysteine(s) was alkylated with iodoacetamide (IAM) in order to block 
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the residue(s) from reacting with the biotinylated alkylating reagent in the following step. 
Third, potassium cyanide (KCN) was used to remove the Cu(I) ion from the protein. 
Fourth, the newly liberated cysteines were then reacted with N-(biotinoyl)-N′-
(iodoacetyl)ethylenediamine to alkylate the cysteine residues with the biotin-conjugated 
iodoacetamide (BIAM).  Finally, the biotin-labeled proteins were isolated from an avidin 
column and were identified by mass spectrometry.  The major advantage of this method 
is that it has the potential to simultaneously identify the copper-binding proteins as well 
as the biotin-tagged cysteines that are involved in copper binding.  
Although at a first glance the selective labeling of Cu(I)-binding cysteines with 
BIAM using reversible metal protection approach appears to be a suitable method to 
identify copper containing proteins, we found several limitations of this approach. First, 
TCEP proved to be reactive towards iodoacetamide derivatives as confirmed by NMR 
spectroscopy. Consequently, the alkylation could not be performed in presence of the 
reducing agent. This problem can be circumvented by the use of immobilized TCEP gel 
(Thermo Scientific Pierce) where the reducing agent is covalently immobilized to beaded 
agarose resin. The one limitation of the immobilized TCEP gel is that the small proteins 
could get trapped in the resin, thus resulting in poor recovery.  
Second, the accessible cysteines, that do not bind copper ions, could not be 
alkylated exhaustively with iodoacetamide which was a key step in this method. A human 
copper chaperone hAtox1 was used in this work as a prototype of Cu(I)-binding proteins 
which have at least one additional cysteine that does not bind copper. Control 
experiments and mass spectrometric analysis with hAtox1 showed that even after 
labeling of the third cysteine with IAM, the amino acid residue still could react with 
BIAM resulting in biotinylation of the cysteine(s) that does not bind copper. Different 
iodoacetamide concentrations and equilibration time were used to optimize the first 
alkylation step, however, IAM concentrations can only be varied within a certain range as 
at higher concentration IAM started to displace Cu(I). Furthermore, another common 
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thiol-reactive reagent N-ethyl maleimide (NEM) was used to alkylate the accessible 
cysteines in presence of the copper ions, which showed even lower reactivity than 
iodoacetamide. 
Incomplete labeling of unbound cysteine(s) with IAM would create a two-fold 
problem. One is the undesired biotinylation of cysteines in various proteins that do not 
bind copper ions, which will evidently increase the false positives while working with 
cellular extracts. The other problem is that the recovered copper-containing proteins will 
have biotin-labeled cysteines other than the ones that bind the metal ion, therefore 
specific identification of the copper-binding cysteines would not be possible. 
5.2.3. Copper-dependent Labeling of Cysteines with Heavy and Light Isotopes 
Differential stable isotope labeling is a common proteomics method to quantify 
the relative abundance of proteins between different biological samples (76). The method 
involves covalent labeling of proteins in two samples with chemically identical reagents 
containing “light” or “heavy” isotopes. Since the different isotopes have identical 
chemical properties, a set of isotopically labeled and unlabeled proteins usually provide 
an accurate measure of their relative abundance when analyzed by mass spectrometry. 
The first example of isotopic labeling of cysteine in proteins employed 
acrylamide and its D
3
-isoform to improve the identification of cysteine peptides during 
mass spectrometry (77). Later on, Isotope Coded Affinity Tag (ICAT) was developed by 
combining a biotin affinity tag and isotope coding in a single alkylating agent (78), which 
made it possible to both isotopically code and affinity select cysteine-containing peptides. 
Cysteines labeled with light and heavy isotopes have been proven to be a useful strategy 
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In this work, we have developed a differential isotopic labeling approach for 
identification of copper-binding proteins. This method as described in Scheme 5.4, 
enabled us to differentiate between copper-bound and unbound cysteines in a protein. 
Similar to section 5.2.2, we will describe the method for a hypothetical protein that 
contains two types of cysteine residues: one binds Cu(I) ions and the other one does not. 
The protein sample was first divided into two equal portions, A and B and reduced with 
TCEP. Cu(I) was added to the reduced sample B. Next, both samples A and copper-
loaded B were individually divided into two pools and one pool from each sample was 





-NEM). After the alkylation step, NEM and D
5
-NEM-labeled samples 
from a single pool were mixed at a 1:1 ratio. Finally, the maleimide-treated protein 
samples, A and B, were individually trypsin digested and the resultant peptides were 
subjected to MALDI mass spectrometry. The difference spectrum of sample A and B 
revealed the peptide fragment containing Cu(I)-binding cysteines. Mass difference 
between NEM and D
5
-NEM is equal to 5, therefore in peptide fragments where one 
cysteine was isotopically labeled, a doublet separated by 5 mass units would be observed, 
whereas in fragments where two cysteines were labeled, such as CXXC motif, a doublet 
would be observed that was separated by 10 mass units.  
The above method was tested for overexpressed hAtox1 as isolated from E.coli 
culture, with the ultimate goal to identify copper-binding proteins from cellular extracts. 
With that goal in mind, the protein was not purified for the standardization procedure as 
the native E.coli proteins would provide the complex background as normally 
encountered in cellular extracts. Following Scheme 5.4, E.coli extract overexpressing 
hAtox1 was labeled with NEM and D
5
































































Figure 5.3. Differential Labeling of hAtox1 with N-ethyl Maleimide and D
5
-N-ethyl 
Maleimide. A) Cysteines in CXXC motif were isotopically labeled in reduced apo-
hAtox1; black arrow: unlabeled parent peak containing the CXXC motif, red arrow: one 
of the cysteines in the CXXC motif was isotopically labeled and the other one was 
unlabeled, green arrow: one cysteine was conjugated with β-mercaptoethanol while the 
other cysteine was labeled with the maleimides, blue arrow: both cysteines were 
isotopically labeled. The number over each arrow represented the ratio of NEM vs. D
5
-
NEM labeled peptides which would be ideally 1. B) cysteines in CXXC motif were 
protected in copper bound hAtox1 and thus were unable to react with the isotopic 
reagents; C) the difference spectrum between A and B revealing the peptide fragments 




First of all, the isotopic labeling was incomplete as a significant amount of the 
parent peak corresponding to the unlabeled peptide fragment containing the CXXC motif 
was still present in Figure 5.3.A (black arrow).  A similar observation was made by 
Kurono et al. which showed incomplete reactivity of maleimide towards thiols 
irrespective of the reaction time and temperature (83). The fragment containing the single 
cysteine, that did not bind copper ion, was not observed in the mass spectrum. It is 
noteworthy that this peptide fragment also did not appear in trypsin digested hAtox1 prior 
to the labeling. Nevertheless, as expected for sample A, the cysteines from CXXC motif 
were isotopically labeled with NEM and D
5
-NEM resulting in a doublet separated by 10 
mass units (Figure 5.3.A, blue arrow). These peaks at 2148.7 and 2158.7 were not present 
in sample B, where CXXC was copper-bound and thus blocking the thiols towards 
labeling (Figure 5.3.B). Interestingly, two additional doublets, each of them  contained 
two peaks separated by 5 mass units, were observed in Figure 5.3.A; one of them 
corresponded to the isotopic labeling of one of the cysteines of the CXXC motif leaving 
the second cysteine unlabeled (red arrow). Another doublet was comprised of one 
cysteine of the CXXC motif conjugated with β-mercaptoethanol, while the other cysteine 
of the same motif was labeled with the maleimides (green arrow). β-Mercaptoethanol was 
used to quench the thiol maleimide reaction, and thus a hetero disulfide bond was 
presumably formed between the reagent and the protein. Neither of these additional 
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doublets was present in sample B, where the copper ion was added. The difference 
spectrum (Figure 5.3.C) between Figure 5.3.A and B showed all of the three doublets 
observed for the reduced apo-protein (blue, red, and green arrow). Furthermore, for each 
doublet, a second set of doublet was observed at a distance of M + 18, where M 
represents the mass value at which the original doublet appeared. Finally, as shown by 
the number over each arrow in Figure 5.3.A, the ratios of NEM vs. D
5
-NEM labeled 
peptides were close to 1 showing the equal reactivity of the reagents toward cysteine 
thiols. 
In place of β-mercaptoethanol, dithiothreitol (DTT) can also be used to quench 
the thiol maleimide reaction. Upon oxidation, DTT forms a stable six-membered ring 
with an intra-molecular disulfide bond, whereas β-mercaptoethanol forms an inter-
molecular disulfide bond. Therefore, DTT might inhibit the conjugation of the reagent 
with the cysteine of the peptide fragments as encountered in the previous experiment with 
β-mercaptoethanol (Figure 5.3.A, green arrow). Use of DTT indeed prohibited the 
heterodimerization between the peptide fragments and the reagent; however, in 
comparison to Figure 5.3.A, the peaks corresponding to the unlabeled parent CXXC-
containing peptide and the isotopically labeled peptide fragments were shifted by 429.2 
mass units towards higher values. Moreover, similar to the previous experiment, the 
second set of doublets was also detected at a distance of M + 18 from the original ones 
even when DTT was utilized. 
As evident from the differential isotopic labeling of hAtox1, the major advantage 
of this method is that the copper binding cysteines can be conveniently detected even in 
the presence of other peptide signals of much higher intensity.  Therefore, this method is 
suitable to identify copper-binding proteins from complex cellular extract where a small 
fraction of the total proteins will bind copper. However, typical copper-binding proteins 
have one metal-binding motif in their entire amino acid sequence, and the proteins where 
Cu(I) is bound by the CXXC motif the two cysteines are separated by two amino acids. 
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Therefore it is expected that only one peptide fragment per protein containing the copper-
binding cysteines can be identified by this method. Although there is evidence in the 
literature where a protein was assigned based on MS/MS spectrum of a single peptide 
fragment (79, 84), however, the confident identification of proteins by such procedure is 
often challenging. Nevertheless, the metal-dependent isotopic labeling can be reliably 
used to confirm copper-binding sites of proteins as illustrated with hAtox1. 
5.2.4. Difference Gel Electrophoresis with Cy3 and Cy5 Meleimide Dyes 
Since its introduction in 1975 (85), two-dimensional gel electrophoresis has 
become one of the fundamental methods in proteomic analyses due to its high resolution 
and sensitivity. However, in 2D electrophoresis no two gels are identical, and hence 
reliable detection of protein differences between two samples using traditional post-
electrophoretic staining methods, e.g. coomassie blue and silver staining, is challenging. 
In order to circumvent the problem of gel-to-gel variability, difference gel electrophoresis 
(DIGE) was developed (86), which enabled the analysis of multiple protein samples 
within one gel. This method is based on covalent modification of proteins in different 
samples with structurally similar but spectroscopically distinct fluorophores. Therefore, 
the post-electrophoretic fluorescent images from different samples separated on the same 
gel can be directly compared and hence this method increases the confidence with which 
differences in protein abundance can be detected.  
The first commercially available 2D DIGE reagents utilize mass and charge-
matched cyanine dyes with N-hydroxy-succinimidyl ester groups to modify lysine 
residues of proteins (87). These are known as minimal labeling dyes as the dye to protein 
ratio is kept deliberately low (approximately 5%). Owing to the typically high lysine 
content of most proteins, the minimal labeling approach was employed in order to avoid 
multiple dye additions on each protein molecule which would generate multiple spots per 
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protein on a 2-D gel and also interfere with the solubility of the protein. As a result of the 













One way to improve sensitivity of the 2-D DIGE technology is to exhaustively 
label an alternative less prevalent amino acid, such as cysteine. The maleimide group 
reacts with cysteine thiols through nucleophilic Michael addition to form a thioether and 
thus can serve as a platform to produce cysteine-reactive DIGE dyes. Although a variety 
of other maleimide-containing dyes have been described in the literature for labeling 
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cysteines in proteins with 2D gel applications (88-91), the CyDye DIGE Fluors (Cy3 and 
Cy5) by Amersham Biosciences are by far the most popular ones (92).  
Encouraged by the use of 2-D DIGE technology in measuring redox changes in 
protein thiols (93-96), we devised a strategy to identify copper-binding proteins using 2D 
DIGE as shown in Scheme 5.5. Here the CXXC motif signifies the cysteine-containing 
copper-binding site of a protein, while the single cysteine represents both the additional 
cysteine in the same copper protein and other cysteine -containing proteins that do not 
bind copper ions under normal physiological conditions. Copper-free apo-protein samples 
would be first divided into two equal portions, A and B. Upon reduction, the copper ion 
would be added to the sample A. Each sample would then be reacted with a different 
DIGE dye, for example, Cy3 for the metallated sample A and Cy5 for the other sample B. 
The two differentially labeled samples with equal protein concentrations would be mixed 
together and separated on a 2D gel followed by imaging with a fluorescence scanner. 
Since Cy3 and Cy5 maleimides have similar chemical reactivity towards thiols, under 
this experimental condition the proteins that do not bind copper ions would show up as a 
yellow-colored spot due to equal intensities of green and red fluorescences of the Cy3 
and Cy5 dyes, respectively. On the other hand, in this example, copper-binding proteins 
would show a 3-fold higher fluorescence intensity for the Cy5 dye compared to Cy3 
making it possible to identify the copper proteins.  
In this work, we first optimized our protocol to differentially label copper proteins 
in a metal-dependent manner with Cy3 and Cy5 dyes. For this purpose, we used a known 
copper chaperone hAtox1 and the labeling was evaluated in a one-dimensional SDS-
PAGE. Furthermore, during this work, MCL-1 and MCL-2 (Figure 2.1) have already 
been characterized as water-soluble, air-stable copper ligands with stability constants 
(logKCu(I)L)  of 16.33 and 13.08 respectively (Table 2.5). MCL-2 is slightly basic (pKa = 
8.98) and hence has a lower apparent affinity (logK′Cu(I)L) at pH lower than its pKa 
(Section 2.1.3). As a consequence, the pre-formed copper complex of MCL-2 has been 
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successfully used to metallate a variety of small molecule ligands of higher affinities 
(Table 2.4). Since most Cu(I)-binding proteins would have comparable or higher 
affinities than MCL-2 at biological pH (97, 98), in this work we further set out to 
examine the applicability of the copper complex of this ligand as a copper source to 
metallate proteins. This will eliminate the use of by far the most common copper 
supplying reagent Cu(I)-acetonitrile complex. Aqueous solution of Cu(I)-MCL-2 is much 
more stable towards oxidation and disproportionation compared to Cu(I)-acetonitrile 
complex dissolved in water. Although Cu(I)-acetonitrile complex is reasonably stable in 
acetonitrile-water mixture, presence of acetonitrile can alter the metal binding property of 
a protein by destabilizing its tertiary structure (99, 100). 
a) Effect of TCEP on Protein Labeling 
A critical step for the effective labeling of cysteine residues is reduction of the 
disulfide bonds. This is typically achieved by the use of reducing agents, such as 
dithiothreitol (DTT), β-mercaptoethanol (BME), tris(2-carboxyethyl) phosphine (TCEP), 
or tributylphosphine (TBP). TCEP is water-soluble, nonvolatile, and reduces disulfide 
bonds more efficiently at a wider pH range (101) and hence this has become a popular 
choice to reduce disulfide bonds in proteins. While it is obvious that thiol-containing 
reductants, including BME and DTT, would react with maleimides, it is generally 
thought that phosphines such as TCEP are nonreactive. However, in an earlier attempt by 
the author of this work to label proteins with fluorescein-5-maleimide, it was found that 
TCEP interfered with the protein labeling (data not shown). Similar observation was 
made by other groups which showed that TCEP inhibits labeling of proteins with both 
iodoacetamide and maleimide dyes (102, 103). In order to circumvent this problem, we 
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1:  Cy3/Cy5 = 3.0 →                                                                                 
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Figure 5.4. Effect of MCL-2 on Protein Labeling. Lane 1: Copper-bound hAtox1 was 
conjugated with Cy5 dye and mixed with Cy3-labeled apo-protein at equal 
concentrations; Lane 2: Copper-bound hAtox1 was conjugated with Cy3 dye and mixed 
with Cy5-labeled apo-protein at equal concentrations. A) Gray-scale Cy3 image showing 
the relative fluorescent signals of proteins labeled with Cy3 maleimide dye; B) Gray-
scale Cy5 image showing the relative fluorescent signals of proteins labeled with Cy5 
maleimide dye; C) Overlay of Cy3 and Cy5 fluorescent signals; D) Gel stained with 
Coomassie blue; E) Expected cysteine labeling of hAtox1 with Cy3 and Cy5 dyes in 
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b) Effect of MCL-2 on Protein Labeling 
Next we evaluated the influence of MCL-2 in protein labeling and surprisingly we 
observed that the copper complex interfered with the labeling efficacy. hAtox1 was 
labeled with both Cy3 and Cy5 dyes in the presence and absence of Cu(I) ions, where 
Cu(I) was supplied by Cu(I)-MCL-2 complex (Figure 5.4). In one sample (Lane 1), 
copper(I)-bound hAtox1was reacted with the Cy5 dye and this was mixed with a Cy3-
labeled reduced sample. In another sample (Lane 2), the Cu(I)-bound protein was labeled 
with Cy3 and the apo sample was labeled with Cy5 dyes. hAtox1 contains a CXXC 
copper-binding motif and a third cysteine that normally does not bind copper. Therefore, 
as evident from Figure 5.4.E, when Cy5 dye was added to Cu(I)-bound hAtox1 (Lane 1), 
the CXXC would not be labeled as the cysteine thiols were engaged in metal 
coordination, however, the third cysteine would be labeled with the Cy5 dye. Conversely, 
all three cysteines would be labeled with the Cy3 dye when added to the apo-sample 
(Lane 1). As a result, the expected ratio of the fluorescence intensities of Cy3 to Cy5 
would be 3 in Lane 1. However, Figure 5.4.B (Lane 1) showed a Cy5 fluorescence 
signal of much lower (more than 3-fold) intensity compared to the Cy3 signal in Figure 
5.4.A (Lane 1). Similar observation was made for the sample in Lane 2 where the Cy3 
fluorescence signal was much lower than the expectation. These results showed that 
whenever the labeling reaction was performed in the presence of the Cu-MCL-2 
complex, the fluorescence output of the labeled protein was much lower than expected, 
indicating a probable interaction between the copper complex of MCL-2 and the DIGE 
dyes. Therefore, in future experiments excess Cu-MCL-2 complex was removed by gel 
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Figure 5.5. Copper-dependent Labeling of hAtox1 with Cy3 and Cy5 Dyes. A) 
Superimposed fluorescence scans of Cy3 and Cy5; B) Gel stained with Coomassie blue; 
C) Expected cysteine labeling of hAtox1 with Cy3 and Cy5 dyes in Lane 1, 2, 5, 6, and 7. 
Lane 1: Following addition of Cu-MCL-2, hAtox1 was labeled with Cy3 dye only; Lane 
2: Following addition of Cu-MCL-2, hAtox1 was conjugated with Cy3 dye and mixed 
with Cy5-labeled untreated protein at equal concentrations; Lane 3: Following addition 
of Cu-MCL-1, hAtox1 was labeled with Cy3 dye only; Lane 4: Following addition of 
Cu-MCL-1, hAtox1 was conjugated with Cy3 dye and mixed with Cy5-labeled untreated 
protein at equal concentrations; Lane 5: Untreated hAtox1 was labeled with both Cy3 
and Cy5 dyes and mixed at equal concentrations; Lane 6: Untreated hAtox1 was labeled 
with Cy3 dye only; Lane 7: Untreated hAtox1 was labeled with Cy5 dye only. 
 CXXC   C--------- 
Cy3 Cu 









 CXXC   C--------- 
Cy3 Cu 





























c) Copper-dependent Labeling of hAtox1 and Fluorescence Quantification 
The efficiency of the differential labeling of hAtox1 in the presence and absence 
of copper was examined and the results are shown in Figure 5.5. Pre-formed copper 
complexes of both MCL-1 and MCL-2 were used for this experiment. Based on the most 
recent literature value of the Cu(I)-binding affinity of hAtox1 (logK′Cu(I)L = 17.4 at pH 7) 
(98), it was  expected that Cu-MCL-1 (logK′Cu(I)L = 15.97 at pH 7) would not be able to 
metallate hAtox1 as efficiently as Cu-MCL-2 (logK′Cu(I)L = 10.99 at pH 7) complex. 
DIGE would also give an opportunity to compare directly the extent of copper 
incorporation into hAtox1 by Cu(I)-MCL-1 and Cu(I)-MCL-2 in a single experiment. 
Furthermore, Cu(I)-MCL-1 and Cu(I)-MCL-2 are structurally similar with identical 
donor atom sets (Figure 2.1); hence, any non-specific interaction between these copper 
complexes and the fluorophores of the DIGE dye should be comparable. Therefore, use 
of the both copper complexes in the same experiment would also enable us to assess 
whether these complexes could introduce any other factor, besides the metallation of the 
proteins, which might influence the experimental outcome. 
The description of the samples in each lane of the gel shown in Figure 5.5 is given 
in the figure legend. As mentioned in the preceding paragraph, CXXC is the copper-
binding motif in hAtox1 which also contains a third cysteine that normally does not bind 
copper. In order to compensate for any instrumental variation between the Cy3 and Cy5 
channels (see experimental methods) of the Typhoon Imager, a control sample was run in 
Lane 5, where an equal amounts of Cy3 and Cy5-labeled apo-hAtox1 were mixed. As 
evident from Figure 5.5.C.5, this produced a Cy3/Cy5 ratio equal to 1.0. Therefore, all 
individual Cy3 and Cy5 fluorescent images in Figure 5.5.A were normalized against the 
respective signals in the Lane 5. The fluorescence signals were further normalized by the 
amount of protein in each lane, which was measured by densitometry of the Coomassie 
stain, to remove any difference from the protein loading especially when comparing 
fluorescence signals between two lanes. The accuracy of the normalization steps were 
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ascertained by measuring the Cy3/Cy5 ratio between Lane 6 and 7. As shown in Figure 
5.5.C.6 and Figure 5.5.C.7, the expected ratio was 1 which agreed very well with the 
normalized experimental Cy3/Cy5 ratio which was 0.95. 
In Lane 1, Cu-MCL-2 was added to hAtox1 to metallate the protein, blocking the 
thiols from further covalent modification by Cy3 in the following step. Consequently, 
only the third cysteine was expected to be labeled by Cy3 in this sample (Figure 5.5.C.1). 
Conversely, in Lane 6, no copper ions were added to the sample, therefore, all three 
cysteines can be labeled by the Cy3 dye (Figure 5.5.C.6). Therefore, the expected ratio of 
Cy3 fluorescence intensities between Lane 6 and 1 should be 3, whereas the 
experimental ratio was 2.4. Another way to measure the correlation of the DIGE labeling 
with the copper status of hAtox1 was to label the copper-bound protein with Cy3 while 
the unbound protein was reacted with Cy5. When these two samples were mixed at equal 
concentrations and loaded in the same lane of the gel (Figure 5.5; Lane 2), we found that 
the normalized Cy5/Cy3 ratio was 2.5 while the expected ratio was 3. This Cy5/Cy3 ratio 
in Lane 2 is very similar to the Cy3 ratios between Lane 6 and 1, where both Cu-bound 
(Lane 1) and unbound (Lane 6) hAtox1 were labeled with the Cy3 dye.   
In contrast, when Cu-MCL-1 was added to hAtox1 followed by labeling with the 
Cy3 dye (Figure 5.5; Lane 3), the normalized fluorescence intensity of Cy3 in Lane 3 
was comparable to the intensity in Lane 6 (ratio of Cy3 in Lane 6 vs. Lane 3 = 1.2). In 
Lane 4, the Cu-MCL-1-treated hAtox1 was labeled with Cy3 and was mixed at equal 
concentrations with the Cy5-labeled untreated hAtox1. Similar to Lane 3, here we also 
found Cy5/Cy3 ratio to be 1.2 indicating that Cu-MCL-1 was not able to significantly 







Scheme 5.6. Key Steps in the Alkylation of Accessible Cysteines with Iodoacetamide 
prior to the Labeling with DIGE Dyes 
 
 
d) Alkylation of Accessible Cysteines with Iodoacetamide prior to the Labeling with 
DIGE Dyes 
In the proposed experimental design in Scheme 5.5, the proteins that do not bind 
copper ions will be labeled equally with the Cy3 and Cy5 dyes and thus will appear as 
yellow spots on the 2D gel image. Since the majority of proteins in biological samples do 
not bind copper(I) ions (29), DIGE labeling of these proteins will result in a considerable 
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proteins. One way to eliminate this problem is to alkylate the accessible cysteines with a 
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Figure 5.6. Alkylation of Accessible Cysteines with Iodoacetamide prior to the Labeling 
with DIGE Dyes. A) and C) Superimposed fluorescent scans of Cy3 and Cy5; B) and D) 
Gel stained with Coomassie blue. Panels A and B showed labeling of hATox1, while 
panels C and D showed that of BSA and Myoglobin. Lane 1: Following alkylation with 
IAM, Cu-hAtox1 was reacted with Cy3 dye and BCS-treated hatox1 was labeled with 
Cy5 dye (Scheme 5.6); Cu-MCL-2 was used as the copper source; Lane 2: Same 
experiment as in Lane 1 with  the dye being swapped, i.e; Cu-hAtox1 was reacted with 
Cy5 dye and BCS-treated hatox1 was labeled with Cy3 dye; Lane 3 and 4: Same 
experiments as in Lane 2 and 1, respectively, with the copper source being Cu-MCL-1; 
Lane 5: Same experiment as in Lane 1 with BSA acting as a control protein which has 
multiple cysteines that do not bind copper ions; Cu-MCL-2 was used as the copper 
source; Lane 6: Same experiment as in Lane 1 with myoglobin acting as a negative 
control which does not contain any cysteine residue; Cu-MCL-2 was used as the copper 
source; Lane 7 and 8: Same experiments as in Lane 5 and 6, respectively, with the 
copper source being Cu-MCL-1. It is noteworthy that the experiments with Cu-MCL-2 
(Lanes 1, 2, 5, and 6) and Cu-MCL-1 (Lanes 3, 4, 7, and 8) were done on two separate 




As depicted in Scheme 5.6, first Cu(I) ions would be added to the protein sample. 
Second the free cysteines would be alkylated with iodoacetamide (IAM). Ideally, IAM 
should block all free cysteines that do not bind copper ions from further labeling; 
however, previously IAM failed to exhaustively alkylate available cysteines (Section 
5.2.2). Therefore, in this experiment, following the addition of IAM the sample would be 
divided into two portions, A and B. Third, in sample A, copper chelator BCS would be 
added to remove the protein-bound copper ions followed by labeling of the resultant apo-
proteins with Cy5. Simultaneously, in the other sample B, Cy3 was added to gauge the 
efficiency of the alkylation step by IAM. 
For the sample in Lane 1, where the copper ion was supplied by Cu-MCL-2, Cy3 
was reacted with Cu-bound hAtox1 while the apo-protein generated by BCS was labeled 
with Cy5. Following Scheme 5.6, the protein in Lane 1 should ideally not be labeled with 
Cy3. However, as expected for incomplete alkylation of unprotected cysteines by 
iodoacetamide, Figure 5.6.A showed that the protein in Lane 1 was labeled with Cy3 as 
well as Cy5 dyes with the fluorescence intensity of Cy5 being higher than that of Cy3 
(Cy5/Cy3 ratio = 1.63). Similar results were obtained with the protein in Lane 2 (Figure 
5.6.A). In contrast, for the samples in Lane 3 and 4, where the copper ion was supplied 
by Cu-MCL-1, the Cy5/Cy3 ratio was almost equal to 1, irrespective of what dye was 
reacted with Cu(I)-bound hAtox1. This correlated with the previous finding (Section 
5.2.4.c) that showed Cu(I)-MCL-1 was inefficient in metallation of proteins. Therefore, 
in this case, even in the presence of copper ions the majority of the three cysteines in 
hAtox1 would be unprotected. If there were no difference of these cysteines towards 
alkylation with IAM, these groups would be expected to have an equal reactivity towards 
Cy3 and Cy5 dye, thus justifying the observed Cy5/Cy3 ratio of 1.   
The equal reactivity of the Cy3 and Cy5 dyes towards available cysteines was 
further consolidated with the labeling of BSA in Figure 5.6.C. In this experiment, BSA 
furnished as an example of cysteine-containing proteins found in the biological sample 
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which physiologically do not bind copper ions. Therefore, this protein should not exhibit 
any copper-dependent differential labeling with Cy3 and Cy5 dyes. Moreover, the 
proteins like BSA would contribute to a considerable fluorescence background in a 2D 
DIGE gel where the proteins in a biological sample will be differentially labeled in 
presence and absence of copper ions following Scheme 5.5. Therefore, BSA would also 
allow us to assess the utility of IAA in order to reduce the fluorescence background as 
described in Scheme 5.6.  The results in Figure 5.6.C (Lanes 5 and 7) showed that while 
IAA could not alkylate the cysteines completely, the reactivity of Cy3 and Cy5 dyes were 
still equal towards the unblocked cysteines, thus resulting in a ratio of 1. As expected, 
there was no difference in the labeling in the presence of either Cu(I)-MCL-1 or Cu(I)-
MCL-2.  
Additionally, in this experiment, myoglobin was used as a negative control as this 
protein does not have any cysteine. This would indicate the extent of non-specific 
interactions of proteins with the DIGE dyes. Surprisingly, myoglobin showed primarily a 
Cy3 fluorescence signal in Figure 5.6.C (Lanes 6 and 8) in the presence of both Cu-
MCL-1 and Cu-MCL-2. Although maleimides preferentially react with cysteine thiols, it 
can also potentially react with lysine amines. Moreover, it had been shown that Cy3 
maleimide reacts with amines at a greater rate than the Cy5 maleimide (95). In 
conclusion, these results (a-d) together showed that the DIGE labeling can be employed 
to differentiate between copper-bound and apo-proteins and therefore this technique has 









Proteomic profiling is gaining increased attention with the development of high-
throughput proteomics techniques, including two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) and difference gel electrophoresis (DIGE), along with the 
advancement in mass spectrometry-based quantitative proteomics which utilizes multi-
dimensional chromatography for extensive separation of peptides and the incorporation 
of signature tags, such as ICAT, into proteins or peptides for quantitative analysis. 
Proteomic profiling in copper biology, which ideally constitutes the identification of the 
protein along with the metal ion cofactor, poses some unique challenges, including 
susceptibility of both the Cu(I)-binding sites in proteins and the metal ion itself  towards 
oxidation and loss of metal ions during sample preparation and protein separation. In this 
work, we developed several “metal free” techniques which did not involve the imaging of 
protein bound copper ions but rather focused on translating the copper binding to a 
protein into a measurable and quantifiable signal that will distinguish a copper-binding 
protein from innumerable other proteins that do not bind copper. While the mobility shift 
assay based on 2D diagonal gel electrophoresis suffered from poor resolution in protein 
separation and selective labeling of Cu(I)-binding cysteines with biotin-conjugated 
iodoacetamide encountered technical difficulties, two other techniques including copper-
dependent labeling of cysteines with heavy and light isotopes and difference gel 
electrophoresis with Cy3 and Cy5 meleimide dyes were able to differentiate between apo 
and copper-bound hAtox1. By combining the copper dependent labeling of proteins 
developed in this work with high-throughput technologies including ICAT and two-
dimensional polyacrylamide gel electrophoresis, this work laid the foundation for 




5.4. Experimental Methods 
5.4.1. Two-dimensional Diagonal Native PAGE 
Native gels (w/o SDS and β-mercaptoethanol) were made consisting of a 10% 
(w/v) acrylamide resolving gel and a 3% (w/v) stacking gel. In all experiments, E. coli 
extract (1mg/ml) overexpressing hAtox1 in HEPES buffer (50 mM, pH 7.5, 0.2 M NaCl) 
was treated with tris(2-carboxyethyl)phosphine (TCEP, 2 mM final concentration) 
followed by addition of [Cu(I)(CH3CN)4]PF6 (0.2 mM, diluted from a 10 mM stock 
solution in acetonitrile) to prepare Cu-bound proteins. Protein sample was then mixed 
with 2X native sample buffer (62.5 mM tris-HCl, pH 6.8, 25% glycerol, 0.01% 
bromophenol blue) before electrophoresis. Proteins were resolved by the first-dimension 
electrophoresis in tris/glycine running buffer (25 mM Tris and 192 mM glycine, pH 8.3). 
Just before the bromophenol blue dye front reached the bottom of the gel, electrophoresis 
was stopped, and the lane of the gel which resolved the protein sample was cut out 
longitudinally approximately 1.5 mm in width. The gel strip was soaked in 2 ml of 
equilibration buffer (0.125 M tris–HCl (pH 6.8), 20% glycerol, 0.002% bromophenol 
blue) for 30 minutes at room temperature comprising the additives as described for each 
experiment in Figure 5.2. Then, the gel was placed horizontally on top of a slab gel 
containing 1 mM BCS where necessary (Experimental gels A and C). In the second 
dimension, proteins were resolved by electrophoresis in the tris/glycine buffer containing 
250 µM BCS where necessary (Experimental gels A and C). After electrophoresis, 
proteins were visualized using GelCode Blue Stain Reagent (Thermo Scientific).  
5.4.2. Selective Labeling of Cu(I)-binding Cysteines with Biotin-conjugated 
Iodoacetamide 
E. coli extracts (1mg/ml) overexpressing hAtox1 in HEPES buffer (50 mM, pH 
7.5, 0.2 M NaCl) was reduced using immobilized TCEP gel (Thermo Scientific Pierce) 
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equilibrated with degassed HEPES buffer. [Cu(I)(CH3CN)4]PF6 (1 mM, diluted from a 25 
mM stock solution in acetonitrile) was immediately added to the reduced protein to 
prepare Cu-bound proteins. The sample was incubated with 5 mM iodoacetamide (IAM) 
for 3 hrs in the dark at room temperature to modify the accessible Cys residues with 
IAM. In order to avoid protein loss from multiple gel filtration steps, IAM was added in 
presence of copper ions. The experimental evidence suggested that [Cu(I)(CH3CN)4]PF6 
did not interfere with the IAM-mediated alkylation at least when IAM was added in large 
excess. The alkylation was quenched by incubating the sample with 10 mM β-
mercaptoethanol for 1 hour at room temperature. The unreacted reagents were removed 
by gel filtration using Micro Bio-spin columns (Bio-Rad) equilibrated with degassed 
HEPES buffer. The alkylated Cu-bound sample was reacted with usually 10 mM KCN  
for 1 hour at room temperature to remove the protein bound copper (use of 50 mM KCN 
did not change the outcome of the experiment). The sample was the reduced by 1 mM 
TCEP reagent. The unreacted reagents were removed by gel filtration using Micro Bio-
spin columns (Bio-Rad) equilibrated with degassed HEPES buffer. The sample was 
incubated with 1 mM BIAM for 1 hour in the dark at room temperature. The excess of 
BIAM was removed by PD-10 desalting column. The biotin-conjugated protein sample 
was purified with monomeric avidin column without any prior concentration step. 
5.4.3. Metal-dependent Labeling of Cysteines with Heavy and Light Isotopes 
E. coli extracts overexpressing hAtox1 (~1 mg/ml total protein concentration) in 
HEPES buffer (50 mM, pH 7.5, 0.2 M NaCl) was reduced with 1 mM TCEP. Sample was 
divided into two pools, A and B. In sample B, [Cu(I)(CH3CN)4]PF6 (0.4 mM, diluted 
from a 10 mM stock solution in acetonitrile) was immediately added to the reduced 
protein to prepare Cu-bound proteins. Each of the samples A and B were divided into two 
parts, while one was reacted with N-ethyl maleimide (NEM, 2 mM final concentration), 




-NEM, 2 mM final concentration), 
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ultimately generating four sample pools. In all four samples the alkylation was quenched 
with β-mercaptoethanol (BME, 20 mM final concentration). The two samples originating 
from A, one NEM-treated and another D
5
-NEM-treated, were pooled and digested with 
trypsin in solution. Additionally, the two samples originating from B were treated 
identically. Finally, samples A and B were subjected to MALDI-MS. Immobilized TCEP 
gel (Thermo Scientific Pierce) and Micro Bio-spin columns (Bio-Rad) were not known to 
us at that time, therefore, we used twice as much maleimide reagent as TCEP to offset the 
interference of TCEP with maleimide reactivity. The available gel filtration method PD-
10 desalting column greatly diluted the protein sample and even combination of a 
subsequent protein concentration step resulted in a significant protein loss and thus this 
step was avoided.  
5.4.4. Difference Gel Electrophoresis with Cy3 and Cy5 Meleimide Dyes 
E. coli extract overexpressing hAtox1 (~ 3 mg/ml) in HEPES buffer (50 mM, pH 
7.5, 0.2 M NaCl) was incubated with the copper chelator BCS overnight at 4 °C. 
Considering hAtox1 as the predominant component of the E. coli extract, amount of BCS 
added was 10 molar equivalence to the protein. Next day, the protein was purified with 
Micro Bio-spin columns (Bio-Rad) equilibrated with degassed HEPES buffer to generate 
the apo-protein. The apo-protein sample was reduced using immobilized TCEP gel 
(Thermo Scientific Pierce) equilibrated with degassed HEPES buffer. To prepare Cu-
bound protein, a 1:1 mix of MCL-2 and Cu-MCL-2 were added to the protein sample, 
where the total concentration of MCL-2 added was 4 molar equivalence with respect to 
the protein again, followed by gel filtration. Labeling of the apo-reduced sample and the 
Cu-bound protein sample with Cy dyes (Amersham Biosciences) were done at 
concentration of the dye being 250 nmol per mg of the protein. The protein samples with 
the Cy dyes were reacted for 1 hour at room temperature in the dark and purified by 
Micro Bio-spin columns (Bio-Rad). The fluorescent images were taken by the Typhoon 
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Imager using the green laser (532 nm) for the excitation of the Cy3 dye and the red laser 
(633 nm) for the Cy5 dye. The emission filter used for the Cy3 dye was 580 nm BP 30 
and that for the Cy5 dye was 670 BP 30. 
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The work in this dissertation was initiated with three key objectives in mind with 
the ultimate goal to improve our understanding of copper biochemistry: (1) development 
of a set of well-characterized copper(I) affinity standards which can be applied to 
determine the Cu(I) binding affinities of proteins and small-molecule ligands; (2) 
characterization of coordination properties of Cu(I)-selective fluorescent probes in order 
to develop Cu(I)-sensors suitable for cellular imaging; and (3) development of methods to 
selectively label  Cu(I)-binding cysteines in copper-proteins which will facilitate the 
identification of putative copper-binding proteins.  
a) Cu(I) Affinity Standards 
Accurate binding affinity determination of Cu(I)-proteins has been challenging partly 
because of the lack of reliable affinity standards reported in the literature.  In this work, a set 
of copper(I) affinity standards was developed which included three new sulfonated thioether-
based ligands (synthesized by Dr. M. T. Morgan) that form colorless, water-soluble, and air-
stable copper complexes and three previously reported Cu(I) chelators. The coordination 
properties, including Cu(I)-stability constants, protonation constants, redox potentials, were 
carefully determined for each of these ligands and were cross-validated by independent 
methods. The results from this work constitute a web of accurately cross-verified Cu(I)-
affinity standards with a wide range of affinities. The applications of these ligands were 
demonstrated with the measurement of the binding affinity of a copper chaperone CusF. 
Since these six ligands encompass a varied range of affinities, this work can be extended to a 
multitude of proteins whose Cu(I)-stability constants can be determined unequivocally by 
competition titrations with these ligands. These ligands also have the prospective applications 




b) Cu(I) Selective Fluorescent Probes 
Cu(I) selective turn-on fluorescent probes are useful in imaging kinetically labile 
cellular copper pool. While the development of Cu(I) sensors was primarily focused on 
improving their photophysical properties, including quantum yields and fluorescence 
contrast ratios, the importance of increasing the aqueous solubility of these probes was 
greatly overlooked. CTAP-2 (synthesized by Dr. M. T. Morgan) was the first Cu(I)-
selective fluorescent indicator which readily dissolved in water. As demonstrated by the 
dynamic light scattering, aqueous solutions of several previously published Cu(I) probes 
contained nanoparticles, whereas CTAP-2 did not indicate any nanoparticle formation. 
Despite the water solubility of CTAP-2, the probe was surprisingly cell permeable. 
However, the Cu(I) binding affinity of CTAP-2 was several orders of magnitude lower 
than that required for the imaging of the endogenous intracellular copper pool. A novel 
biochemical application of CTAP was also developed in this work involving in-gel 
detection of a copper chaperone under non-denaturing condition. In future endeavors to 
develop water-soluble Cu(I)-selective fluorescent probes, synthetic efforts should focus on 
improving Cu(I)-affinity. 
c) Selective Labeling of Cu(I)-binding Cysteines 
In order to screen for putative copper-binding proteins from complex cellular 
extracts, several proteomics-based methods were developed in this work. Since cysteine 
acts as an ubiquitous ligand in Cu(I)-binding in proteins, the strategies were adopted to  
selectively label cysteines in a copper-dependent manner. The most promising method in 
this work involved copper-dependent labeling of cysteines with Cy3 and Cy5 dyes. Based 
on the work on one-dimensional gel electrophoresis, this method can successfully 
differentiate between copper-bound and unbound proteins in a quantitative fashion. This 




applications, including identification of putative copper(I)-binding proteins, comparison 
of protein profiles between normal and disease conditions, and biomarker discovery. 
